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ABSTRACT

Neuron-Glia (NG) Interactions: A microfluidic examination of NG emergent responses
for repair
Presented by: Tanya Singh
Advisor: Dr. Maribel Vazquez
Department of Biomedical Engineering
Neuron-glia communication is crucial to the development, plasticity, and repair of the
nervous system (NS). While neurons are well known to conduct electrical impulses that transfer
biological information and stimuli throughout the NS, our understanding of the roles of glia
continues to evolve from when the cells were largely believed to act solely for neuronal support.
Recent decades of research has shown that glia can alter metabolism, conduct impulses and
change phenotype for NS repair. NG interactions have, thereby, become heavily researched in
varied areas of biomedical engineering, including embryogenesis, neural regeneration, growth,
and intracellular synaptic activity. However, while NG interactions are known to regulate
survival, differentiation, communication, and targeted migration of neural cells, the molecular
signals that orchestrate these behaviors remain incompletely understood. As a result, many
emerging studies have embraced microfluidics to regulate the spatial and temporal stimuli
delivered to neural cell groups and measure subsequent NG responses.
The overall objective of this thesis was to examine emergent NG behavior in response to
chemical stimuli within

controlled

microfluidic

environments.

Experiments examined

NG

behavior in the central and peripheral NS critical to neural repair. In the first model, we
examined the behavior of transformed glial progenitors (in the form of Medulloblastoma (MB)),
known

to

emulate

developmental

processes,

to

external

stimuli

using

controlled

microenvironments. We used a microfluidic system called the bridged lane, which allows for
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steady-state, 1D, controllable concentration gradients along the length of its’ microchannel. The
system was used to evaluate in vitro migratory responses of MB-derived cells to external
signaling from Epidermal Growth Factor (EGF) and stromal cell-derived factor 1-alpha (SDF-1).
Data demonstrated that MB cells exhibit dosage-dependent chemotaxis towards increasing
concentration gradients. However, as glial behaviors are intricately linked with that of neuronal
cells, we next used a more comprehensive neural model to examine the collective behavior of
neural progenitors in response to chemotactic stimulation. Experiments examined the collective
behavior of NG progenitor cell populations in response to stimulation via fibroblast growth
factor (FGF) gradients using a developmental model of the central nervous system (CNS) in the
Drosophila Melanogaster, 3rd instar larvae stage. Surprisingly, our data demonstrated that cells
migrated larger distances and with higher directionality within collective groups of both neuronal
and glial progenitors than in populations of glia only. Taken together, these results helped
elucidate different modalities for directed movement that can be used for therapeutic techniques
that leverage the interdependent NG relationship.
The last model examined NG contributions to the formation of neuromuscular junctions
(NMJ) in the peripheral nervous system (PNS). The glial component of the NMJ, the Schwann
cells (SCs), are essential to NMJ development and function including remodeling and
regeneration. SCs are critical for PNS regeneration, where studies have shown SC are able to
trans-differentiate in order to create glial bridges that bypass non-functional neuronal nodes and
isolate damaged neurons. However recent NMJ models mainly focus on motor neurons (MN)
and muscle cells (MCs), some in vitro work has been utilized to study SCs, but their overall roles
still remain to

be well-defined

and

studied.

To

that end,

the experiments used a

compartmentalized microfluidic platform to demonstrate reproducible differentiation of skeletal

vi

myotubes with increased viability and length following the time-dependent addition of neuronal
and glial cells. We lastly probed the guidance cues and migratory patterns of NGs towards
various growth factors to elucidate emergent NMJ response. Our data illustrated there is a coculture effect on receptor expression dependent on stimulation time. The data point to SCs as
key players in stabilizing and maintaining in vitro NMJ models that will aid the development and
testing of emerging therapies for neuromuscular dysfunction.
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1. Introduction
1.1. Overview
The functionality of the nervous system is based on the interactions of its cellular
constituents, neurons, and glial cells. Neurons perceive, integrate and transmit information,
whereas glial cells perform a number of different tasks to guarantee and modulate neuronal
function

4.

The relevance of glial cells for neuronal network properties is reflected by the

proportional increase of their number with increasing complexity of the nervous system.
Whereas in complex mammalian brains the glia outnumbers neurons by far, invertebrates such as
Drosophila have comparably few glial cells. It has become increasingly obvious that reciprocal
neuron–glia interactions have an essential role in enabling our brain to function properly. There
is no doubt that neurons provide the mechanics of neural computing but the more complex and
efficient a nervous system is, the more glial cells are present. In insects and other more primitive
organisms, only a small percentage of all neural cells are of glial type, whereas in humans, glial
cells outnumber neurons by a factor of ten 5 . Herein, we explore the NG relationship within
various cellular models, existing in the central and peripheral nervous systems. In the central
nervous system (CNS), we focused on two models, pediatric cancer-stem cell migration and NG
collective migration within Drosophila 3 rd instar larvae, respectively. In the peripheral nervous
system (PNS), we focused on the neuromuscular junction, which is a chemical synapse
responsible for the proper functioning of voluntary muscle movement.

1.2. Background: Structure and Function
The bi-directional communication between neurons and glia is essential for axonal
1

conduction, synaptic transmission, and information processing and thus is required for normal
functioning of the nervous system during development and throughout adult life. The signals
between neurons and glia include ion fluxes, neurotransmitters, cell adhesion molecules, and
specialized signaling molecules released from synaptic and nonsynaptic regions of the neuron6, 7 .
Glia communicate with other glial cells through intracellular waves of calcium and via
intercellular diffusion of chemical messengers.

By releasing neurotransmitters and

other

extracellular signaling molecules, glia can affect neuronal excitability and synaptic transmission
and perhaps coordinate activity across networks of neurons all by sensing activity-dependent
changes in the chemical environment shared by the two cell types

7, 8 .

Conversely, neural impulse

activity regulates a wide range of glial activities, including their proliferation, differentiation, and
myelination.
1.2.1. CNS Synapses
A synapse is a specialized structure between a neuron and another cell (neuron, muscle
fiber, or gland cell), across which a nerve impulse is transferred by a direct electrical connection
or by a chemical compound called neurotransmitter. -The close relation between astrocytes,
synapses, and neurons prompted the “tripartite synapse” hypothesis

9, 10 .

According to this

hypothesis, synapses are comprised of three parts, the presynaptic terminal, postsynaptic
membrane,

and

associated glial cells. The astrocyte processes possess neurotransmitter

receptors. The receptors expressed by astrocytes match the neurotransmitters released at the
synapses they cover. Neurotransmitters released by the presynaptic terminal, which themselves
have metabotropic receptors for the transmitters they release, activate receptors in both the
postsynaptic neuron and the associated astrocyte. This results in the generation of a
postsynaptic potential in the postsynaptic neuron and a Ca 2+ signal in the astrocyte

11 .

2

What are the support cells and their roles?
The CNS mainly consists of
the brain and the spinal cord. Its
main function is to

receive and

integrate sensory information and to
respond

accordingly.

The

CNS

consists of neurons and glial cells, as
shown in Figure 1. Glial cells are the
support cells of the nervous system,

Figure 1: Cells of the CNS1 .
also known as neuroglia.

Neurons: A neuron is the basic structural and functional unit of the nervous system. A neuron
has four main components: dendrites, a cell body, axons, and the synaptic terminal. Dendrites
receive and collect information from one end of the cell to the other by generating and
propagating electrical signals. Neurons can communicate with their neighboring cells by
releasing neurotransmitters through a synapse, which is a space between two cells.

Astrocytes:

are the non-myelin forming glial cells that are closely associated with neurons in

the brain. Astrocytes ensheath synaptic junctions, associate with nodes of Ranvier, and respond
to disease and injury by clearing cellular debris, secreting trophic factors and forming scars.
Some astrocytes span the entire width of the brain radially, providing scaffolding along which
neurons migrate during fetal development. Others stretch from blood capillaries to neurons,
transporting ions and other substances to sustain neurons and to regulate the extracellular
environment.
3

Oligodendrocytes: are myelin-forming cells, that wrap layers of myelin membrane around
axons to insulate them from electrical impulses, similar to that of Schwann cells (SCs) in the
PNS. They are responsible for the high-speed propagation of information in axons and are active
partner for neurons. These glia also provide trophic support, affect the structure of axons, and
modify electrical properties by controlling their diameter, and clustering of specific ion channels
at the node and paranode region

12 . Only

axons larger than 1micron are myelinated

Microglia: derive from bone marrow monocyte precursors

14 .

13 .

They respond to injury or disease

by engulfing cellular debris and triggering inflammatory responses. They are essentially the
immune cells of the CNS.

Activation of miroglia is not well understood but it is hypothesized

that both a lack of trophic/regulatory molecules released during normal CNS activity and the
appearance of abnormal molecules could be a trigger.

Neurotransmitters regulate microglial

activation since it has receptors for glutamate, dopamine, -aminobutyric acid (GABA), and
noradrenaline

7, 8 .

Therefore, any changes in astrocyte-neuron activity can trigger an alerted state

in microglia. Hence, astrocytes and neurons provide robust regulation of microglial activation.
What is the importance of CNS glia?
Astrocytes, in the CNS, have the capacity to alter synaptic transmission by sensing
changes in Ca2+ (calcium). They use purinergic receptors for NG signaling. A rise in cytoplasmic
Ca2+ in an astrocyte is associated with changes in synaptic strength in adjacent synapses in
culture

15, 16

or in the intact retina

17 .

Interestingly, sudden increases or decreases in spike firing

are both observed after a transient rise in astrocytic cytoplasmic Ca 2+. Whether the response to
astrocyte activation is inhibitory or excitatory may be determined by differential effects on
neurotransmitter release or uptake or by astrocytes activating an intervening inhibitory neuron in
the synaptic circuit

18, 19 .

In each case, imaging techniques reveal that the rise in cytoplasmic
4

Ca2+ concentration in astrocytes is accompanied by an increase in extracellular concentration of
ATP

20 . Similar

responses are exhibited by terminal SCs in the PNS.

In a similar fashion, astrocytes can communicate with adjoining astrocytes via extracellular
signaling molecules that are released and then the signal is propagated along. Molecules such as
glutamate sensed at synapses cause cytoplasmic Ca 2+ changes in astrocytes as well as ATP
secretion, which activates membrane P2Y receptors generating an increase in intracellular Ca 2+,
and calcium-dependent secretion of glutamate are all responsible for spreading signals among
cell through the brain and modulate activity at nearby synapses 7 . Overall, these mechanisms
involved not only enable astrocytes to help disseminate information but also help regulate the
ionic extracellular environment, providing potential evidence for regulating synaptic strength in a
bi-directional manner.
Chemical signaling and regulation in the CNS
In brief, chemical communication coordinates behavior of nerve and glial cells in various
processes such as differentiation. Molecular signaling mediates all brain function and it is quite a
complex network of chemical pathways that are involved and have evolved from development
into adults. There are different types of signaling mechanisms such as electrical which allows for
synaptic

transmission

which

utilizes

action

potentials,

and

subsequent

release

of

neurotransmitters. Other well-characterized signaling mechanism include paracrine signaling,
which acts over a longer range and involves the secretion of chemical signals onto a group of
target cells, and endocrine signaling, which refers to the secretion of hormones into the
bloodstream where they can affect targets throughout the body

21 .

In embryogenesis, chemical

signaling, and the resultant cell migration are critical for orientation of the tissue structures of the
CNS. Neurons form first and are followed by glia. This process occurs through migration of
5

neurons from the neural plate along glial tracks and is regulated by lineage differentiation and
subsequent chemical gradient signaling.
Molecular signaling tightly regulates determination of cell lineage fate in development. The
maintenance of stem and progenitor states is performed by extracellular chemical environment,
as is the progression of differentiation. Molecules involved in the progression of differentiation
in neurons and glia are vast and some are summarized here: sonic hedgehog signaling (SHH),
retinoic acid (RA), Wnts, bone morphogenic proteins (BMPs), fibroblast growth factor (FGF),
epidermal growth factor (EGF), Notch, and purinergic ligands

22, 23 .

RA plays important roles in many aspects of neural development and activity. These include
axon regeneration in the adult, neuronal differentiation and patterning of the neural plate and
neural tube in the early embryos

24 .

RA is implicated in specifically organizing the posterior

hindbrain and anterior spinal cord. Similarly, RA works synergistically with other molecules
such as sonic hedgehog (Shh), FGF and bone morphogenetic protein (BMP), to determine the
fates of sensory neurons, inter neurons and motor neurons

23 .

Shh is a protein essential for embryonic development i.e. growth and pattering of the brain and
spinal cord. They are also necessary for the differentiation of motor neurons in the ventral spinal
cord. Shh acts as a morphogen, and induces different cells fates at different concentration
thresholds, low concentrations induce ventral neurons, high induce motor neurons and very high
floor plate cells. Aberrant regulation and transduction of the Shh signaling pathway has been
implicated in birth defects, tissue regeneration, stem cell renewal, and cancer growth

25 .

With the

aid of Shh signaling, BMPs generate ventral regions of the forebrain. Loss of BMP signaling is
implicated in neural induction but later in development, BMP promotes the generation of
neuronal and astro-glial cells but prevents oligo-glial differentiation

23 .
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FGF signaling has been implicated in the induction and patterning of neural tissues in vertebrate
embryos. They have been associated in promoting proliferation, isolation, and maintenance of
neural progenitor cells via basic FGF, FGF2

23 .

It has also been noted that FGF signaling works

in association with other pathways such as Wnt, Shh, Notch and TGFβ (transforming growth
factor).
Purinergic regulation also contributes to neural stem cell maintenance and differentiation

26

as

well as information propagation in the brain between astrocytes-neurons and astrocytesastrocytes in adults. The principle molecules active in this signaling are ATP and adenosine. We
have previously discussed the extent to which ATP release by astrocytes activates P2Y surfaces
receptors which initiates Ca2+ signaling. In specific, P2Y1 metabotropic receptor has been
implicated in modulating neurogenesis changes depending on the physiological conditions and
the simultaneous presence of EGF and FGF. In fact, specific stimulation of this receptor in
neural progenitor cells increases cell proliferation and migration, but only when the growth
factor concentration is low or absent

26, 27 .

Conversely, when the growth factor concentration is

higher, activation of P2Y1 has an anti-proliferative effect.
Chemical composition of extracellular matrix (ECM) molecules can also impact CNS cell
response. The stiffness and elasticity of the matrix

28 ,

its protein composition, and chemical

structure, as well as ECM fiber size, pore size and distribution

29

have all been shown to affect

cell migration is meaningful ways. For example, matrix stiffness can determine cell fate,
differentiation, and tissue function
and perceives external forces

30-33 ,

34-36 .

while ECM elasticity can influence how a cell senses

Further, ECM chemical components affect matrix-ligand and

integrin-receptor interactions, which directly impact signal transduction cascades and cell-to-cell
communication that regulate such critical processes as gene expression and transcription.
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Role of progenitors in cancer progression
Cancer results from abnormal cell division and proliferation, both of which are largely
governed by stem and progenitor cell populations. CNS progenitors may be the cell of mutation,
i.e. the source of the tumor, or can act in a supportive manner within the tumor niche. Two major
types of primary brain tumors are gliomas and medulloblastoma (MB); the most common tumors
diagnosed in adult and pediatric brain, respectively. Gliomas are tumors derived from glia or
glial precursors. The exact cause of gliomas is not known. Glioblastoma (GBM), the most
common and aggressive subtype of the malignant gliomas, is characterized by intense
proliferation, invasion, and intra-tumor heterogeneity. GBM and MB both have the ability to
self-renew and proliferate which is integral to tumor development and perpetuation.
Cancer stem cell (CSC) theory: Current theory states that tumor-initiating cells or CSCs are
characterized as a small fraction of cancer cells that have an indefinite ability for self-renewal
and pluripotency and are responsible for initiating and sustaining of the bulk of cancer

37 .

CSCs

are thought to have originated from the transformation of neural stem cells (NSCs) and their
progenitors or they dedifferentiate from mature brain cells and reacquire phenotypic and
functional similarities of NSCs. A recent study by Chaffer et al. 38 found that transformed human
CD44lo cancerous mammary epithelial cells could spontaneously dedifferentiate into CD44hiCSCs in vivo, indicating the existence of bidirectional inter-conversions between CSC and nonCSC cancer cells. De-differentiation is implicated to be driven by genetic regulation from
exogenous factors such as EGF and PDGF, especially in the maintenance of neurospheres in
culture. PDGF autocrine stimulation was shown to dedifferentiate cultured astrocytes and
induced oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in
vivo when infected with PDGF-encoding or EGF-encoding retroviruses

39 .
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Some cancers, such as MBs, are thought to originate in the cerebellum, with approximately 25%
originating from granule neuron precursor cells (GNPCs) after aberrant activation of the Shh
pathway

40 .

Dysregulation of Shh signaling has been implicated in glioma development as well

through glioma-associated oncogene (Gli) transcription factors

41 .

While the role of Shh

signaling is well established in CNS cancer pathology, its role in gliomagenesis remains
controversial because a lack of animal models

42 .

A recent study in zebrafish showed that

activated Shh signaling was tumorigenic; development of retinal and brain tumors was observed
when Smoothened (Smoa1), Hedgehog ligand involved in the signaling transfer of Gli, in neural
progenitor cells was expressed as well as overexpression of progenitor markers such as GFAP,
Sox2 and S100 42 .

In MB, the Patched (Ptc) receptor is an antagonist of the Shh signaling pathway, and mutations
of Ptc will activate the pathway. Therefore, Shh blockage via a small molecule inhibitor in mice
harboring a Patched (ptc1) mutation eliminated MB
pathway depletes the CSC populations in GBM

44 .

43 .

Similarly, blockage of the Shh signaling

Several Hh signaling pathway inhibitors, such

as vismodegib and sonidegib, have been developed for cancer treatment. These drugs are
regarded as promising cancer therapies, especially for patients with refractory/advanced cancers
41 .

Cell migration is a critical step in the process of metastatic propagation of tumor cells from the
primary tumor to local and distant sites
factors,

including chemoattractants,

45 .

Migration of tumor cells is controlled by numerous

chemorepellents,

extracellular matrix components,

and

9

electric fields as purported by several reports

45-48 .

For the treatment of CNS cancers, it is critical

to understand the underlying mechanisms of tumor growth and renewal by progenitor cell pools.
Studying the mechanisms of chemotaxis and

cell-cell communication for CNS cancer

subpopulations is also of critical interest for developing new targets and improving the efficacy
of current treatments.

Mechanism for tumor migration: migration of cancer cells is highly complex, involving
interactions with ECM, and chemoattractants/molecules that either diffuse from blood vessels
and/or are produced by neighboring cells. As such the molecular mechanisms involved in tumor
migration and metastasis are poorly understood. It has been speculated that diffusible signals via
cytokines and generation of concentration gradients provide cues for migration away from the
primary tumor site. Studies exploring CNS tumor cell invasion has identified four commonly
overexpressed tyrosine kinases for anti-invasive therapies: EGFR (epidermal growth factor
receptor), c-MET, PDGFR (platelet-derived growth factor receptor), and VEGF (Vascular
epidermal growth factor receptor)

40, 49 .

Tumor cell migration can vary but three main modes of

migration are suspected: mesenchymal, amoeboid, and collective migration49 .
Mesenchymal migration is predominantly found in fibrosarcoma’s, gliomas, and in epithelial
cancers following progressive dedifferentiation. Cells undergo movement patterns seen in
mammalian cell migration: cell polarization, protrusion of leading edge, traction at the trailing
edge, and detachment

40 .

These movements are dependent on integrin-mediated adhesion

dynamics after which proteases are released to cleave ECM attachments, cell contraction occurs,
focal contacts disassemble, and filaments turnover.
On the other hand, amoeboid migration utilizes “fast gliding” mechanism driven by weak or less
10

adhesive interactions with the substrate

49 .

Lymphocytes and neutrophils exhibit this shape-

driven movement dictated by cortical filamentous actin, where mature focal contacts, stress
fibers, and focalized proteolytic activity are lacking

50 .

Such shape-driven migration allows cells

to circumnavigate, rather than degrade, surrounding ECM. Amoeboid movement allows cancer
cells to undergo early detachment and metastatic spread from primary tumors most commonly
observed in small-cell lung carcinomas and lymphomas.
Lastly, collective migration is a well-described phenomenon that occurs during embryogenesis,
such as the migration of cell clusters or sheets in the ectoderm following the closure of the neural
tube

51 .

lines

53

In vitro studies of keratinocyte sheets

52

and cell collective from tumor explants and cell

showed that aggregated cells can move as a functional unit, where cell-cell adhesion that

occurs in cell groups leads to a specific form of cortical actin filament assembly along cell
junctions. This allows the formation of a larger-sized, multicellular contractile body

53 .

Here, a

subset of highly motile cells at the front of the body are designated as “path-generating cells”,
that create migration traction via pseudopod activity

53 ;

cells in inner and trailing regions are

passively dragged during dissemination. In tumors, collective migration has been observed as
protruding sheets that maintain contact with primary site, or as cell clusters that detach from their
origin and extend along paths of least resistance

40 .

To further add on to the complexity of the

tumor niche, cells may transition between collective and individual cell migration with
dedifferentiated cells to increase dissemination and metastatic spread

49 .

Approaches for the study of NGs
Briefly, advances in microfabrication techniques have made microfluidic system easier to
design

and

manufacture;

with

the

majority

of

the

devices

constructed

of

using

polydimethylsiloxane (PDMS) via soft lithographic techniques pioneered by the Whitesides
11

group

54 .

Microfluidics is a powerful tool that is becoming an increasingly useful for cell

biologists and engineers alike, owing to its ability to precisely control, monitor, and manipulate
cellular microenvironments.

Tumor models: Applications of microdevices for cancer studies utilized 2D and 3D coated
microchannels with various ECM proteins to illustrate the selectivity of cancer cell migration in
distinct ECMs, as well as, to measure traction forces and leading edge protrusions of a variety of
cancer cell types

55 .

Further, systems have been developed that generate linear and non-linear

cytokine gradients in order to more accurately investigate the chemotactic behavior of cells
derived from primary tumors. Outside of tumor models, microfluidic platforms are highly
dynamic and facilitate study of various aspects such as CNS axonal injury, regeneration,
immunoassays, sorting and manipulation of cells, and transport mechanisms. Taylor et al. 56
Developed a microfluidic platform enabling them to selectively lesion axons and biochemically
analyze their somata for immediate early gene expression.

Drosophila Model: Drosophila melanogaster, also commonly known as the fruit fly, is a
versatile model organism that has been used in research to study a broad range of phenomena
from multiple aspects of development to biological mechanisms underlying disease such as
neurodegeneration. It is a highly versatile system, with the availability of live imaging of biological
processes. Various signaling pathways, such as Shh, have been extensively studied in
Drosophila as the biochemical pathway is highly conserved from Drosophila to mammals.
Drosophila cells have been used in genome-wide RNA interference screens to rapidly identify
cellular factors required for replication of influenza and dengue viruses

57 .
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At its larval stages, Drosophila contains different types of sensory neurons that are patterned in a
segmental configuration. They sense various environmental cues such as mechanical, visual and
chemical and relay information to the CNS to help elicit stereotypic motor behaviors. This simple
architecture continues to be exploited for studying numerous developmental-genetic and
neurobiological problems primarily through deploying surgical, histological, transgenic and
behavioral methods

58 .

imaging, drug screening

To that end, microfluidics have been employed to study such systems for
59, 60 , and

migratory responses to diffusible signals

61, 62 .

1.2.2. PNS Synapses: What is the Neuromuscular Junction (NMJ)?
The neuromuscular junction (NMJ) is a type of a specialized chemical synapse between
myelinated motor nerve axon and muscle
fibers.

The NMJ connects the nervous

system to the muscular system via these
chemical synapses. It is an integral part of
an efficient biological amplification system,
which

converts

minute

nerve

action

potentials into muscle contraction. Action
potentials are the basic mechanism for the
transmission of information in the nervous
system and in all types of muscle.
Figure 2: Schematic showing motor neuron
extension from the ventral horn in the spinal
In brief, the skeletal muscle fibers are cord to the specialized connection with the
muscle 2 .
innervated by motor neurons whose cell
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bodies are located in the ventral horn of the spinal cord. Motor neurons have long axons that
branch extensively near the point of contact with the target skeletal muscle, also known as the
nerve terminal region. This is the region where the nerve axon makes contact with skeletal
muscle and is called a synapse. In this case, we have a specialized synapse called the NMJ or the
motor end plate. The basic arrangement of a chemical synapse, at the NMJ, consists of a
presynaptic membrane, a synaptic cleft, and a postsynaptic membrane. The gap between the preand postsynaptic membranes is known as the synaptic cleft. Information is transmitted across the
synaptic cleft via neurotransmitters, a substance that is released from the presynaptic terminal
and binds to the receptors on the postsynaptic terminal.

The main function of the NMJ is to transmit signals from motor neurons to skeletal muscle fibers
quickly and reliably to ensure precise control of skeletal muscle contraction and therefore
voluntary movement. The highly specialized architecture of the NMJ helps to ensure its’
functional reliability, where the Schwann cells (SCs) help to maintain this structure. The glial
component of the NMJ is the SCs, which have been shown in research to be essential in the
development and function of the NMJ where they play many important roles in the remodeling
and regeneration. SCs also form the myelin sheath around motor nerve fibers which helps
increase the conduction velocity of the action potential along the nerve axon.
What are the support cells and their roles at the NMJ?
Anatomically the NMJ is divided into two parts, the first part consists of the axon
terminal of a motor neuron and the second part consists of the motor end plate of a muscle fiber.
At the axon terminal, glial cells in the central nervous system (CNS) and peripheral nervous
system (PNS) support the nervous tissue. Glial cells are non-neuronal cells that maintain
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homeostasis, form myelin, and protect the neurons in the brain and the PNS. Neuroscience
currently identifies four main functions of glial cells: 1) to surround neurons and potentially hold
them in place, 2) to supply nutrients and trophic factors to neurons, 3) to insulate one neuron
from another, and 4) to remove dead neurons or other debris. The motor end plate consists of
myofibers or muscle fiber, which is the smallest contractile unit of skeletal muscle. Skeletal
muscle is responsible for the voluntary movement of bones that underlies movement and work
production.

Motor neurons (MNs): A neuron is the basic structural and functional unit of the nervous
system. The glial cells help to maintain and support the neurons. A neuron has four main
components: dendrites, a cell body, axons, and the synaptic terminals (Figure 2). Dendrites
receive and collect signals coming from other cells. The signal is then transmitted from the
dendrites to the cell body, where the signal is processed. The axons take the signal away from the
cell body and the signal travels down the axon towards the synaptic terminal. When the signal
reaches the synaptic terminal, it comes into contact with sacs of chemicals known as
neurotransmitters. The signal causes the sacs of chemicals to merge with the outer membrane
releasing the neurotransmitters to the receiving muscle fiber, which has receptors on its
membrane for these neurotransmitters. Thus, the signal is transferred from a neuron to a muscle
fiber.

Schwann Cells: Schwann cells (SCs) are the main glial cells in the PNS. SCs are intimately
associated with the nerve terminal and form a cap over the face of the nerve membrane that is
located away from the muscle membrane, also known as perisynaptic Schwann cells

63 .

They
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also form a dense myelin sheath (Figure 2) to insulate the motor axon allowing for action
potentials to travel at a greater velocity towards the nerve terminal. A single SC makes up a
single segment of an axon’s myelin sheath64 . Therefore, multiple SCs are required for the entire
length of the axon. A single axon can be several millimeters long. Further SCs are also invovled
in cleaning up debris and guiding the regrowth of motor axons after nerve injury as well as
modulating synaptic transmission

Skeletal Muscle Cells (Myocytes): Skeletal muscle is a striated muscle that is attached to the
bone via tendons. The function of tendons is to help transmit the load that is generated from the
muscles to the bones. They also act as stabilizers for joints due to their viscoelastic properties.
Skeletal muscles have various levels of organization as shown in Figure 2. Briefly, skeletal
muscle is composed of dense bundles of muscle fibers connected together. Each fiber is a long,
thin, multinucleated cell that is highly specialized for its contractile function65 . There are two
types of muscle fibers: type I (slow) and types II (fast) and each contain these multinucleated
cells called myocytes

66 .

The multinucleated cell state arises from the fusion of embryonic cells

called myoblasts during muscle differentiation
which are 1-2m in diameter

65 .

65 .

Each muscle fiber contains multiple myofibrils

These muscle fibers allow for the contraction of the muscle by

the sliding movement along the actin and myosin filaments. So, when a neural impulse is
delivered to the muscle, by the motor neurons originating in the CNS, the muscle contracts to
allow for body movement or reaction to the impulse.

What is the importance of Schwann cells at the NMJ?
Schwann cells (SCs) are the main glial cells that maintain homeostasis, form myelin, and
provide support and protection for neurons in the peripheral nervous system (PNS). There are
16

two types of SCs, myelinating and non-myelinating. Myelinating SCs warp around axons of
motor sensory neurons to form the insulating myelin sheath. The myelin helps increase the
conductance of the nerve impulse to travel at a greater velocity down the axon. SCs are also
present perisynaptically on the nerve terminal plasma membrane, forming a cap. These SCs are
called perisynaptic Schwann cells (PSCs). PSCs are non-myelinating SCs and they are important
because recent research has shown them to be essential for the maintenance and development of
the NMJ. PSCs and SCs have been found to play a role in nerve development and regeneration,
trophic support for neurons, as well as modulation of the neuromuscular synaptic activity.

Role of Schwann cells in regeneration
Three general themes will be discussed in
relation to PSC contribution to synapse plasticity
and stability: 1) PSCs respond to changes in
neurotransmitter

release

and

denervation

with

changes in protein markers, 2) PSC/SCs interact
with other elements of the NMJ and help reestablish synapses during reinnervation, and 3)
PSCs respond to and contain numerous molecules
known

for

properties

trophic and

synapse organization

67 .

Studies have shown and supported Figure 3: The proposed role of Schwann
cells in inducing and guiding nerve
the hypothesis that PSCs extend elaborate sprouting in partially denervated muscle
3.
processes ahead of and guide nerve terminals
during sprouting and followed by denervation

68 .

Following denervation, PSCs invade the

synaptic cleft and can release ACh in a fashion that is dependent on gene transcription as well as
17

functional expression of new neurotransmitter receptors

69, 70 .

This phenomenon is most likely

due to cytoskeletal changes which were observed via changes in glial fibrillary acidic protein
(GFAP). Studies done in frog NMJs after axotomy and blocking of Ca2+ channels with ω conotoxin-GVIA

revealed

GFAP

expression

is

markedly

increased

71 .

Upon

further

investigation, it was indicated that GFAP expression does not result from the nerve cut but is
related to synaptic activity. Specifically GFAP expression was directly dependent on reduced
presynaptic transmitter release, not secondary changes affected via the muscle fiber, because
blocking postsynaptic AChRs was not associated with these effects

67, 71 .

Moreover, growth-

associated protein 43 (GAP-43) and p75 (low-affinity NGF receptor) has been reported to be
upregulated after axotomy. The GAP-43 expression likely results from a loss of nerve contact or
degeneration products as GAP-43 levels drop after reinnervation72 .

In mammals, during synaptic remodeling and reinnervation, PSCs guide nerve terminal sprouts
(Figure 2).

Studies have shown this importance by partial denervation of the nerve. When nerve

inputs to the same muscle are partially damaged, PSCs from the denervated junctions extend
processes and form PSC bridges by contacting PSC processes from adjacent innervated
junctions70 . A similar process is involved with full denervation. During the reinnervation
process, regenerating axons that found endplates after following myelinating SC tubes to the
muscle did not stop. In fact, they continued to grow beyond the endplate region, where they
followed the PSC process extensions very closely. In this manner, the processes act as a bridge
between endplates for reinnervating axons.
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In vitro studies of co-cultures of the NMJ
Multiple studies in the CNS have already proven that astrocytes play multiple roles in
synapse formation, plasticity, and function. Therefore, the contribution of glial cells should be
taken into consideration in synapse studies for a robust model and the NMJ should be considered
a tripartite structure73,
Xenopus75,

76 ,

74 .

Multiple motor neuron-muscle co-cultures have been described in

chick77-79 , mouse80,

81 ,

and rat tissues82,

83 ,

as well as utilizing embryonic hSC-

derived motor neurons synapsed to myotubes from the C2C12 cell line

84, 85 .

Recently, Umbach

et al.86 looked at functional NMJs via co-cultures between embryonic stem cell-derived motor
neurons and C2C12 myoblasts to encourage active NMJ formation and to develop an in vitro
assay to measure synapse activity of motor neurons at the NMJ. Although no SCs were
incorporated, some of the factors released by SCs such as brain-derived neurotrophic factor
(BDNF), glial-cell line derived neurotrophic factor (GDNF), and ciliary neurotrophic factor
(CNTF) were added to the co-cultures. This allowed motor axons to make contacts with muscle
cells. But the authors emphasized that their cultures only survived a maximum of 8-9 days,
which could be due to the absence of support from SCs.

Current in vitro models used for the study of nerve regeneration and motor neuron diseases
include, cell culture, three-dimensional tissue (3-D) slices, and animals87,

88 .

Animal models are

very useful in reproducing injury models, but it is very difficult to study the effects of a specific
cell type or cell-cell communication in whole organisms. When cultured in vitro, the lifespan of
purified primary motor neurons is short and not well suited for long-term study of chronic
injuries89 . Gingras et al.90 described an in vitro long-term culture model for the study of axonal
migration and myelination of motor neurons in a 3-D collagen-chitosan sponge supported by
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Schwann cells and fibroblasts. The study showed that vigorous neurite elongation was detected
in the sponges after only 14 days of neuron culture, reaching more than 850m90 . The model
allowed for the maturation of motor fibers as one-third of them were positive for neurofilament
H. Neurites were subject to myelination when Schwann cells were present, as shown by myelin
basic protein immunostaining. This model showed spontaneous formation of thick myelin
sheaths around motor axons after 28 days in culture 90 .

Similarly, Hyung et al.91 recently developed a co-culture model, utilizing primary motor neurons
and Schwann cells harvested from CD-1 mice, to show in vitro myelination on a 3mm Matrigel
hydrogel. Dissociated MNs were seeded onto a feeder layer of SCs, which interact with and wrap
around the axons of MNs as they differentiate in culture. Their study showed that the MN -SC cocultures survived over 3 weeks and extended long axons. Co-labeling of myelin basic protein
(MBP) and neuronal microtubules revealed that SC formed myelin sheaths by wrapping around
the axons of MNs. The authors also studied the effects of an antioxidant substance, coenzyme
Q10(Co-Q10), that markedly facilitated myelination91 . In this study, SCs are cultured for 7DIV
before MNs are added atop of the SC feeder layer, with MNs displaying increases in axon
diameter by 21DIV. This study is an enhancement of the work done by Gingras et al. and
Haastert et al.92 The study by Gingras et al. required 21 days of culture before the addition of
MNs and showed efficient axon outgrowth via addition of exogenous neurotrophic factors as
mentioned above. On the other hand, Haastert et al. reported that when cultured on a feeder layer
of SCs, MNs without neurotrophic support matured in culture for 20DIV, but that fraction of
MNs gradually reduced from 70% 3DIV down to 12% on 20DIV. In this co-culture system
although MNs matured with enlarged somas myelination of MN axons via SCs was lacking92 .
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Taken together, Hyung et al. were able to show myelin sheaths around MN axons on DIV 14 and
DIV 21 via transmission electron microscopy along with immunolabeling of their cultures. These
studies highlight the importance of SCs, but also a need for supportive matrix molecules, various
enzymes, and trophic factors for enhanced myelination of MN axons.

Schwann cells are known to secrete growth factors and extracellular matrix molecules that
promote neuronal survival and help guide MN axons during regeneration after nerve injury93 .
Establishing co-cultures between neuronal and Schwann cell lines has been considered difficult,
probably because of their high proliferative activity and phenotypic differences from primary
cultured cells94 . Transplantation of SCs is a promising strategy for enhancing peripheral nerve
regeneration. However it has been shown that after in vitro expansion on SCs, they tend to dedifferentiate into a state that is usually observed in vivo after injury93 . A recently study by Jesuraj
et al.93 , explored the role of GDNF as a promoter for the differentiation of SCs into their native
phenotype in vitro through stimulation of the GDNF family receptor (GFR)-1 to remyelinate
regenerating axons. Their study was able to show that when SCs are activated, (GFR)-1
promotes phosphorylation of Fyn that is responsible for mediating downstream signaling for
differentiation and proliferation. They used inhibitors to block Fyn activation and demonstrated
that the cultures require GDNF-mediated differentiation. However, the knockdown studies also
showed that when these cultures were supplemented with GDNF, Fyn activation is restored to
baseline levels, thus suggesting an alternative mechanism may also be involved. One suggestion
is that NCAM levels increase in SCs in response to GDNF therefore there may be some
homophilic binding occurring to stimulate the activation of Fyn95, 96 .
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Dorsal root ganglion (DRG)/Schwann cell co-culture models have also been established and
widely used for PNS myelination. In these models, DRGs are isolated from 14-day-old rat
embryos, while Schwann cells are purified from the sciatic nerves from 3-4 day rat pups97 .
However, the potential of the DRG/Schwann cell co-cultures are compromised by the scarcity of
rat PNS mutants and by the difficulty encountered in adapting the model for use with mouse
cells, for which there are already numerous spontaneous and bio-engineered mutants

98 .

Thus,

there has been a huge effort put forth into developing protocols for mouse co-culture models.
One study we described was by Umbach et al. where they utilized mouse embryonic stem cellderived MNs co-culture with C2C12 differentiated myoblasts. One downside to working with
mouse models and co-cultures is the high cost associated in culturing these cells. For optimal
results associated with mouse co-cultures, protocols established by Päiväläinen et al.97 , require 3dimensional substratum, a myelination-promoting culture medium containing pituitary extract,
N2 supplement and forskolin, and low serum concentration.

Studying such complex mechanism of NMJ myelination and regeneration via animal models or
in vitro cultures is highly important and has provided much needed insights. But animal models
are highly complex, have a potential for low reproducibility, is time consuming, and labor
intensive99 . More importantly, they do not allow for the study at the single-cell level necessary
for determining precise mechanisms. On the other hand, in vitro models allow the study of
biochemical pathways, gene expression, and phenotypic changes at the single neuronal axon
level, which is extremely relevant in various platforms of study99 . Recent advances in
microfabrication technologies, such as photolithography, have provided an advanced culture
platforms allowing compartmentalization of sub-cellular components of neurons, allowing the
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users to grown and manipulate neurons for various modeling and study of axonal behavior and
co-culture systems.
1.2.3. Overview of microfabrication techniques: What is microfluidics, system
design, and manufacturing?
Microfluidics is the study of designing and manufacturing device systems that process or
manipulate small amounts of fluids microliter (10 -6 ) to picoliter (10-12 ) in networks of low
dimensional (micron-sized) channels. These systems allow specific analytical study of various
chemical and biological systems and have been extensively used for the study of cell behavior.
Fabrication of microfluidic devices in poly(dimethylsiloxane) (PDMS) by soft lithography
provides faster access, are less expensive, and do not require a cleanroom for fabrication. Soft
lithography or micromolding, is a set of techniques based on printing and molding using
elastomeric stamps in PDMS with the pattern of interest
control

the

microfluidics,

surface
and

molecular

structures,

maintain the ability to

fabricate

100 .

Soft lithography has the ability to

channel structures

manipulate cells.

appropriate

for

Some applications of soft

photolithography have been to generate controlled microenvironments that establish chemical
concentration gradients and to study the migration of cells towards these chemical gradients 101 .
Others have utilized soft lithography techniques to develop microfluidic platforms capable of
controlling temperature gradients in an environment that mimics the range of physiological
conditions for therapeutic treatments102 .

In brief, photolithography is a process used to transfer a pattern from a mask onto a thin film of
photosensitive polymer (photoresist) and then onto the surface of a substrate. The most common
substrates for soft lithography are amorphous glass (SiO2) and monocrystalline silicone (Si).

23

These photosensitive polymers, also known as photoresist, can be both positive and negative. A
positive photoresist becomes soluble when exposed to certain wavelengths of UV light, whereas
the negative photoresist crosslinks when exposed to light. Following this, a solvent is utilized to
remove the un-crosslinked photoresist and the polymerized features remain. The patterns that we
are creating on the silicone substrates are determined by the design of the photomask, which
blocks the features that are exposed to light and thus crosslinked/polymerized. The thickness of
the features on the silicone substrate are determined by the application of the photoresist layer,
which is typically done by controlling the rotational velocity of the circular substrate and using
photoresists of varied velocity103 . This process then creates a master mold, with which we can
now shape elastomers for the purpose of device manufacture 103 . PDMS is usually used due to its
flexibility, ease of surface modification, oxygen permeability, and optical clarity

104 .

After the

PDMS device has been manufactured, the device is bonded to a glass surface; this creates a
closed fluidic system to analyze various biological and chemical cues.

Photolithographic techniques have been utilized in pharmaceutical and medicinal research as this
technique offers highly reproducible mass-fabrication of systems with complex geometries and
functionalities such as novel drug delivery systems and biosensors105 . With the help of
photolithography, one can manipulate the channel dimensions in such a way that pure onedimensional flow is being tested. This is the type of accuracy photolithography provides. When
fabricating a device for the NMJ we must consider the geometry, materials, and any potential
confinements issues that we might encounter. Motor neuron axons can be millimeters long
therefore when designing compartmentalized systems and to create axonal guidance we should
take such dimensions into account. We do not want to design a system that will create
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confinement issues for the cells causing cell death. There is a minimal thickness (20μm) 106 below
which fluid and molecular transport parameters limit cell viability in vitro. Further when cells are
encased with impermeable materials such as glass, this prevents perfusion, thus sufficient
medium volume space is required to maintain viable cells. Therefore, we must take into account
the fabrication and functional limits when designing systems.

Microfluidics use for study of co-cultures
A microfluidic system can be described as a set of channels that have micron-scaledimensions (typically between 5-500m), and are used to manipulate fluids104 . Although
traditional in vitro culture techniques have elucidated significantly to our understanding of how
neurons behave. These models lack the ability to provide controlled environments to grow or
guide neurons, or enable precise probing of cells 99 . Microfluidic technologies enable the
development of powerful platforms to grow and manipulate neurons in order to model and study
axon injuries. Techniques such as photolithography, etching, and deposition methods to construct
microscopic structures in glass, silicone, or polymeric materials such as PDMS can be utilized to
develop microfluidic systems. Such devices provide perfusion to cells or enable probing of cells
and cell compartments with chemical reagents as well as precise control over cellular
microenvironments107 . Microfluidic platforms further facilitate study at the single-cell resolution
of axons isolated from soma through compartmentalization. The most well-known microfluidic
devices for neuronal study are compartmentalized LOC (lab on a chip) systems fabricated
through PDMS soft lithography104 . PDMS has several properties making it an excellent choice
for biological studies: as a material it is inexpensive, flexible, and easily fabricated and bonded
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on other substrates/materials, biologically inert, non-toxic to cells, impermeable to water,
permeable to gases and optically transparent down to 230nm, facilitating microscopy104 .
Compartmentalization enables more in-depth studies of myelination, injury models, neurite
outgrowth, drug screening and protection, signaling, as well as the study of networks ranging
from cellular to organ levels in organotypic cultures56,

108 .

One of the first most cited microfluidic

LOC device designed to study neurons in their various compartment structures (soma, axon,
dendrites) was the device created by Jeon’s group 56 . Several studies since then have used this
type of device or its derivative for examining axon injury, regeneration, or formation and
function of co-culture systems. Peyrin et al.109 developed a three-compartment microfluidic
device to study simultaneous axonal degeneration and death mechanisms of CNS axons
subjected to axotomy with precise spatio-temporal control. The injury was induced by a brief and
isolated flux of detergent in the central compartment. In their proof of concept for the device,
they observed rapid Wallerian-like degeneration in the distal axons subjected to axotomy,
consistent with in vivo axotomy. Li et al.110 developed an integrated microfluidic platform to
chemically induce axonal injury and study the recovery and regeneration of axon either in coculture

with

glial

cells

in

a

controllable

chamber

using

valves

or

treatment

with

monosialoganglioside, a drug aiding neuronal regeneration. Their results indicated that axons
were more resistant to injury upon localized application of acrylamide compared with the soma,
and that axons had self-destruct programs different from the soma, where injury to the soma
caused secondary axon collapse.
LOC devices that mimic the repulsive or attractive chemical cues present in the regeneration
environment provide insights into how to best guide re-growing axons towards appropriate
targets. In the event of injury, neurites need to perform the non-trivial tasks of reorganizing and
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re-establishing existing connections. Kothapalli et al.

111

developed a novel microfluidic device

to study neurite guidance under the influence of chemogradients. The neurons were cultured in
microchannels on a physiological three-dimensional environment of collagen type I, and
gradients were established of chemoattractants. The gradients developed were stable up to 48 h.
This time frame allowed for the qualitative and quantitative study of neurite turning, providing
valuable insights into the development, maintenance and reorganization of complex neural
networks. The ability to monitor and guide regrowing axons can enhance our efforts in
promoting functional recovery.
Park et al.112 utilized microfabrication techniques to establish a microfluidic platform with 100
parallel microchannels separating two culture compartments to establish a co-culture between
mouse embryonic stem cell (mESC)-derived MNs and C2C12 myotubes. They were able to
elucidate the proper timing required to differentiate and have stable interactions between the two
cells types where both compartments were coated with poly-D-lysine and Matrigel. Similarly,
Southam et al.113 utilized a derivative of the device developed by Jeon’s group sold by Xona
Microfluidics, where they developed a protocol describing in vitro development of robust motor
neuron axon growth within cultures with glia and skeletal myocytes, primary cells obtained from
rats. Within 10 days in vitro (DIV) culture of motor neurons with glia, the axons can be seen
reaching from the proximal side to the distal side of the device. The cultures lasted for 18DIV, as
the viability of the motor neurons was continuous improved with the addition of glia and muscle
cells at defined times at each stage of development. Immunocytochemical staining of the spinal
cultures showed that predominantly astrocytes (15+/-2)%, oligodendrocytes (27+/-3)%, and
microglia (7+/-2)%, with a minor population of fibroblasts (10+/-6)% was present113 . Such
populations of glia are present in the CNS.
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Similarly microfluidic models have been utilized by Zahavi et al. 114 to show bidirectional
molecular communication between motor neurons and the muscle through microgrooves to form
functional NMJs. Using this system, the authors were able to differentiate between the proximal
and

distal effects

of oxidative

stress

and

glial-derived

neurotrophic factor (GDNF),

demonstrating a dying-back-degeneration and retrograde transmission of pro-survival signaling,
respectively. In their study, GDNF facilitated axon growth at the distal side and signals for cell
survival in the soma. Hence, retrograde transport of muscle-secreted GDNF in motor neuron
axons was observed, which is supported by a study by Coulpier and Ibanez (2004) 115 that showed
retrograde-only transport of survival signaling as well as neurite extension upon distal
application of GDNF in sympathetic neurons114 . Furthermore, they show that GDNF acts
differently on motor neuron axons versus soma, promoting axonal growth and innervation only
when applied locally to axons. As proven by a study showing that the conditional ablation of the
GDNF receptor RET in motor neurons leads to a reduced number of NMJs and severe disruption
of pre-synaptic terminals116 , suggesting a local BDNF effect.
1.2.4. Neuron-Glia in Disease, Injury, and Limitations
Onset of neurodegenerative diseases and injuries represent a major health problem,
especially within the aging population. Some of these disorders include but are not limited to
Alzheimer’s (3 million cases/year), Parkinson’s (200,000 cases/year), Huntington’s (200,000
cases/year), Amyotrophic lateral Sclerosis (ALS-20,000 cases/year), Multiple Sclerosis (MS200,000 cases/year), spinal cord injury (SCI) and Guillan-Barre Syndrome (Peripheral nerve
demyelination-20,000 cases/year). Although the symptoms are divergent, there is a progressive
loss of neurons in specific regions and a subsequent onset of gliosis.
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Reactive glial changes occur in most, if not all, neurodegenerative diseases. These changes
include gliosis in astrocytes and activation of microglia, where a dense glial scar is formed that
has both positive and negative consequences

117 .

The glial scar promotes repair by limiting tissue

damage but such reactive and inflammatory responses make significant contributions to neuronal
damage in neurodegenerative diseases especially since the ECM molecules comprising the glial
scar

are

potent

inhibitors

of axon

regeneration

118,

119 .

Similarly,

dysregulation of

oligodendrocytes (OL)-mediated metabolic support of neurons might contribute to neuronal
death in multiple neurodegenerative diseases, including MS and ALS, where myelin loss directly
affects nerve transmission

120 .

SCI and peripheral nerve injuries (PNI) can be caused by automobile accidents or sports injuries.
Some of the injuries and diseases lead to numbness, loss of function, and even paralysis,
depending on the severity of damage. So, to date these injuries continue to be a major clinical
challenge. 20 million Americans suffer from peripheral nerve injury caused by trauma and
medical disorders. Nerve injuries result in approximately $150 billion spent in annual health-care
dollars in the United States

121 .

The national prevalence for SCIs is 270,000 cases

122 .

Whereas,

diseases or injuries causing de-myelination can result from genetic (Charcot-Marie-Tooth (PNS)
or hypomyelinating disease (CNS)), autoimmune (Guillain-Barré syndrome (PNS) or MS
(PNS)), metabolic (diabetic neuropathy), and mechanical (spinal cord injury and carpal tunnel
syndrome)

119 .

There are currently no cures for demyelinating diseases or injuries. Proteomic analyses of myelin
from different demyelinating disease models may provide insights into pathogenesis and
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potential treatments for these diseases

119 .

Also, not all injuries are repairable, depending on the

severity of the damage, surgical intervention is required. Consequently, over 200,000 peripheral
nerve repair procedures are performed annually in the US

123 .

There are also quite a few

limitations and challenges to studying these models in research, as there is no confirmed in vitro
model faithfully emulating disease or injury of the mature spinal neurons

124 .

Having multiple

neighbors as support cells for adult primary cells as well as being able to generate and maintain
populations of adult mouse-derived mature spinal neurons in vitro is needed- as a decline in
intrinsic survival capacity has been observed without trophic support and neighboring cells.
Also, despite multiple studies demonstrating the beneficial effect of Schwann cells on
neuroregeneration in conventional co-culture systems, no study has thus far succeeded in
incorporating Schwann cells into in vitro model of NMJs

124 .

This difficulty can presumably be

overcome by adopting a compartmented culture method.
1.3. Specific aims and summary
In vivo, the interaction of neurons and glia are crucial for the development of the nervous
system (NS). These interactions are facilitated by the fine-tuned migration of neurons and glia
along dedicated trajectories. Neurons are widely known to conduct electrical impulses/currents,
elucidating their role in the transfer of information throughout the NS. Glial cells, in the central
(CNS) and peripheral nervous systems (PNS), are mostly known to support the nervous tissue.
The global objective for this project was to examine emergent NG behavior in response to
chemical

stimuli

within

microfluidic

environments.

Understanding

how

the

environment

stimulates NGs to precise locations in the nervous system is of fundamental importance in
biology and medicine, as abnormal migration is the basis of a variety of human neurological
diseases and dysfunction6 . In this body of work, we observed the synergistic relationship of NGs
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in three cellular models encompassing the central and peripheral NS. Hence the following aims
are proposed to help elucidate their influence.

Aim 1: Evaluate the chemosensitivity of transformed-glial progenitor cells (t-GPCs). In the
brain, cell migration is important during development, plasticity, function, and repair. In
addition, it’s also important in cancers and diseases as it is well accepted that cancer cells have
progenitor and stem-cell like properties in that they have the ability to de-differentiate. The focus
of this aim is on directed cell migration to external chemical cues also known as chemotaxis. We
utilize GPCs from Medulloblastoma (MB), which is a CNS glial tumor that metastasizes to the
spinal column. Due to these cells ability to retain their stem and progenitor like properties we
refer to them as t-GPCs. MB provided a model for t-GPCs, believed to be critical for motility
and metastasis. These studies include:
1A: Identify growth factors with highest chemosensitivity for t-GPCs.
1B: Measure in vitro migratory behavior of t-GPCs in controlled microenvironments.
Summary: The behavior of transformed NG progenitors was examined (in the form of
Medulloblastoma (MB)), known to emulate developmental processes, to external stimuli
using controlled microenvironments. We used a microfluidic system called the bridged

lane, which allows for steady-state, 1D, controllable concentration gradients along the
length of its’ microchannel. The system was used to evaluate in vitro migratory responses
of MB-derived cells such as the fraction of motile cells, directionality, and cell path
length under Epidermal Growth Factor (EGF) and stromal cell-derived factor 1-alpha
(SDF-1) stimulation. The data demonstrated MB cells traverse from high to low ligand
concentration gradients and respond strongly to EGF in a dosage and gradient-
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dependent manner while exhibiting increased EGF-R activation. In addition, high
concentration gradient fields of EGF caused more cells to move longer distances in a
highly directional manner as opposed to SDF-1. This work provides evidence that EGF
and its receptor play an important role in MB migration than previously documented.

Aim 2: Examine how GPC chemotaxis is influenced by NG collective behavior. Analyzing
migration responses of neural-glial progenitor cells derived from Drosophila Melanogaster
towards fibroblast growth factor (FGF). These studies include:
2A: Evaluate the behavior of GPCs collectively with Neuronal Progenitor Cells (NPCs).
2B: Examine the collective chemotaxis behavior in a microfluidic environment.
Summary: A more comprehensive neural model was utilized to examine the collective
behavior of neural progenitors in response to chemotactic stimulation. Experiments
examined the collective behavior of NG progenitor cell populations in response to
stimulation via fibroblast growth factor (FGF) gradients using a developmental model of
the central nervous system (CNS) in the Drosophila Melanogaster, 3rd instar larvae
stage. Surprisingly, our data demonstrated that cells migrated larger distances and with
higher directionality within collective groups of both neuronal and glial progenitors than
in populations of glia only.

Aim 3: Manipulate collective NG behavior to develop an in vitro model of the
Neuromuscular Junction (NMJ). SCs originate from the highly motile neural crest. However,
the guidance signals for these SCs are unknown. Neurotrophins are expressed early in
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developing embryos and have been shown to be critical for the survival and pattering of glia and
neurons

125 . These

studies aim to examine:

3A: Modality of collective chemotactic NG response in the PNS.
3B: Examine the influence of NG response for tri-cellular NMJ model.
Summary: This model was developed to build upon our previous understanding of
coordinated NG responses. We also hypothesized that glial involvement is much more
dynamic and is necessary for synaptogenesis as well as overall remodeling and regeneration.
Therefore, we moved into a larger system in the PNS-the Neuromuscular Junction (NMJ), to
further our understanding into NG responses for repair strategies. Initially this study probed
the guidance cues and migratory patterns of NGs towards various growth factors to
elucidate emergent NMJ response. Our data illustrated there is a co-culture effect on
receptor expression dependent on stimulation time. This study aimed to identify different
growth factors potential for migratory response. BDNF was utilized in microfluidic studies,
as it is known for its maintenance capacity upon neurons & to observe its collective response
on NGs. Subsequently, the experiments utilized a compartmentalized microfluidic platform to
demonstrate reproducible differentiation of skeletal myotubes with increased viability and
length following the time-dependent addition of NG cells. Our data validated our hypothesis
and showed that NG interactions are important in their maintenance capacity for the number
of SKM myotubes present for the tri-culture model. We further validated this response by
observing mean fluorescence activity in tri-cultures versus SKM myotubes alone (control).
Results

displayed

higher presence of

alpha-bungarotoxin,

post-synaptic nicotinic

acetylcholine receptor marker on SKM myotubes, in tri-cultures versus control samples.
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2. EGF as a New Therapeutic Target for Medulloblastoma
Metastasis (PMID 26594253)
2.1. Chapter Summary
Medulloblastoma (MB) is a malignant pediatric brain tumor known for its aggressive metastatic
potential. Despite the well-documented migration of MB cells to other parts of the brain and
spinal column, MB chemotaxis is poorly understood. Herein, we examined the in vitro migratory
and cellular responses of MB-derived cells to external signaling of Epidermal Growth Factor
(EGF), hepatocyte growth factor (HGF), platelet-derived growth factor (PDGF-BB), and the
stromal cell-derived factors 1-alpha (SDF-1). Experiments utilized transwell assays and
immunocytochemistry to identify receptor activation in MB migration, and used a microfluidic
platform to examine directionality, trajectory, and gradient-dependence of motile cells. Data
illustrates that MB-derived cells respond strongly to EGF in a dosage and gradient-dependent
manner with increased EGF-R activation and show that high EGF gradient fields cause an
increased number of cells to migrate longer directed distances. Our results provide evidence that
EGF and its receptor play a more important role in MB chemotactic migration than previously
documented and should be considered for developing migration-target therapies against MB
metastasis.

Keywords
Pediatric cancer; Chemotaxis; Microfluidics; Gradients
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2.2. Introduction
Medulloblastoma (MB) is a family of highly-invasive tumors most commonly diagnosed in the
pediatric central nervous system

126-130 .

While clinical treatments have more than doubled the

overall 5-year survival rate to upwards of 60%

129, 131-133

, additional therapies are needed to target

the aggressive MB migration that is uncharacteristic of other brain tumors, but is a hallmark of
MB recurrence, metastasis, and radioresistivity

129, 130, 134-139 .

The migration of cancer cells within

the CNS is decidedly complex, affected by cellular interactions with heterogeneous extracellular
40, 140-

matrix (ECM) as well as mixed cellular responses to concentration fields of biomolecules
143 .

However, the mechanisms behind the migration of MB-derived cells along CNS gradients of

biomolecular concentration, or chemotaxis, remain understudied and incompletely understood 129,
140 .

Particular complexities arise in MB, because chemoattractant fields that rouse cells away

from primary tumors can be secreted by healthy or transformed distant and neighboring cells
144-148 .

40,

Further, clinical studies have illustrated that the spread of MB cells occurs predominantly

to the spinal column via a combination of two-dimensional (2D) and three-dimensional (3D)
movements

76, 149-152 .

Such spreading results from tumor cells that drop into the cerebrospinal

fluid and tend to seed in parts of the spine

153-157 .

As a result, the movement of MB cells on the

surface of the spinal column can be examined on 2D substrata to plausibly physiologically
approximate the metastatic behavior of these pediatric brain tumors.

Traditional cell migration studies have looked to transwell 158-160 and wound healing assays

161-163

to report numbers of cells that become motile in response to external signaling from growth
factors, such as Epidermal Growth Factor (EGF) and Platelet-Derived Growth Factor (PDGF)
164 .

However,

chemotaxis

is

becoming

more-commonly

examined

via

the

physical
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microenvironment of the cell, where dynamic concentration fields facilitate ligand-receptor
bindings which initiate signal transduction cascades

40, 165, 166 .

Here, precise manipulation of the

cell microenvironment has been facilitated by the wide-adaptation of benchtop microfluidic
devices

160, 167, 168 ,

which enable multifaceted evaluation of cell migratory behaviors in lieu of

cell numbers alone. A large number of laboratories have demonstrated concentration- and
concentration gradient-dependent behavior of non-cancerous cells, such as fibroblasts
progenitor cells
cancers

174 .

170

and keratinocytes

171 ,

169 ,

retinal

as well as tumors found in breast 172 , colon 173 and CNS

Our own laboratory has illustrated that select populations of cells derived from CNS

tumors can respond acutely via migration to ultra-low concentration gradients of select
chemoattractants
dosage

140, 169, 174 ,

148, 175, 176 .

while others have shown greater chemotactic response with specific

Microfluidic analysis is, thus, well positioned to meaningfully aid in the

development of migration-targeted therapies for MB via insight of migratory parameters relevant
to metastasis, such as cell distance traveled, motility, gradient-sensitivity, ECM interaction and
numerous others.

In this work, we examine MB migratory behavior in response to external signaling from 4 of the
most extensively studied

chemoattractants of CNS tumors using benchtop assays and

microfluidics: Epidermal Growth Factor (EGF), Platelet-derived Growth Factor (PDGF),
Hepatocyte Growth Factor (HGF), and Stromal Derived Growth Factor (SDF-1 or CXCL12).
Our results illustrate that MB-derived cells exhibit gradient-dependent behavior in EGF fields,
which are able to guide MB along longer migration distances with superior directionality and
increased receptor activation. These results distinguish EGF as a principal molecule with
meaningful potential impact as an anti-migratory therapeutic to MB metastasis.
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2.3. Materials and Methods
2.3.1. Cell culture
In vitro cell culture was maintained using Daoy cell line (ATCC, Cat. No.HTB-186)

140, 142 ,

Eagle's Minimal Essential Medium (EMEM) (VWR, Cat. No.12001-582) supplemented with
10% fetal bovine serum (VWR, Cat. No.45000-734), 2% L-glutamine (VWR, Cat. No.45000676) and 1% Penicilin-Streptomycin (VWR, Cat. No.45000-650). Intact monolayers were
maintained, and harvested cells were seeded onto sterile polystyrene tissue culture flasks (VWR,
Cat. No.BD353136). MB cells were incubated at 37 ºC with 5% CO 2 with cell medium changed
every 2 days. Cell migration experiments were initiated with cells that were inserted into
microchannel after MB cells reached 80% confluence.
2.3.2. Cell Migration Assay
The Boyden chamber assay

140, 174

was used to measure the number of MB cells that migrated

towards different concentrations of external growth factors. This widely used assay consists of
two compartments filled with EMEM medium and separated by an 8 micron-porous membrane
(VWR, Cat. No.62406-198), as shown in Figure 4A. MB cells were seeded in the upper
compartment and were allowed to migrate through the porous membrane into the lower
compartment for 6 hours at 37 ºC in a 5% CO 2 incubator. Approximately 1x106 cells/mL were
seeded in 300μl of EMEM complete medium (EMEM with FBS) in each upper chamber, while
700μl of serum-free medium (EMEM only) was pipetted into each lower chamber. Lower
chambers also contained concentrations of 1, 10, 100, and 1000 ng/mL of EGF (Life
Technologies Corporation, Cat. No. E3476); HGF (R&D Systems, Cat. No.2207-HG/CF);
PDGF-BB (R&D Systems, Cat. No.220-BB-010); and finally, SDF-1 (PreporTech, Cat. No.25020A). All growth factor solutions were diluted in EMEM serum-free medium using serial
37

dilution. After 6 hours of incubation, the membrane was fixed and stained with fixative solutions
(VWR, Cat. No. B4132-11A), which stained the cell cytoplasm and nuclei. The number of cells
that migrated to the underside of each membrane was determined by using the convectional
checkerboard analysis

140, 174, 177.

2.3.3. Immunostaining of Receptors
MB cells were plated at a concentration of 1x10 3 cells/mL in EMEM complete, on borosilicate
glass well plates (Lab-Tek, Cat. No.155383). The cells were incubated for 2 hours at 37°C in 5%
CO2 to facilitate attachment. Adhered cells were exposed to ligands at concentrations that
resulted in the largest numbers of motile cells in the transwell assay results. At 37°C, each cell
plate was exposed to 5 minutes of: 100ng/mL EGF (Life Technologies, Cat. No. PGH0311),
100ng/mL CXCL12 (Life Technologies, Cat. No. PHC1364), 10ng/mL HGF (Life Technologies,
Cat. No. PHG0324), and 100ng/mL PDGF-BB (Life Technologies, Cat. No. PHG0044). The
supernatant was then aspirated, and each well was rinsed 3 times with 0.5 mL phosphate
buffered saline solution (PBS), (Sigma-Aldrich, Cat. No. D8537). Each well was fixed using
10% paraformaldehyde (Sigma-Aldrich, Cat. No.HT501128) for 10 minutes and rinsed twice
with PBS. The samples were permeabilized using a 1% solution of Triton-X (Sigma-Aldrich,
Cat. No.X100) and 0.1%BSA in PBS solution for 10 minutes, then blocked for 60 minutes with
1% BSA in PBS blocking solution and rinsed twice with the same blocking solution.

Samples were then exposed to the primary antibody for each receptor studied for 2 hours at
22°C: 5μg/mL anti-EGFR (Life Technologies, Cat. No.700308), 5μg/mL anti-CXCR4 (Life
Technologies, Cat. No.35-8800), 2μg/mL anti-c-Met (Millipore, Cat. No.07-2242), and 3μg/mL
anti-PDGFR (Life Technologies, Cat. No.701142). Each well was rinsed 3 times with 1% BSA
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blocking solution. A fluorescent secondary anti-rabbit IgG (Millipore, Cat. No. AP132F) was
used for EGFR, c-Met, and PDGFR samples, and a fluorescent anti-mouse secondary antibody
(Millipore, Cat. No. MAB1976) was used for CXCR4 samples. All samples were exposed to the
secondary antibody at a concentration of 5μg/mL for 30 minutes at 22°C, and then rinsed twice
with blocking solution. Nuclear staining (Life Technologies, Cat. No. R37605) was performed
for 20 minutes at 22°C, after which the samples were rinsed twice with PBS and covered in
glycerol (Life Technologies, Cat. No.15514-011) for preservation. In addition, the expression of
EGFR was measured at different time points of 0, 14, 22, 36, and 42 hours. The
immunocytochemistry assay was performed as described above using goat-anti mouse IgG
secondary antibody (Life Technologies, Cat. No. A-11005) for EGFR.
2.3.4. Bridged μLane and Experimental Set up
Our microfluidic device, the μLane, was utilized to image the real-time migratory responses of
individual MB cells within microenvironments of defined EGF and SDF-1 gradient profiles. The
bridged μLane system operates via a combination of uniaxial bulk convection and diffusion to
achieve controlled chemical concentration gradients over time, as described previously

101, 169, 174 .

This mass transfer mechanism termed as convective-diffusion has been widely-studied by
several groups for bioengineering applications, to determine the transport of differently sized
solutes and proteins through the walls of capillaries
fibers

186-188 ,

and intervertebral discs

189-191 .

178-180

and arteries

181-185 ,

skeletal muscle

The two-dimensional mass transport of ligands within

the microsystem was modeled via finite-element-analysis (FEM) in Matlab 7.7 (MathWorks,
Natick, MA) and verified experimentally as described previously by our group

101, 169 .
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The framework of the μLane system consists of two layers of Polydimethylsiloxane (PDMS)
(Fisher Scientific, Cat. No.NC9644388) bonded to a glass slide using ozone gas. The first layer
of PDMS consists of a closed microchannel of 100µm-width and 1.3cm-length with a volume of
0.1μL, which connects two fluidic reservoirs of 9μL each, called the source (SRR) and the sink
(SKR) reservoir. The second layer of PDMS consists of two chambers of 170μL each, called the
source (SRC) and the sink (SKC) chamber, connected by an open, hemispherical bridge channel
to maintain the hydrostatic equilibrium of the system 101,

169, 170 .

Both chambers are vertically and

fluidically connected with both reservoirs (Figure 6).
The μLane system works by using the larger volumes of the SRC, SKC and bridge channel on
the second layer of PDMS to generate concentration gradients within the smaller volumes of the
SRR, SKR and microchannel on the first layer

101, 140, 169, 170 .

After inserting cells along the

microchannel length, the cell culture media is used to fill the SRR, SKR, SRC, SKC, and the
bridge channel. The ligand solutions (EGF or SDF-1) are then manually inserted drop-wise into
the SRC until the solution makes contact with the cell culture media solution within the bridge
channel and SKC to initiate the molecular transport within the system. The small differences in
the density of the reagents and in the liquid levels in the SRR and SKR generate hydrostatic
pressure differences that initiate an ultra-low bulk flow within the microchannel in the first layer
101, 169, 170 .

This minuscule bulk flow was measured to be 0.37 μm/sec using fluorescent beads, as

described previously

101 .

Such a low bulk flow facilitates the transport of ligand solutions from

the SRR to the SKR, to accelerate the time required to attain a steady-state gradient profile of
ligand solutions along the 13-mm length of the microchannel. In the absence of this bulk flow,
the transport of our reagent via diffusion alone would require over 470 hours to reach a steadystate distribution within the length of the μLane instead of the 18 hours measured, as reported by
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our group

101, 140 .

Mathematical models of reagent transport within our μLane system were

performed via MatLab to determine the steady-state concentration distribution as seen in Figure
7A. The initial EGF or SDF-1 concentration within the SKC, SKR, microchannel and SRR was
set to 0-ng/mL, as per absence of ligand. The initial ligand concentration within the SRC was set
to 100-ng/mL to reflect the sample concentration used during experiments. These boundary
conditions were solved using Equation (1), as shown below 101 ,

C
+ u  C = D 2C
t

(1)

Where C (ng/mL) is ligand concentration, t (hours) is time, u (μm/sec) is fluid velocity, and D
(cm2 /s) is diffusion coefficient, or diffusivity, of the reagent molecule. Experimental validation
was also performed using fluorescently labeled Dextran (~ MW 10KDa), to confirm steady-state
is reached in our system after 18 hours, and is maintained for several days

101, 140.

For our experiments, the μLane system was coated with 10-μg/mL of laminin (Becton,
Dickinson and Company, Cat. No.354232)

140, 142 ,

which was allowed to gel for one hour at room

temperature (25°C) under sterile conditions. Unbound laminin was aspirated, and cells were
manually seeded into the microchannel using a 1-mL syringe (VWR, Cat. No.BD309659). A cell
solution (1x106 cells/mL) was injected into the SRR and SKR. Cells were allowed to adhere and
visibly spread prior to the initiation of the experiment as illustrated in Figure 6D. Finally, the
bridge channel was loaded with EMEM complete medium to connect the SRC and SKC,
initiating the system. In this work, EGF (100-ng/mL) or SDF-1 (100-ng/mL) was individually
loaded drop-wise into the SRC and allowed to reach steady state in the microchannel for 18
hours at 37°C

101 ,

prior to imaging of MB cell migration within this precise biochemical

environment; therefore, all data is collected within steady-state concentration gradient fields for
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24 hours. Our group has previously showed that MB cells migrate and proliferate in-vitro until
72 hours in the µLane system

140 .

2.3.5. Statistics
One-way ANOVA and Post Hoc Test (Tukey) were used to analyze the data using IBM SPSS
Statistics Program (IBM Corp., Released 2011, version 20.0. Armonk, NY). A one-way ANOVA
test at a 95% confidence interval was performed for statistical significance across growth factors.
The Post Hoc Test (Tukey) was performed to determine the disparity among different groups.
Only p-values <0.05 were considered statistically significant. Unpaired student’s t-test at a 95%
confidence interval was implemented to determine significance of relative receptor expression
using IBM SPSS Statistics Program (IBM Corp., Released 2011, version 20.0. Armonk, NY).
2.3.6. Imaging and Processing
Transmitted light microscopy images were obtained using an inverted microscope (Nikon
TE2000) and a cooled CCD camera (CoolSNAP EZ CCD Camera, Photometrics, Tucson, AZ)
with a 20X objective magnification (Nikon Plant 20X, Morrell Instrument Company Inc.,
Melville, NY). Fluorescent imaging was performed using Leica CLSM confocal microscope and
a Zeiss LSM 710 confocal microscope, both at 63x magnification with oil immersion objective.
Image J was utilized to track cells and process images (Chemotaxis and Migration Tool plugin
(ImageJ 1.46r)

140, 192 .

Fluorescence intensity was measured using an average over the entire cell

area via ImageJ. Transmitted light image data was analyzed using Nikon software (Nikon
Instrument Element 2.30 with 6D module, Morrell Instrument Company Inc., Melville, NY) and
ImageJ (NIH) Software. Bright field images of the microchannel were automatically captured
every hour for 24 hours at every 1000 microns in the y-direction of the µLane, followed by cell
tracking (n cells~180 cells) and analysis. Lastly, the cell tracking software was used to develop
42

Wind-Rose plots

169, 170

of cell trajectories in response to EGF and SDF-1 gradient fields, over 24

hours.

2.4. Results
This work examined the migratory and cellular responses of MB-derived cells in response to
external signaling from EGF, HGF, PDGF-BB, and SDF-1.
2.4.1. Motility Studies
The first set of experiments measured the average numbers of MB-derived cells that migrated
toward different concentrations of EGF, HGF, PDGF-BB, and SDF-1 through transmembrane
assays, as illustrated in Figure 4 and Table 1. As seen, numbers of motile cells were statistically
different in response to signaling from different concentrations of EGF and HGF when compared
to controls (i.e. no ligand). Further, a mid-level concentration of 100-ng/mL of EGF was
observed to attract the largest numbers of motile cells overall (Fig. 4B.2).

By contrast, the

number of MB cells that migrated in response to external signaling from concentrations of SDF1 did not exhibit statistical difference from controls or each other (Fig. 4B.4). Similarly, the
number of motile MB in response to signaling from different concentrations of PDGF-BB did
not display statistical differences from controls (Fig. 4B.3).
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Figure 4: Migration of MB- derived cells to different concentrations of selective
chemotactic ligands. (A1) Schematic of transwell assay with motile cells attached to the
underside of the porous membrane. (A2) Stained nuclei and cytoplasm of motile MB-derived
cells toward different concentrations of (B1) EGF, (B2) HGF, (B3) PDGF, and (B4) SDF-1. The
control groups indicate number of cells that migrated towards serum-free medium. An asterisk
(*) indicates statistically significant data with p-values <0.05 against control group.

2.4.2. Relative Receptor Expression
The basal expression levels of the respective receptors were then compared against their
activation levels upon ligand stimulation. Confocal images in Figure 5 illustrate differences in
cellular distribution of activated receptors, as well as differences in fluorescent intensity after
ligand stimulation. As seen, basal receptor expression appears to be uniformly distributed
throughout the cell cytosol, with lowest intensities measured for EGF-R. Upon ligand activation,
receptor expression is increased, but remains largely distributed throughout the cytosol.
However, EGF-R expression is also observed to be acutely concentrated along the outer cell
membrane. Analysis of fluorescence intensity then represented relative receptor expression
levels upon ligand-stimulation. MB stimulated with EGF exhibited the highest increase in
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Figure 5: Receptor activation within motile MB-derived cells. Immunocytochemistry of basal
receptor expression of MB cells without ligand stimulation to (A1) EGF, (B1) SDF-1, (C1) HGF,
and (D1) PDGF-BB. Receptor activation post-stimulation with (A2) EGF, (B2) SDF-1, (C2)
HGF, and (D2) PDGF-BB. The expression level of receptor following ligand stimulation of (A3)
EGFR, (B3) CXCR4, (C3) c-Met, and (D3) PDGFR-BB normalized to basal control levels. Scale
bars are 100µm. An asterisk (*) indicates statistically significant data with p-values <0.05.
receptor expression for EGF-R, with a 3.5-fold increase in intensity over basal EGF-R
expression measured in unstimulated controls (Fig. 5A). By contrast, the expression of CXCR4,
the receptor for SDF-1, was approximately 2-fold higher than its basal intensity levels in cells
unstimulated with ligand (Fig. 5B), while no statistical difference was measured between the
activation levels of c-Met, the receptor for HGF (Fig. 5C), and control cells, as well as between
45

PDGFR-BB (Fig. 5D) in ligand-stimulated cells compared to controls. MB cells stimulated with
EGF for different time points of 0, 14, 22, 36, and 42 hours displayed no relevant significant
difference in receptor expression for EGF-R across time points and were all higher than the
unstimulated control (See supplementary Figure 9).
2.4.3. Migratory response to controlled concentration and gradient fields
The migratory behavior of MB was next examined using our microfluidic system, called the
μLane and shown in Figure 6, for real-time cell imaging and analysis. The transport of EGF and
SDF-1 along the μLane was modeled computationally, and verified experimentally as previously
reported by our group

101 .

The system produced a range of concentration gradients along the

microchannel length at steady-state, as shown in Figure 7A

140, 169 .

Concentration gradients of

this study are defined as the average difference in growth factor concentration (ng/mL) along the
microchannel length (mm). Five orders of concentration gradient, G1 -G5 , were delineated along
the microchannel as illustrated

in Figure 7A: 10+1 <G1 <100 ng/(mL.mm), 100 <G2 <10-1

ng/(mL.mm), 10-1 <G3 <10-2 ng/(mL.mm), 10-2 <G4 <10-3 ng/(mL.mm), and 10-3 <G5 <0. The lowest
gradient, G5 , was located near the source reservoir (growth factors only) and occupied
approximately 1-mm-length of the microchannel, while the highest gradient, G1 , was located
near

the sink

reservoir and

occupied

an approximate,

3-mm-length of microchannel.

Concentration gradients, G2 , G3 , and G4 , occupied the remaining 9-mm-length of microchannel
(distance in between the source and the sink reservoirs) with approximately 4 mm, 3 mm and 2
mm segments, respectively. Note, the core distributions of EGF and SDF-1 along the
microchannel are very similar to one another given their respective molecular weights of 6.045
KDa and 7.9 KDa, and hence only one representative gradient distribution is shown. Further,
cells were distributed evenly along all segments of the channel prior to the start of experiments.
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Figure 6: The μLane system and MB migratory responses. (A) Schematic of the bridged
μLane system, showing cells inserted within the sink (SKR) and source (SRR) reservoir, and
adhered along the microchannel. Chemotactic agents (e.g. EGF, SDF-1) are loaded into the
source chamber (SRC), and transported to SKR to reach steady-state concentration distribution.
(B) Top view image of the first layer PDMS bonded onto a glass slide. Two 9-nL reservoirs are
connected by a microchannel of 13mm in length and 100µm in diameter. (C) Top view image
of second layer PDMS bonded to the first layer. The source (SRC) and sink (SKC) chambers
are connected by a bridge channel. (D) Raw data image of motile MB cells within μLane
system at (D1) source reservoir, (D2) mid channel, and (D3) sink reservoir.
The migration of MB-derived cells in response to the different concentration gradient fields of
EGF and SDF-1 were described using three parameters: (1) Fraction of motile cells, f, defined as
the number of cells that migrated more than two cell diameters in the μLane, normalized by the
total number of cells within the channel; (2) cell directionality, D, defined as the percentage of
cells whose net center of mass was preferably towards the positive, x-displacement or along the
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gradient direction; and (3) Average cell path length, PL, defined as the total distance traveled by
cells.

Figure 7: Concentration distribution along μLane and number of motile cells. (A)
Concentration profile of EGF and SDF-1 along 13-mm microchannel length of μLane
system. Concentration gradients are identified by five orders of magnitude in the
microchannel: 10+1 <G1 <100 ng/(mL.mm), 100 <G2 <10-1 ng/(mL.mm), 10-1 <G3 <10-2
ng/(mL.mm), 10-2 <G4 <10-3 ng/(mL.mm), and 10-3 <G5 <0 ng/(mL.mm). (B) Fraction of
MB-derived cells observed to respond via migration to the different concentration gradient
fields (G1 through G5 ) of EGF and SDF-1.
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First, the average percentage of motile cells along the entire microchannel was similar for both
growth factors. Table 2 shows that 72.82% of MB became motile in response to EGF signaling,
while an average 67.3% of MB became motile in response to SDF-1 concentration fields. Values
of motile fraction varied with gradient fields, fG1 -fG5 , for both EGF and SDF-1, as shown in
Table 3. As seen, the highest fraction of MB cells became motile when exposed to higher
concentration gradient fields of EGF, G1 (f1=28.3%) and G2 (f2=18.6%), followed by decreasing
percentages of motile cells within lower gradient fields of EGF, G3 (f3=11.9%), G4 (f4=10.3%)
and G5 (f5=3.7%). Similarly decreasing fractions of cells were seen to migrate in response to
concentration gradient fields of SDF-1, with highest fractions at G1 (f1=18.2%) and G2
(f2=20%), followed by significant decreases in the fraction of motile cells at concentration
gradient fields G3 (f3=13.8%), G4 (f4=8.7%) and G5 (f5=6.5%). As shown in Figure 4.B, the
fraction of nonmotile cells was 27.2% and 32.8%, when exposed to similar concentration
gradients of EGF and SDF-1, respectively. Statistical significance was observed between
concentration gradient fields of EGF while no statistically significant difference was found
across the gradient fields of SDF-1.

Next, the average directionality of motile MB was determined by examining individual cell
trajectories. The term directionality was previously introduced by our group as the ratio of the
number of cells whose centroids migrated more than 80 µm to the total number of cells in the
microchannel

169 .

The paths of MB cells in the presence of EGF and SDF-1 concentration

gradient fields were optically tracked within the μLane system to generate the representative
Wind-Rose plots shown in Figure 8A. Note that although cell trajectories are each positioned at a
common origin for comparison, cell paths were measured along all microchannel segments,
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exposed to all gradient fields G1 -G5 . Representative trajectories illustrate that cells migrated
preferentially towards lower concentration gradients of EGF (i.e., towards the right). By contrast,
SDF-1 fields resulted in MB migration that was both towards and away from lower SDF
gradients without preference. The directionality of motile cells along the entire microchannel
was higher for cells stimulated with EGF (61.6%) than SDF-1 (44.2%), shown in Table 2. As
seen, cell directionality within specific gradient fields, DG1 -DG5 , decreased with decreasing
gradient for both EGF and SDF-1, shown in Table 3. EGF DG1 indicates that 28.3% of motile
cells migrated directionally when exposed to G1 of EGF (i.e. within the first 3mm of channel
length), while SDF DG1 denotes that only 18.4% displayed directional migration for the same
gradient field of SDF-1. The highest fraction of MB cells directionality was reported at higher
concentration gradient fields of EGF, DG1 (28.3%) and DG2 (15%), followed by decreasing
percentages for directionality within lower gradient fields of EGF, DG3 (7%), DG4 (8.6%), and
DG5 (2.7%). Similarly decreasing fractions of directionality were reported in response to
concentration gradient fields of SDF-1, with highest fractions at DG1 (18.4%) and DG2 (10.5%),
followed by decreasing fractions of directionality at DG3 (9.8%), DG4 (2.2%), and DG5 (3.3%).
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Figure 8: Motility of MB-derived cells in the μLane system. (A) Representative
trajectories of cells that migrated in response to 100ng/mL of EGF and 100 ng/mL of SDF1 stimulation. Three cell paths are shown in dashed for EGF and three in solid for SDF-1,
24 hours post steady-state. Note that concentration gradients decrease from left to right
within the μLane. (B) Maximum accumulated distance of motile cells stimulated by
concentration profiles generated by using 100ng/mL of EGF and 100 ng/mL of SDF-1,
respectively, in the SRR of the μLane.
In addition, Wind-Rose plots display the average maximum cell path length, PL, of motile cells
tracked along the entire microchannel. Using this data, 32% of motile MB migrated distances
greater than 200 microns (or 20 cell-diameters) when exposed to EGF gradient fields, as seen in
Figure 5.B. By contrast, 97.3% of cells exposed to SDF-1 gradients migrated distances less than
200 microns. MB within our μLane system in the absence of growth factors or concentration
gradients (i.e. controls) displayed migration distances between 50 and 200 microns

140 .

As
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shown, increasing percentages of cells were seen to migrate in response to higher gradient fields
of EGF. A larger percentage of motile MB were observed in response to G1 fields of EGF at
every distance, while only cells exposed to G1 migrated the longest distances greater than 300
microns. In comparison, MB exposed to lower gradient fields of SDF-1 (G3 -G5 ) exhibited the
longest migration. Notably, zero cells were observed to migrate less than 100 microns when
exposed to any EGF gradient field G1 -G5 , while zero cells were seen to migrate greater than 300
microns when exposed to any SDF-1 gradient fields G1 -G5 .

2.5. Discussion
The chemotactic migration of MB-derived cells has been surprisingly understudied despite its
well-known metastatic potential and aggressive invasion into the brain and spinal cord

140, 193 .

Our study is among the first to examine and compare the migratory responses of MB to dosagedependent signaling from EGF, HGF, PDGF-BB, and SDF-1, the most widely-acknowledged
chemoattractants of CNS tumor cells

194 .

The first set of experiments utilized conventional

transwell assays to illustrate that MB migration was most concentration-dependent to EGF
signaling. As shown in Figure 4, MB exhibited dosage-dependent migration in response to
signaling from EGF and HGF, but seemingly dosage-independent responses to PDGF and SDF-1
signaling. Further, EGF simulated the migration of approximately twice the number of MB cells
than did PDGF, HGF, or SDF-1. Results from immunocytochemistry support the strength of MB
chemotactic response to EGF signaling, as activation of its receptor, EGF-R, was two times
larger than activation of other respective receptors. While strong MB chemotactic response to
EGF signaling is consistent with previous findings from our group and others

140, 195 ,

it is most

significant here because it is signaling from SDF-1, rather than EGF, that has been reported as
the strongest MB chemoattractant

176 .

Inhibitor AMD310, which cleaves CXCR4, has been
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reported to decrease MB tumor growth in mouse xenografts, chemotaxis and proliferation

176 .

However, in vivo use of EGF-R inhibitors such as Tarceva and Gefitinib have reported no
changes in motility of cells derived from glioma

196 ,

and non-small-cell lung cancer

197 ,

and thus,

were minimally used on MB. We contend that MB chemotactic response may not have been
measured most meaningfully in the past, which has stymied development of anti-migratory
therapies for MB metastasis.

For this reason, we used microfluidic systems to more precisely

study MB migratory responses using parameters relevant to metastasis.

Using the μLane system, we were able to image real-time cell behavior in response to a wide
range of concentrations and gradients of EGF and SDF-1 and distinguish directed-migration of
chemotaxis. MB migratory behavior was observed to be concentration gradient-dependent for
both EGF and SDF-1 signaling, as the fraction of motile cells decreased with decreasing
concentration gradient in both cases. However, motile MB traveled longer distances within the
μLane in response to EGF signaling, with an average PL of 264.5 ± 67.8 µm, compared to an
average PL of 125.5 ± 48.6 µm when responding to signaling from SDF-1. Further, cell
trajectories illustrated an MB directional bias towards decreasing EGF gradients not present with
SDF-1 signaling, with 18.3% of cells migrating towards decreasing EGF gradients compared to
15.3% of MB in response to decreasing SDF-1 gradients. Importantly, this behavior was
observed along the entire μLane length, for cells exposed to all concentration gradient fields, G1 G5 . Here, the cell directionality compared to other methods provides insight into whether MB
cells stimulated with ligand solutions (EGF or SDF-1) followed a directional migration along
gradient fields. Other methods to measure cell migration include the persistence length and
average velocity to determine the chemotactic sensitivity of stable gradients in 3D

198-201 .

While
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the persistence length provides the ratio of the net distance traveled to the total distance, it would
not report the number of cells that migrate along ligand concentration gradients, which is highly
significant to studies developing migration-targeted therapies for tumors of the CNS.

This consistent MB behavior illustrates that EGF signaling from high concentration gradients
initiates the most motile MB, and further enables cells to travel the longest distances. MB cells
were seen to migrate towards increasing ligand concentration, which also corresponds to
decreasing EGF gradient fields in our system. This response is significant because it reflects MB
sensitivity to high concentration gradients (G1 -G2 ), which were generated via much greater
nonlinear changes in ligand concentration as compared to low gradient fields (G3 -G5 ). Previous
work from our group has illustrated keen abilities of MB to migrate in larger numbers in
response to increasing EGF concentration via pERK signaling

140 .

MB cells were seen to travel

out of a cell reservoir when exposed to increasing gradients and concentration. In the current
study, we now demonstrate that MB can become less motile when exposed to signaling from
increasing concentration but diminishing EGF gradient fields.

Data from the current study highlights the high fraction of motile MB in response to high
concentration gradients of EGF. These results have high clinical interpretation, as they point to
high gradient fields and low concentration fields as optimal for MB migration. This is an in vivo
scenario where paracrine signaling from neighboring cells initiate the most MB migration, such
that cell displacement diminishes as cells approach the signaling source, where gradients are low,
and concentration is high. In addition, our findings may aid clinical development of anti-
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migratory therapeutics with the potential to inhibit MB metastasis along the spinal column via
EGF signaling.

2.6. Conclusion
In summary, our results illustrate that MB migration is both concentration and concentration
gradient-dependent in response to EGF signaling. Further, our findings illustrate that high
gradient fields of EGF result in the largest number of motile cells which travel long distances and
in a highly directional manner towards decreasing EGF gradients. These findings point to EGF
as a viable molecule for migration-targeted therapies for MB.
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Tables:
Table 1: Average number of MB-derived cells that migrated in transwell assays toward
different concentrations of examined growth factors. Values were experimentally measured
and are shown with mean and standard deviation. (*) denotes growth factor concentrations
not measured in the current study.
Growth

0 ng/mL

1 ng/mL

10 ng/mL

100 ng/mL

1000 ng/mL

Factors

[Mean ± SD cells]

[Mean ± SD cells]

[Mean ± SD cells]

[Mean ± SD cells]

[Mean ± SD cells]

EGF

102 ± 5

*

156 ± 5

212 ± 7

174 ± 5

SDF-1

60 ± 2

67 ± 6

69 ± 14

72 ± 5

74 ± 4

HGF

99 ± 5

126 ± 10

160 ±13

122 ± 7

*

PDGF-BB

82 ± 5

83 ± 5

93 ± 8

100 ± 5

*

Table 2: Migratory parameters of MB-derived cells along the µLane system in response to
concentration gradients generated by 100ng/mL of EGF and 100 ng/mL of SDF-1,
respectively. Values were experimentally measured and are shown as percentages, means
and standard deviations. (ncells ~180 cells for each ligand).
Migration Parameters

EGF

SDF-1

Fraction of motile cells (f) [%]

72.8%

67.3%

Cell Directionality (D) [%]

61.6%

44.2%

264.5 ± 67.9 µm

125.5 ± 48.6 µm

Average Maximum Cell Path
Length (PL) in µm [Mean ± SD]
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Table 3: Migratory parameters of MB-derived cells in response to gradient fields, G1-G5,
generated by of 100ng/mL of EGF or SDF-1 along the µLane system. Fraction (f) and
directionality (D) of motile cells shown as percentages of total cell number. Average
maximum cell path lengths (PL) shown with mean and standard deviation. (ncells ~ 180 cells
for each ligand).
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Supplemental Figure:

Figure 9: EGF-R activation levels on MB migration. The EGF-R expression measured after
EGF stimulation (100 ng/mL) for 14, 22, 36, and 42 hours. The expression of receptor was
normalized to basal control levels (0 ng/mL of EGF) at t=0. (*) indicates statistically significant
data with p-values <0.05.
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3. Controlled Microfluidics to Examine Growth-Factor induced
Migration of Neural Progenitors in the Drosophila Visual System
(PMID 26738658)
3.1. Chapter Summary
The developing visual system in Drosophila Melanogaster provides an excellent model with
which to examine the effects of changing microenvironments on neural cell migration via
microfluidics, because the combined experimental system enables direct genetic manipulation, in
vivo observation, and in vitro imaging of cells, post-embryo. Exogenous signaling from ligands
such as Fibroblast Growth Factor (FGF) are well-known to control glia differentiation, cell
migration, and axonal wrapping central to vision. The current study employs a microfluidic
device to examine how controlled concentration gradient fields of FGF are able to regulate the
migration of vision-critical glia cells with and without cellular contact with neuronal progenitors.
Our findings quantitatively illustrate a concentration-gradient dependent chemotaxis toward
FGF, and further demonstrate that glia require collective and coordinated neuronal locomotion to
achieve directionality, sustain motility, and propagate long cell distances in the visual system.
Microfluidic

systems

in

combination

with

a

genetically-amenable

experimental

system

empowers researchers to dissect the signaling pathways that underlie cellular migration during
nervous system development. Our findings illustrate the need for coordinated neuron-glia
migration in the Drosophila visual system, as only glia within heterogeneous populations
exhibited increasing motility along distances that increased with increasing FGF concentration.
Such coordinated migration and chemotactic dependence can be manipulated for potential
therapeutic avenues for NS repair and/or disease treatment.
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Keywords
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3.2. Introduction
Neuronal-glia interactions are critical for the development and function of the nervous system
(NS) of both vertebrates and invertebrates. Glia and neurons are well-known to migrate to
specific target locations during NS development, but the molecular signals that orchestrate this
migration remain incompletely understood. While concentration gradients of a variety of growth
factors are well-known to determine the positioning and fate of embryonic stem cells

202-204 ,

the

gradients that mediate the coordinated migration of cells of neuronal-glial lineage are largely
unexplored. An understanding of the mechanisms that regulate such coordinated neuronal-glia
migration may provide insights into possible therapeutic approaches for the myriad of
neurological diseases caused by aberrant migration (e.g. lissencephaly, polymicrogyria, gliomas),
as well as advance potential regenerative strategies to aid in NS repair.

Neurological study has increasingly embraced microfluidics-based technologies, with numerous
systems used to examine varied aspects of embryogenesis
and intracellular synaptic activity

207-209 ,

among others

205 ,

210, 211 .

neural regeneration and growth

206

Previous work from our group has

developed microdevices to analyze NS behaviors in response to controlled environments
generated without the use of forced flow

101, 174, 212, 213 .

Such a system is distinctive for study of

NS cell migration, as the external pumps and micro-valving routinely used to stream biochemical
agents in many existing devices are well-known to alter the responses of cells unaccustomed to
physiological flow

182, 214 .

The developing visual system in Drosophila Melanogaster provides an

excellent model with which to examine neuronal-glial migration via microfluidics, as the
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combined experimental system enables direct genetic manipulation, in vivo observation, and in
vitro imaging of cells, post-embryo.

During the development of the Drosophila visual system, retinal basal glia (RBG) are generated
in the developing brain and migrate into the developing eye imaginal disc. The RBG have been
implicated in the targeting of the photoreceptor cell axons to the optic ganglia. While the genes
involved and the cellular interactions regulating the development of the photoreceptor R-cells
and RBG have been well studied for Drosophila, the environmental cues that initiate the
coordinated
understood

and/or collective migration of these vision-critical cells remain incompletely
215, 216 .

Genetic studies have illustrated that conserved signaling pathways, such as

Notch-Delta, Epidermal growth factor receptor (EGFR) and Fibroblast Growth Factor Receptor
(FGFR), are central to cell fate specification and pattern formation in the developing visual
system

217, 218 .

RBG migration

In particular, our group has demonstrated that Notch loss of function disrupts
218 ,

while exogenous EGF signaling has been shown to activate long-distance

migration of retinal progenitor cells

170 .

In addition, FGF ligands are known to control glia

differentiation, migration, and axonal wrapping central to vision

219, 220 .

FGF signaling molecules

are believed to be produced at a localized source and then dispersed into targeted tissue. This
dispersion occurs via the transient formation of concentration gradients that then dictate the
expression of different genes to lead to tissue patterning and morphogenesis

221 .

In the present study, we examined the extent to which FGF concentration profiles and gradients
play a role in regulating critical neuronal-glia migration during development of the visual
system. We employed microfluidics to investigate the chemotaxis of RBG cells derived from the
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third larval instar stage of Drosophila Melanogaster. Our results are among the first to illustrate
that RBG exhibit concentration-gradient dependent chemotaxis to FGF signaling, and more
significantly, these glial cells require coordinated and/or collective neuronal locomotion to
achieve directionality, sustain motility and advance large migration distances.

These results

highlight the importance of coordinated migration between neuronal-glial cells in the developing
visual system, as well as reinforce the advantages of microfluidics-based systems for the study of
integrated neural cell response.
3.3. Materials and Methods
3.3.1. Drosophila Stock, Neural Cell Dissociation, Culture and Viability
Drosophila were cultured on the standard corn meal agar medium and reared at 23° C. To
specifically label and mark glia with GFP we used the GAL4-UAS system

222 .

Briefly, repo-

Gal4/Tb flies were crossed to UAS-GFP flies and the larvae form the progeny of the genotype
repo-Gal4; UAS-GFP were used for all series of experiments in this study. Flies of this stock
express GFP+ glial cells that then fluoresce green in the visual system. Flies were mated for 3
days, and subsequent F1 offspring produced 12 days later were dissected in the 3 rd instar larvae
stage. The procedure for culturing glia was adapted from a widely-accepted method established
to culture neural cells from Drosophila larvae

223 .

In brief, third instar larvae were surface

sterilized with 70% ethanol and placed in PBS (Mediatech Inc., Herndon, VA). Brain complexes
were then dissected out using fine #5 stainless steel tweezers and placed in a solution of 0.5
mg/mL collagenase (Gibco, Grand Island, NY) in phosphate buffered saline (PBS). Brain tissue
was then finely chopped, covered and incubated at 25C room temperature for 1 hour with slight
manual agitation. The cell suspension was then centrifuged and re-suspended in culture medium
consisting of 90% revised Schneider’s Drosophila medium (Lonza, Walkersville, MD) and 10%
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heat-inactivated FBS (Mediatech Inc., Manassas, VA) with 50 mg/mL penicillin (Mediatech
Inc.) and 50 μg/mL streptomycin sulfate (Mediatech Inc.), as shown in Figure 10. Cells were
incubated at room temperature at atmospheric CO2 levels. The brain complexes of 50-75 files
were used per experimental condition. Cells were cultured for 5-6 days and examined via MTT
assay to verify >93% viability prior to experiments.

Figure 10: Derivation of Drosophila-derived neural cell populations. (A) Illustration of
GAL4-UAS system. Repo-Gal4 flies are mated with UAS-GFP. Offspring express GFP in glia
only. Drosophila were bred and grown in house and brain complexes of those in the larva stage
were extracted for cell testing. (B) Confocal image of Drosophila whole brain complex,
confirming presence of GFP+ glial cells.

3.3.2. Fluorescent Activated Cell Sorting (FACS)
Experiments were performed using glia from two groups of cells extracted from the drosophila
NS and sorted via FACS: (A) A heterogeneous neural cell population derived from dissociated
brain complexes, which contained cells of both neural and glial lineages; and (B) A homogenous
population of GFP+ cells of glial lineage, only. FACS was performed using a BD FACS Aria II
(BD Biosciences, San Jose CA) with accompanying FACS Diva 6.1.3 software (BD Biosciences,
San Jose CA). A 488-nm wavelength laser through a 530/30 filter was used to detect fluorescent
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signature of GFP (541 nm). The 633 nm laser through a 660/20 filter was used to detect To-pro-3
Iodide. 10 μL of To-pro-3 Iodide (Invitrogen, Eugene OR) at 25 μg/mL was added to the sample
and incubated for 15 minutes.
3.3.3. µLane Microfluidic System
Experiments used our established microfluidic system, called the bridged μLane, whose design
and operation has been described previously in greater detail

101, 140, 174, 212 .

As shown in Figure

11, the system is fabricated via elastomeric molding of two layers of conventionally-used Poly
dimethyl siloxane (PDMS,) that are bonded to one another, and to a boron silicate glass
microscope slide. The first layer includes a 150-μm diameter by 15-mm long microchannel, as
well as a source and sink reservoir, which have volumes of 9-μL each. The second layer consists
of 170-μL source and sink chambers, and a larger hemispherical bridge channel connecting them.
During operation, the biochemical agent of interest, in this case FGF, is inserted into the source
chamber, while the remainder of the system is filled with PBS or media. The bridge channel is
filled with media last, as its function is to precisely balances the liquid levels in the source and
sink chambers to minimize the hydrostatic pressure difference between them
FGF via so-called convective diffusion

223-225

101 .

Transport of

then establishes a concentration gradient between

the source and the sink reservoir that spans several orders of magnitude. This distribution of FGF
concentration can be maintained for several days and is modeled computationally and verified
experimentally. Concentrations of 10-ng/mL, 100-ng/mL, and 1000-ng/mL of FGF were used to
generate concentration profiles for testing of cell migration within the µLane. For control
experiments, media was added into the

Lane system in lieu of FGF.
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Figure 11: Description of Bridged µLane System. A) Schematic of microfluidic system used
in the current study. The reservoirs hold a 9µl volume and both chambers hold a 170 µl volume
each. Images of Lane system B) First layer of PDMS: Two reservoirs connected by a 15-mmlong microchannel C) Second layer of PDMS: Sink and source chambers connected by a bridged
channel D) GFP+ glial cells within the microchannel at 0, 24, and 48 hrs, respectively E) FGF
distribution within laminin-coated μLane system, predicted analytically and measured
experimentally. Experimental data confirms that a steady-state FGF distribution occurs within
the entire length of the channel before 24 hours.

To mimic concentrated biological ECM microenvironments in the NS

142, 226-228 ,

μLane systems

were filled with 50μg/mL of Laminin (BD Biosciences, Bedford, MA, Cat. No. 354232) and
incubated at 37 C for 1 hour. The source of laminin is from Engelbreth-Holm-Swarm murine
sarcoma basement membrane. Broadie et. al describe the breakdown of the Drosophila ECM
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molecules specifically two well conserved laminins, Laminin A and a minor Laminin W both
sharing common β and γ chains with distinct α, with different tissue distributions
was allowed to gel within the

229 .

Laminin

Lane for 1 hour at room temperature to generate 2D

microenvironments. Laminin was then aspirated from the channel interstitial spaces leaving the
protein adhered to the channel surfaces, only. During experiments, the microchannel, sink
reservoir, sink chamber, and bridge channel were first filled with PBS solution. As performed
previously by our group, fluorescently-labeled FITC-Dextran (20 kDa, Sigma-Aldrich, St. Louis,
MO, Cat. No. FD20S-100MG) was used to model FGF-8 due to similar molecular weight. For
2D experiments, Dextran at a concentration of 40μg/mL was added drop wise to the source
chamber until the reagent made contact with the PBS in the bridge channel, initiating the
experimental system.
Two-dimensional numerical simulations of the bridged μLane system were performed in order to
model the transport within the entire microsystem, i.e. the microchannel, both the SRR and SKR
reservoirs in the 1st layer PDMS, the bridge channel, and both the SRC and SKC chambers in the
2nd layer PDMS. The mass transport within the entire microsystem was modeled using the 2-D
continuity

equation,

convective-diffusion

equation,

momentum

equation,

and

hydrostatic

equation, as described previously in detail by our group. Free solution diffusivities and effective
diffusivities of growth factor proteins were determined in the microsystem by modeling the
transport within the system microchannel using convective-diffusion, shown below
𝝏𝑪
𝝏𝒕

𝝏𝑪

+ 𝑽𝑩 𝝏𝔁 = 𝘿

𝝏²𝑪
𝝏𝔁²

181 :

(1)

Where C (μg/mL) is concentration, t (s) is time, D (m2 /s) is diffusivity, VB (m/s) is bulk velocity,
and x (m) is position. The time-evolving solution to this equation was modeled computationally
via finite-element-analysis (FEM) in Matlab 7.7 (MathWorks, Natick, MA). The boundary
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conditions fixed the source reservoir (X0 =0) at 40 μg/mL and the sink reservoir (XL=15mm) at 0
μg/mL for all experimental times. The system initial condition was set such that the
concentration along the entire length of the microchannel was 0 μg/mL at t=0. In order to
determine bulk flow velocity, VB, 1.9-μm-diameter fluorescent beads (Duke Scientific, Palo
Alto, CA, Cat. No. G0200) were injected in the system and visualized via fluorescence
microscopy, as done previously. Note that Equation 1 reduces to Fickian diffusion in the absence
of convective flow.
3.3.4. Well Plates
Experiments utilized 96 well plates (Corning Inc., Corning, NY) coated with Laminin as
described above, and 100-μL of cell solutions per well to image migration of both cell
populations to defined concentrations of FGF. Concentrations of 1-ng/mL, 10-ng/mL, and 100ng/mL of FGF were used for testing, while no FGF was used for controls.
3.3.5. Microscopy and Imaging
Dissected eye brain complexes from larvae were cleaned and mounted with Vectashield medium
(Vector Laboratories, Burlingame, CA). Images were taken with a Zeiss CLSM-510 (Zeiss, Jena,
Germany) and a 40X objective. An argon laser with excitation of 488 nm was used activate the
GFP+ cells. Images were obtained as Z-stacks and processed with LSM software, which
converted the Z stacks to a projection. Imaging within the

Lane system was performed using a

Nikon TE2000 inverted microscope with a 20x objective and a cooled CCD camera (CoolSNAP
EZ, Photometrics, Tucson, AZ) with Nikon software (Nikon Instrument Element 2.30 with 6D
module, Morrell Instrument Company Inc., Melville, NY).
Fluorescent images of the μLane were taken every hour for 72 hours at the points
x=4mm, x=8mm, and x=12mm, where the origin was defined as the point where the source
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reservoir abutted the microchannel. Imaging was performed using a Nikon TE2000 inverted
microscope with a 20x objective and a cooled CCD camera (CoolSNAP EZ, Photometrics,
Tucson, AZ) with Nikon software (Nikon Instrument Element 2.30 with 6D module, Morrell
Instrument Company Inc., Melville, NY).
3.3.6. Data Analysis and Statistics
Data were analyzed using the Chemotaxis and Migration Tool (Ibidi, Verona, WI) in ImageJ
(NIH). Cells were individually tracked using the manual tracking plug-in. Cell trajectories were
plotted, along with accumulated distance and motility. In addition, the Chemotactic index, CI,
was used as the measure of directed cell migration, as defined in Equation 2 169 :

(2)
Where x is distance toward gradient and d is total accumulated distance. Values approach 1 as
cells move more directly toward the gradient, are negative for cells moving away from the
gradient. CI approaches zero in the absence of a gradient.

3.3.7. Statistical Analysis
Statistical significance between groups was evaluated using a student’s t-test. In the gradient
experiments, the Raleigh test was used to assess uniformity of the cell distribution.
3.4. Results
This study examined how the chemical cues from the microenvironment influence coordinated
migration of cells of glial and neuronal lineages. In general, during Drosophila neural
development glia have been shown to provide both attractive and repulsive guidance cues to NS
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neurons as well as require their associated axons for trophic support. Parker and Auld

230

have

shown specifically that the midline glia are crucial for the proper formation of horizontal
commissural axon tracts in the Drosophila CNS. In a review by Lemke

231 ,

reciprocal

interactions between differentiating glial cells and neurons define the course of nervous system
development even before the point at which these two cell types become definitively
recognizable. Glial cells control the survival of associated neurons in both Drosophila and
mammals, but this control is dependent on the prior neuronal triggering of glial cell fate
commitment and trophic factor expression. The first set of experiments used FACS to generate
two groups of cells from the drosophila CNS: (A) A heterogeneous population derived from
dissociated brain complexes, which contained cells of both neural and glial lineages; and (B) A
homogenous population of GFP+ cells of glial lineage, only. As seen in Figure 12, Drosophila
brain complexes are imaged after utilizing the Gap4-Repo system to genetically introduce GFP+
glia into live Drosophila. As shown, glia are seen to migrate from the optic stalk (~250 microns
in cross-section) to prescribed locations in the eye upon being ushered by concentration gradients
of key growth factors

220 .

These eye complexes were then removed and FACS sorted for GFP+

glia, as seen in Figure 13. Here, analysis of FACS revealed less than 10% of the viable cells
derived from larvae NS presented as GFP+ glia, requiring increased sample sizes to ensure that
both the heterogeneous and homogeneous populations retained recovery of 10 5 cells for each
experimental test. Furthermore, viability tests were performed on all FACS sorted populations to
ensure that live cells (>90%) were used for migration testing.
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Figure 12: Derivation of Drosophila-derived neural cell populations. Drosophila larvae.
Panel (A) shows an early third instar developing eye imaginal disc attached to the brain lobe.
Arrow points to the glia migrating from the brain through the optic stalk into the developing eye.
Panel (B) shows a late third instar eye imaginal disc with glia migration in to the eye disc
complete. The glia migrate and stop at the Morphogenetic Furrow (MF) [Arrow]. Ahead of the
MF dividing undifferentiated cells can be seen labeled with the mitotic marker, anti- PhosphoHistone 3 antibody. The developing photoreceptors are not labeled.

Figure 13: Selection of homogeneous and heterogeneous neural cell samples. FACS analysis
of cells derived from brain tissue of third instar larvae drosophila. A) A four-quadrant
distribution (Q1-Q4) of cells stained with a To-pro-3 Iodide as a viability marker (APC-A)
against a GFP signature (FITC-A). Cells in Q3 and Q4 are considered viable cells, while cells in
Q2 and Q4 are denoted as GFP positive. Points in Q4 represent cells that are both alive and GFP
positive. B) A representative FACS sorting for cells that are GFP positive/negative only. Points
denoted in P3 denote cells that are GFP+.
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Once cell samples were sorted into two populations, their migratory responses to exogenous FGF
signaling at different concentrations were examined using 96 well plates. As seen in Figure 14,
glia from homogeneous populations migrated less than 20 microns in response to increasing FGF
concentrations of 1-, 10-, and 100-ng/mL. By contrast, glia of heterogeneous populations
migrated steadily larger distances of up to 3-fold higher than that of homogeneous glia when
exposed to the same FGF concentration fields. Furthermore, Figure 14 illustrates that migration
of glia from both populations was non-directional and radially semi-uniform within each plate at
all concentrations examined. In addition, experiments measured the average accumulated
distances traveled and average motilities of glia from both the heterogeneous and homogeneous
populations when exposed to different concentrations of FGF, shown in Figure 15. As seen, glia
from heterogeneous populations migrated statistically-significant larger distances in response to
increasing FGF concentrations and demonstrated increased average motilities in response to
signaling from increasing concentrations of FGF. By contrast, populations of homogeneous glia
illustrated no statistically-significant differences in migration distances or average motilities in
response to signaling from increasing FGF concentrations.
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Figure 14: Trajectories of homogeneous (sorted) and heterogeneous (unsorted) neural cell
samples in response to FGF signaling. Plots illustrate representative trajectories from cells of
homogenous population exposed to (A1) media only (control), (A2) 1-ng/ml (A2) 10-ng/ml and
(A3) 100ng/ml of FGF.
Plots of representative trajectories of cells from heterogeneous
populations of (B1) media only (control), (B2) 1-ng/ml (B2) 10-ng/ml and (A3) 100ng/ml of
FGF. Each plot contains 10 paths, and each path contains 1 data point every 2 hours for 48
hours. Concentrations shown are uniform; 10 cells were tracked for each concentration.

The final set of experiments used the

Lane system to examine migratory responses from glia of

both homogenous and heterogeneous cell populations to signaling from defined concentration
gradients of FGF. Here, the molecular transport within the microchannel was, first, validated
experimentally to characterize the concentration distribution within the system. Bulk flow within
the system was examined using fluorescent beads with and without the use of the bridge channel,
as described previously

101 .

Beads were seen to migrate with different velocities in the

microsystem with and without the bridge channel. An average bulk velocity of V avg=92.3±1.4
µm/s was measured within the µLane system in the absence of the bridge channel (n=12
channels), but an average velocity of Vavg=0.27±0.06 µm/s was measured within the bridged
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µLane system (n=16 channels).

In addition, no bulk flow was measured within the bridge

channel when beads were used, confirming that transport within the bridge was diffusiondominated

and

did

not significantly affect transport within the microchannel nor alter

concentrations of the large volume SRC and SKC chambers over experimental time scales of up
to 72 hours.

Figure 15: Accumulated distances and motilities of heterogeneous and homogeneous neural
cell populations. (A) Average accumulated distance traveled and (B) Average motility of cells
from both populations. Values reported are mean with error bars (+/-) standard deviation. An *
Indicates p<0.05 compared to the control.

The spatial and temporal patterns of FGF profiles generated within this system were rigorously
analyzed by solving the convective–diffusion flux between the system reservoirs and channels,
exactly. As seen in Figure 11, the

Lane was able to generate multiple concentration gradient

fields within one experimental setting. The spatial distribution of ligand within the microsystem
generated a wide range of gradients along the 12-mm-long channel length that were sustained for
5-7 days. Here, some gradient fields were generated via small changes in absolute concentration
of attractant, and were therefore shallow and approximately linear, while other gradient fields

212

were created via much greater changes in attractant concentration, and were thus steeper and
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highly non-linear. Lastly, as seen in Figure 11, the experimentally-obtained data were within 2%
of the analytically-predicted value.

With a validated

Lane system, heterogeneous and homogenous populations of neural-derived

cells were then inserted into the

Lane to examine glia viability, morphology and migration in

response to different concentration gradients of FGF. Raw data images illustrate that glia do not
modify their rounded morphology within any portion of the channel when exposed to varied FGF
concentrations and gradients. Further, continued GFP expression from glia denoted that cells
remained viable throughout the experimental test period of 72 hours. Figure 16 illustrates
sample trajectories of glia derived from both homogenous and heterogeneous populations in
response to signaling from different concentration gradient fields of FGF.
homogeneous

samples

did

not

exhibit

statistically-significant

As seen, glia from

differences

in

accumulated

distance or motility, with values of each remaining approximately constant for the different FGF
profiles studied. By contrast, the trajectories of glia from heterogeneous populations illustrate
that cells increased their migration distance up to 6-fold when responding to concentration
gradients of increasing FGF concentration. Further, glia from heterogeneous populations
illustrated optimal CI values at gradient fields of intermediate FGF concentration of 10-ng/ml.
Lastly, average motility of these cells was seen to increase in a statistically significant manner in
response to gradient fields of increasing FGF concentration.
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Figure 16: Migration of heterogeneous cell populations to concentration gradients of FGF.
A) Plot of cell trajectories normalized to the origin. Each plot contains 10 trajectories generated
using data points gathered every 2 hours. Gradient increases from left to right as indicated by the
arrows. Each line on the grid is 20 microns. B) Values of chemotactic index for all experimental
conditions. C) Values of average motility for all experimental conditions. Reported values are
mean data with standard deviation error bars. An * indicates p<0.05 compared to control.

3.5. Discussion
Coordinated neuronal-glia interactions are known to be critical for the development, function and
response of the visual system. Yet, how the collective but finely-tuned migration of these cell
populations is regulated by their microenvironment remains incompletely understood. Results of
the current study illustrated distinct migratory behaviors between homogenous populations of
glia, and glia from heterogeneous populations containing cells of both glial and neuronal
lineages. Using conventional well technology, glia of the homogeneous populations were seen to
migrate radially, and with constant motility and distance independent of the FGF concentration
used. By contrast, glia within heterogeneous populations exhibited increasing motility along
migration distances that increased with increasing FGF concentration. We propose that these
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differences can be attributed to glia-neuronal interactions that are absent in the homogeneous
glial population. We note that while FACS is known to influence cell viability

232-234

glia from

both populations expressed comparable intensity levels of GFP and their migration remained
constant over multiple experiments for several days.

Our migration data is significant because

RBG glia were initially only believed able to migrate into the eye disk via physical mechanisms
of haptotaxis, i.e. crawling along a substrate

235, 236 .

However, more recent work suggested

abilities of RBG to migrate towards differentiating photoreceptors without using a continuous
physical substratum

216 .

The data from our study support this later phenomenon, which point to

short-range diffusible signals as regulators of RBG-neuron interactions,

in addition to

hypothesized contact-mediated processes that require physical interactions between cell types.
Such neuronal-glia coordinated migration has been previously unstudied, and points to the
importance of examining so-called collective migration

237-241

for potential therapeutic avenues

for NS repair and/or disease treatment.

We next utilized a microfluidics system, the

Lane, to examine the migration of RBG in the

presence of defined concentration gradients of FGF.

While traditional benchtop technologies

such as Boyden chambers and agarose assays have contributed greatly towards identifying
combinations of cytokines that generate directed cell movement (Reviewed in

242-245 ),

these

systems cannot be used to measure mechanistic parameters of migration, such as motility and
directionality. By contrast, our quantitative and tunable

Lane system empowers researchers to

examine the migration of cell populations as a function of the ligand(s), concentration(s), and
concentration gradient field(s) used.

While it is well-established that no in vitro system can

physiologically replace the in vivo environment, microfluidics offer unique advantages of
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biological scale that enable closer approximation to in vivo conditions. For instance, the

Lane

device creates a microenvironment for RBG that is 100um in diameter, which approaches
dimensions of the in vivo optic stalk

246 .

This creates an experimental test system where cells

experience diffusible signals, matrix interactions, and cell to cell contacts on physiological
scales. Thus, in this work, we used FGF as a diffusible signal because of its well-established role
220 ,

in signaling transduction critical to eye development
in the developing visual system of Drosophila

142 ,

laminin as ECM because it is ubiquitous

and neuronal-glia cell densities that approach

physiological numbers based on in vivo spacing and dimensions

Using FGF as a model cytokine in this work, the

106 .

Lane was able to generate multiple

concentration gradient fields within one experimental setting that were sustained for 5-7 days.
This exploits the analytical nature of microfluidic devices as the

Lane can examine which

ranges of concentration and gradient (i.e. concentration distribution over specified distances)
stimulate migratory responses from cells. Such a tunable system facilitated the experimental
tracking of 25–50 distinct cells for each FGF gradient field. Three different concentrations of
FGF were used to generate gradient fields within the

Lane. Glia of the homogenous population

were not observed to migrate appreciable distances (less than 1 cell diameter) in our system,
although cells remained viable within the device for several days as evidenced by their GFP
expression and unchanged morphology. Amazingly, glial cells of the heterogeneous population
were seen to migrate in highly directed trajectories along increasing FGF gradient, and with
increasing motility. These results point to an obvious chemotactic dependence on FGF
concentration gradient, as cell trajectories and distances traveled were much larger for cells
exposed to signaling from FGF gradient fields than from concentration alone. Our results further
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underscore the presence and significance of coordinated neuronal-glia migration in the
development of the Drosophila visual system. Cells of the homogeneous glial population did not
exhibit measurable movement, while glia of the heterogeneous population illustrated directed
migration within gradient fields, as well as sensitivity to specific FGF concentration. These data
underscore the impact of the coordinated migration of neuronal-glia cells requisite for
development of the visual system.

3.6. Conclusion
Our studies presented here illustrate the efficacy and power of microfluidic systems in
combination with a genetically amenable experimental system to dissect the signaling pathways
that underlie cellular migration during nervous system development. Taken together, these
findings illustrate the significance of the coordinated neuron-glia interaction for migration in the
development of the Drosophila visual system. Our results show that glia within heterogeneous
populations

exhibited

increasing

motility

along

migration

distances

that

increased

with

increasing FGF concentration. Such coordinated migration and chemotactic dependence of these
cells can be manipulated for potential therapeutic avenues for NS repair and/or disease treatment.
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4. Neurons Enhance Schwann Cell Migration in a Microfluidic
Device
4.1. Chapter Summary
Schwann cells (SCs) are the primary glial cells of the peripheral nervous system (PNS) where
they play a vital role in maintenance

6,

repair, and regeneration of neuromuscular junctions

(NMJs). They migrate along outgrowing axons and associate with axons along their entire length
prior to ensheathment or myelination. How axonal growth and the migration of Schwann cells
are coordinated at the level of neuron-glial signaling is the fascinating subject of ongoing
research. Literature has shown chemoattraction of glial cells towards neurotrophic factors. But
neurotrophin signaling still remains very complex because it is involved in mechanisms as
distinct as the regulation of cell migration, cell proliferation, cell survival, and chemotaxis
248 .

125, 247,

Various neurotrophins and neurotrophic factors have been implicated to play key roles in the

regeneration of damaged axons, but the distinct roles played by neurons and SCs are unclear. In
this study, we evaluated adult S42 SC chemotactic migration towards a panel of growth factors
with varying concentrations to elucidate a key chemoattractant for SC-MN (motor neuron) cocultures. Additionally, we utilized a microfluidic system, the Lane system, to provide highly
controlled chemical environments in order to quantify migratory patterns in SC-MN co-cultures.
As well as highlight two different seeding mechanisms and its’ effect on neuron-glia
relationship.

Keywords
Schwann cells; Neurons; Microfluidics; Cell migration; BDNF
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4.2. Introduction
The complex interplay between glia and neurons is essential for the development and function of
the nervous system. Schwann cells (SCs) are the myelinating glia of the peripheral nervous
system (PNS) that originate during development from the highly motile neural crest 125 and
ensheath peripheral nerve axons to help propagate action potentials. SCs are also present at the
synapse between motor neurons (MNs) and skeletal muscle fibers. SCs cap the nerve terminal.
The terminal capping SCs are non-myelinating and are known as the perisynaptic SCs (PSCs).
This three-cell structure is known as the neuromuscular junction (NMJ), as shown in Figure 17,
which is also the chemical synapse responsible for converting action potentials into muscle
contraction.

Figure 17: Illustration of the Neuromuscular Junction (NMJ). This schematic shows two of
the three primary NMJ cellular components and their positioning with respect to the synapse.
Schwann cells (SCs, green) are seen to myelinate the axon and cap the end of the Motor Neuron
(MNs, yellow) whose motor terminals comprise the pre-synaptic bulb of the NMJ.
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SC proliferation, migration, and myelination are controlled by signals released from neurons in
the form of neurotrophins, a family of growth factors initially found to be critical for neuronal
survival, development, and outgrowth in both central and peripheral nervous systems

249 .

Neurotrophins have been implicated recently as key factors involved in SC development

250 .

Although, the effects of neurotrophins on survival and differentiation of various neuronal
populations have been well studied, little is known about their role in synaptic development,
function

251 , guidance

signals, and migration for SCs, especially during nerve repair.

In peripheral nerve injury, neurotrophins and neurotrophic factors play a key role in the
regeneration of damaged axons but the distinct roles played by neurons and SCs are unclear
252 .

Peripheral nerve injuries occur as a result of sudden trauma and can lead to loss of sensory

and motor function to peripheral limbs. Peripheral nerve injury affects up to 2.8% of trauma
patients and leads to high rates of morbidity and healthcare expenditure

253, 254 .

Injured peripheral axons have a certain degree of capacity for axonal regrowth, but the
regenerative process is slow and generally functional recovery is very poor and far from
satisfactory

252, 255 .

One reason for decreased regeneration could be due to a decline in

neurotrophic support in tissue surrounding the regenerating axons over time (reviewed in

256 ).

To

facilitate regeneration, treatment approaches have included manipulation of neurotrophins. In
particular, brain derived neurotrophic factor (BDNF) has been shown to be important in the
growth of regenerating axons into peripheral nerve grafts

257, 258.
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Cell migration is a complex phenomenon. Cells need to re-arrange their cytoskeleton, become
polarized if responding to a guidance molecule; make adequate plasma membrane protrusions;
and simultaneously generate traction and retraction of the cell body

125, 259, 260 .

Literature has

shown chemoattraction of glial cells towards neurotrophic factors, but neurotrophin signaling
still remains very complex because it is involved in mechanisms as distinct as the regulation of
cell migration, cell proliferation, cell survival, and chemotaxis

247, 248, 261.

BDNF can be produced and secreted by Schwann cells (SCs) following peripheral nerve
injury. An elevated level of BDNF prevents neuronal death, enhances neuronal activity, and
promotes axon growth

262-264 .

Inversely, a reduced level of BDNF retards neurite elongation

and inhibits axon regrowth and remyelination

252, 257, 258 .

Obviously, BDNF plays important

roles in peripheral nerve development and regeneration. Although it is still not clear which cell
type produces BDNF or how it is being transported. Alternatively, BDNF has been shown to
enhance myelination in SCs through p75 NT R and to subsequently inhibit migration through the
RhoA/Rho kinase pathway

265-267.

Recently BDNF has also been implicated to play an important role in the pathophysiology of
many neurodegenerative disorders

268 .

Clinical use of exogenous BDNF, however, is limited by

its short half-life, potential side effects, and delivery problems such that systems can provide
sustainable growth factor concentrations over time

255, 269, 270 .

As well as, limited studies in

research exploiting how these concentrations gradients affect adult SCs, in controlled
microfluidic

environments.

Therefore,

searching

for

an

effective

strategy

for

clinical

application of BDNF has become an interesting topic in recent years. In this work, we aimed to
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identify adult S42 SC chemotactic migration towards a panel of growth factors including BDNF,
Glial-cell derived neurotrophic factor (GDNF), Ciliary neurotrophic factor (CNTF) epidermal
growth factor (EGF), and stromal derived factor-1 (SDF-1), known to stimulate migration. As
well as utilize a microfluidic platform to quantify collective response of SC-MN co-cultures and
to subsequently deduce S42 SC chemotaxis parameters. Two distinct seeding protocols were
tested to infer upon series (time-dependent) versus parallel (mixed population) effects on cocultures. We demonstrated that BDNF has a dose-dependent response on adult S42 SC
migration. Additionally, our microfluidic studies highlight that adult S42 SCs, in the series
condition, traversed longer distances within the μLane system in the presence of BDNF versus
no BDNF. This was also true when compared to the parallel conditions in the presence of BDNF.

4.3. Materials and methods
4.3.1. Cell Culture
S42 Schwann cell (S42, ATCC CRL-2942) and B35 motor neurons (B35, ATCC CRL-2754)
were thawed, plated, and cultured in sterile Dulbecco’s Modified Eagle Medium (DMEM,
ATCC Cat. No. 30-2002) containing 10% fetal bovine serum, and 1% penicillin-streptomycin
(Gibco Cat. No. 15070063). Before passaging, B35 cultures were rinsed with 0.05% trypsin
(Gibco Cat. No. 25300) for 4 min at 37 ºC and centrifuged at 200Xg for 4 min. Cells were
cultured (37 ºC, 95% humidity, 5% CO2) and passaged (80-90% confluency) on sterile tissue
culture treated flasks. Similarly, S42 cells were thawed and plated as stated in the above culture
conditions for B35 cells but were plated on culture flasks treated with 15 ug/mL poly-L-lysine
(Sigma Cat. No. P-9155) for at least 2 hours at 37 ºC. Before using the flasks, poly-L-lysine
solution was removed, flask was rinsed once with DPBS and allowed to air dry, uncapped, in an
upright position in a biological cabinet for 30 min before introducing cells.
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Cell proliferation medium was changed every 2 days and cultures were allowed to reach 80%
confluency before harvesting for use in the μLane system. Prior to microchannel seeding, B35
motor neurons and S42 Schwann cells were stained with CytoTracker Green (Thermo Fisher
Scientific Cat. No. C7025) at a concentration of 15M and CytoTracker Red (Thermo Fisher
Scientific Cat. No. C34552) at a concentration of 10M respectively.

4.3.2. Cell Migration Assay & Quantification
The Boyden chamber assay

140, 174

was used to measure the number of S42 Schwann cells that

migrated towards different concentrations of brain derived neurotrophic factor (BDNF, SigmaAldrich, B3795-10UG). This widely-used assay consists of two compartments filled with
DMEM medium and separated by an 8 micron-porous (polyethylene terephthalate (PET)
membranes, tissue culture treated) transwell (VWR, Cat. No.62406-198). S42 cells were seeded
in the apical compartment and were allowed to migrate through the porous membrane into the
basolateral compartment overnight at 37 ºC in a 5% CO2 incubator. Approximately 5x10 4
cells/mL were seeded in 300 μL of DMEM complete medium in the apical compartment, while
700 μL of serum-free medium was pipetted into the basolateral compartment for control samples.
Basolateral compartments also contained concentrations of 10, 100, and 200 ng/mL of BDNF in
serum-free DMEM.

After overnight incubation, excess media was aspirated, and the non-motile cells were removed
from the apical surface of the membrane by quickly cleaning the insert surface with a cotton
swab. Following, all transwell samples were exposed to 700 μL of 0.25% trypsin (Gibco) for 15
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min to dislodge cells on the basal membrane. Samples were then neutralized with DMEM,
collected in microcentrifuge tubes, centrifuged at 200Xg for 5 min, supernatants were aspirated,
and pellets were frozen for up to 2 weeks.

A CyQuantT M cell proliferation assay kit (ThermoFisher Scientific, C7026) was utilized to
quantify frozen pellets. The pellets were thawed at room temperature. Following which, 200 μL
of the CyQuant GR dye/cell-lysis buffer was prepared according to manufacturer protocol and
added to each sample. Samples were gently mixed and incubated for 2-5mins at room
temperature. Solutions were then placed in 96 well plates, and sample fluorescence was
measured using a microplate reader at 480 nm excitation/520 nm emission maxima. Further, a
standard curve for S42 cells was generated, via manufacturer protocol. Cell pellets were
generated as mentioned before at a density of 10 5 cells/mL. Pellets were thawed, 1.0mL of
CyQuant GR dye/cell-lysis buffer was added, and cells were resuspended via vortexing. A
dilution series with cell numbers ranging from 50 to 50,000 cells in 200 μL volumes was
generated and a 200μL sample with no cells was used as a control and fluorescence was
measured at 480/520 nm.
4.3.3. Microfluidic Device Design and Fabrication
The μLane system has been previously described

271

by our group to analyze chemotactic and

chemokinetic movements of cells derived from various sources

61, 272 .

The μLane system was

utilized to image real-time migratory responses of individual S42 Schwann cells co-cultured with
B35 motor neurons. The system consists of two layers of polydimethylsiloxane (PDMS) that
serve to connect the upper source & sink reservoirs with a microchannel bonded onto the glass
slide.
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Devices were fabricated in a two-step process using a 10:1 prepolymer mixture of PDMS
elastomer mixture (Sylgard 184, Dow Corning). The first layer consists of a closed microchannel
with a length of 13 mm, width of 100 μm, and volume of 0.1 μL which connects two 9 μL
reservoirs. The second layer consists of two 170 μL chambers connected by an open bridge
channel. These source and sink reservoirs are connected to the respective source and sink
chambers (Figure 18). Glass slides were cleaned via Piranha overnight, rinsed with deionized
water, and gently dried with nitrogen gas. Microfluidic devices were then ozone-bonded to glass
slides to create a closed system.

Figure 18: μLane System. (A) Schematic illustration of the µLane system, including source and
sink chambers with a connecting bridge channel, as well as source and sink reservoirs with a
connecting microchannel (B) Side-view schematic of the µLane system, illustrating the two
layers of PDMS and the connecting chambers and reservoirs and (C) image of µLane system
with red dye.

Transport within the adjoining microchannel is defined via the convective-diffusion equation (1),
used to quantitatively determine the concentration profile within the system:

ⅆ𝐶
ⅆ𝑡

+ 𝑢̅ ⋅ 𝛻̅𝐶 = 𝐷 ⋅ ∇2 𝐶

(Eqn. 1)

Where C represents ligand concentration in ng/ml, t is time measured in seconds or hours, u is
bulk velocity in m/s, and D represents molecular diffusivity in m2 /s.
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4.3.4. Experimental Set-up

Glass bonded devices were coated with laminin (LAM) (Thermo Fisher Cat. No. 23017015) at a
concentration of 10 μg/mL, incubated for one hour, and rinsed with PBS before use. Cells were
then seeded into the microchannel according to three different seeding conditions, all of which
are illustrated in Figure 19. The first condition, the control samples, Schwann cells (SCs) only,
involved seeding SCs within the microchannel via 1 mL syringe (BD Biosciences Cat. No.
309659) into the source and sink reservoirs. The source and sink chambers, as well as the
connecting bridge channel, were immediately filled with the cell proliferation medium. Postadhesion, recombinant BDNF protein (R&D Systems Cat. No. 248-BD-005) at a concentration
of 100 ng/mL was introduced in a dropwise fashion into the source chamber and allowed to form
a steady-state gradient over 18 hours before imaging. The second condition, series samples,
involved seeding both cell types, injected into the microchannel, in a time-dependent manner.
Motor neurons (2 x 106 cells/mL) were first seeded and allowed to adhere overnight, ultimately
forming a sheet of branching neurons (Figure 19). Following, Schwann cells (8 x 10 6 cells/mL)
were injected over the neuronal sheet in the microchannel, forming a co-culture, the next day.
After an hour of incubation, BDNF (100 ng/mL) was introduced in a dropwise fashion into the
source chamber and allowed to form a steady-state gradient before imaging. The third condition,
parallel samples, also involved seeding both cell types simultaneously into the microchannel as a
single population. As in the other conditions, BDNF was added to the source chamber and
imaging took place after a steady-state gradient was achieved.
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Figure 19: Experimental Setup. Schematic illustration of the three conditions tested in this
study: (A1) Schwann cells only, (A2) parallel seeding of motor neurons and Schwann cells, and
(A3) series seeding of motor neurons (MN) and Schwann cells (SC). Bright-field microscope
images of seeded motor neurons in the µLane at the (B1) mid-microchannel and (B2)
Fluorescent staining of MN (green) and SC (red) within microchannel overnight. Scale bar= 40,
50μm

4.3.5. Imaging
Real-time cell images were gathered using a Nikon TE2000 epi-fluorescence, inverted
microscope equipped

with short-and-long-range objectives and a cooled CCD camera

(CoolSNAP EZ, Photometrics, Tucson, AZ). Images were obtained in both phase-contrast and
fluorescence modes (for stained cultures) and images were captured every 30 minutes over eight
hours at five positions along the microchannel. The Manual Tracking tool in the ImageJ (Fiji)
software was used to track cells within the μLane system over time and the Chemotaxis and
Migration tool for subsequent analysis. All images were analyzed using the National Institute of
Health (NIH) ImageJ software.

Confocal imaging via Zeiss LSM 710 microscope was utilized to visualize the TrkB integrin
expression. Mean values of integrin expression were assessed by measuring the fluorescence
intensity of individual cells (total sample size n=12) using Image J (Fiji) software and their
protocol for measuring cell fluorescence
(https://theolb.readthedocs.io/en/latest/imaging/measuring-cell- fluorescence- using- imagej.html).
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4.3.6. Cell Metrics
The projected area (A) and the perimeter (P) for each cell were measured under the defined
culture conditions. The average cell morphology was analyzed using the cell shape index (CSI)
273

described by Equation (2) as used previously by our group and others

𝐶𝑆𝐼 =

271, 273-276:

4𝜋𝐴
𝑃2

(Eqn. 2)

Where A and P represent the surface area and perimeter of individual cells. A CSI value of 1
represents a perfectly round object while a value approaching 0 indicates a more oblong shape.
Between 15-50 cells for each testing condition were used to determine the respective, average
values of CSI reported as reported in Table 5.

The cell path length (d) represents the accumulated trajectory lengths from start to end and was
calculated by summing the traveled distances over time for each individual cell. The chemotactic
index (CI) is defined as the ratio of cells displaced in the direction of the gradient (Δ𝑥) to the
total accumulated distance (d), shown in Equation (3)277 :

𝐶𝐼 =

Δ𝑥
ⅆ

(Eqn. 3)

Directionality (D) is defined as the net distance between the cell trajectory start point and last
point (n) divided by the total accumulated distance (d), represented in Equation (4).

𝐷=

𝑛
ⅆ

(Eqn. 4)
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4.3.7. Immunostaining
Samples were prepared, as per the three conditions mentioned in section 2.4 Experimental SetUp on NuncT M Lab-TekT M Chambered, 4well, confocal coverglass (ThermoFischer, Cat. No.
155383PK) coated with LAM at a concentration of 10 g/mL and control (CTRL) with B35 and
S42 cells plated on uncoated well plates for 10 min and 2 hours. Cells were seeded at a ratio of
1:4 (B35 MN:S42 SCs). Post overnight incubation, cell medium was aspirated, samples were
rinsed 3x with 1X PBS, and fixed with 2-4% formalin for 10 min. Substrates were then rinsed
3x, permeabilized with 0.1% Triton-X in PBS for 15 min and incubated for 60 min with 1%
blocking solution (PBSA). After incubation, the substrates were washed with 1% PBS-BSA
solution, exposed to 0.873 μg/mL (1:1000 dilution) of anti-TrkB antibody [EPR17805-146]
(Abcam, ab187041) and incubated overnight at 4 °C. Following, samples were washed with
0.2% PBS-BSA, incubated with 2.5 μg/mL (1:800 dilution) goat anti-rabbit IgG (Invitrogen,
A32732) secondary antibodies for 30 min. Samples are then rinsed 3x with 0.2% PBS-BSA,
incubated with DAPI (Hoechst 33342) for 5 min, and rinsed again 3x with PBS.

4.3.8. Statistical Analysis
A paired t-test at a 95% confidence interval was performed using the Matlab software
(MathWorks, Natick, MA) to compare the different seeding conditions and concentrations as
well as student t-tests,

with two-tailed

distributions and two-sample unequal variance

assumptions. Further, one-way ANOVA was utilized to test significance between growth factor
groups followed by Tukey post-hoc. Significance level was set to p<0.01.
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4.4. Results
4.4.1. Cell Migration Assay
Initial experiments measured the number of S42 Schwann cells that migrated towards varying
concentrations of BDNF through transwell membranes as shown in Figure 20. The figure
highlights that the number of motile S42 Schwann cells were statistically different in response to
signaling from 100 and 200 ng/mL when compared to control and 10 ng/mL (p<0.01). The
average number of motile cells for control were 5859.7  509.8 whereas the averages for 10,
100, 200 ng/mL where 4284.9  597.5, 11671.58  3120.1, and 12978.8  2618.5 respectively.
No statistical significance was found between control and 10 ng/mL, and between 100 and
200ng/mL concentrations. On the other hand supplemental figure 26, CNTF showed the highest
chemoattraction for S42 SCs at 100ng/mL similar to that of EGF, but EGF was not statistically
significant. Lower CNTF readings were measured at 10 and 200ng/mL, only 200ng/mL was
statistically significant to control. SDF-1 showed higher fluorescence reading at 10 and 200
ng/ml and this response was much lower for 100ng/mL, indicating fewer cells were stimulated,
but overall SDF-1

stimulation was not statistically significant.

GDNF

stimulation was

statistically significant to control only at 10ng/mL concentration, as well showing the highest
chemoattraction within its group. With 100 and 200ng/mL stimulation showing decreasing
chemoattractive responses.
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Figure 20: Transwell cell migration in response to BDNF. The graph shows the relative
number of cells measured per transwell to indicate cell migration towards increasing growth
factor concentrations (ng/ml). *indicates p<0.01 against control and # indicates p<0.01 against
10ng/ml treatment. N=5.

4.4.2. Migratory Response to BDNF Gradient Fields
S42 Schwann cell migratory responses were then quantified with and without the presence of
BDNF and motor neurons in a co-culture μLane system. As shown in Table 4 and 5, the
following migratory parameters were considered for each of the three conditions tested as
mentioned in materials and methods section 4.3.6: cell path length (m), chemotactic index (CI),
directionality, cell shape index (CSI), fraction of motile cells (FMC), and maximum accumulated
distance (M.A.D; m). Schwann cell migration to a BDNF gradient of 100 ng/mL was measured
in each condition. As shown in Figure 21, the average cell paths in response to BDNF for all of
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the conditions were statistically significant (p < 0.001) when compared to the control condition.
The series condition exhibited the greatest cell movement, with an average of 94 ± 28 μm (Table
5), also displaying statistically significant difference (p < 0.001) from the Schwann cell only and
parallel conditions.
A

B

*

*

*

Figure 21: Summary of Schwann Cell Migration. (A) Average accumulated distances (± SD)
of motile Schwann cells within the microchannel in each condition. (B) Fraction of motile
Schwann cells in the absence or presence of 100 ng/mL of BDNF, displayed as percentages of
total cell numbers. * indicates significance against controls p<0.001

Directionality is defined as the percentage of cells whose center of mass migrates preferentially
toward the source reservoir along the gradient direction. The directionality of motile cells was
higher for the parallel condition than the series condition as summarized in Table 5. CSI was
calculated using the circularity formula as stated in section 2.6, in which a value of 1 represents a
perfectly circular cell and a value approaching 0 indicates a more elongated cell shape. As our
data highlights for each condition tested, S42 Schwann cells with and without the presence of
BDNF maintain a more circular shape except in the case of Schwann cell only +BDNF, the cells
exhibit a more elongated morphology. Overall, Schwann cells without the presence of BDNF
displayed slightly higher CSI values versus without BDNF.
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The fraction of motile Schwann cells with and without the presence of BDNF was assessed, with
the majority of cells in the control condition migrating a total distance of less than 50 μm, Fig.
22A. For the series condition, the fraction of motile cells as shown in Fig. 22B with respect to
M.A.D, were seen to traverse longer distances, >150 μm, in the presence of BDNF versus no
BDNF. Without BDNF most motile cells were binned between 0-25 μm M.A.D, whereas in the
presence of BDNF cell M.A.D were more distributed with many more cells traversing >50 μm
bins. For the parallel condition, with and without BDNF, M.A.D is more distributed between 025, 25-50, and 50-100 μm bins, with the least FMC seen in the 100-150 bin.
SC only

A

Series

B

Parallel

C

Figure 22: Quantitative metrics to elucidate Schwann cell behavior within the µLane
system. (A) Average accumulated distances (± SD) of motile Schwann cells within the
microchannel in each condition. Fraction of motile Schwann cells in the absence & presence of
100 ng/mL of BDNF, added (B) serially and (C) in parallel, into the µLane system, displayed as
percentages of total cell numbers. * indicates significance against controls p<0.001

4.4.3. Co-culture BDNF receptor expression
Further all three test conditions, SC only, series, and parallel samples, were exposed to 100ng/ml
BDNF for 10mins & 2hs to monitor the presence of the relative upregulation of its receptorTrkB, shown in Figure 23. The mean fluorescence intensity expression levels for test samples
were compared against their controls. As seen in Figure 24, for the SC only condition, samples
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exposed to BDNF at 10min & 2h were both statistically significant compared to control with
p<0.05 for control vs. SC (2h) & p<0.0001 for control vs. SC (10min) & SC (10min) vs. SC
(2h). For the parallel condition, samples exposed to BDNF for 2h were statistically significant
compared to its control (p<0.05), but no significance was found for parallel samples exposed for
10 min. Also, the average fluorescence intensity expression was much lower (1.12  0.95) for 10
min parallel samples when compared to SC only (4.80  2.13) & series (5.18  1.43) at 10min.
By contrast, the series test conditions at 10 min and 2h were highly significant to its control,
p<0.0001.

Figure 23: Receptor expression of brain-derived neurotrophic factor (BDNF), TrkB, in
culture samples. Three different seeding conditions, (A1-A3) Parallel seeding of B35 MNs and
S42 SCs, (B1-B3) Series, and (C1-C3) S42, Schwann only were imaged- with three different
treatment conditions: no BDNF, 10 min BDNF exposure, and 2h BDNF exposure. Scale
bar=5µm.
95

**

*
**

**

**

*

Figure 24: Mean fluorescent intensity values of brain-derived neurotrophic factor (BDNF)
receptor, TrkB expression, in culture samples. Three different seeding conditions-S42 only,
Series, and Parallel seeding of B35 MNs and S42 SCs- with three different treatment conditions:
no BDNF, 10 min BDNF exposure, and 2h BDNF exposure. *indicates p<0.05, **indicates
p<0.0001

4.5. Discussion
Schwann cells (SCs) originate during development from the highly motile neural crest and are
the primary glial cells of the PNS. During development varying cell chemotactic cues are
responsible for the migration of SC precursors to their proper targets in the periphery. Such
diffusible signals become important not only for determining cell fate but also provide
chemotactic and chemokinetic signals for growing axons and stimulating the motility of other SC
precursors. Adult SCs also play a vital role in the maintenance 6 , nerve damage repair, and
regeneration of NMJs in case of injuries. Specifically, SCs remove myelin debris and guide
directed growth of regenerating axons by undergoing dedifferentiation, proliferation, and
migration. Additionally, SCs are known to produce neurotrophic factors such as BDNF, GDNF,
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NGF, and NT-3, which are necessary for neuronal growth and survival. Current use of
neurotrophic factors such as BDNF for clinical use is limited due to the absence of safe and
reliable delivery systems that can provide sustainable effective concentrations over time

270, 278 .

Additionally, there are limited studies exploiting how these concentrations gradients affect adult
SCs, in controlled microfluidic environments. This work illustrates an in vitro co-culture model
aimed to quantify and elucidate SC chemotactic behavior in the presence of BDNF and other
neurotrophins. We further utilized a microfluidic system to provide highly controlled chemical
environments in order to quantify migratory patterns in SC-MN co-cultures. As well as highlight
two different seeding mechanisms and their effect on neuron-glia relationship.

Our study is among the first to examine and characterize the chemotactic response of S42 adult
rat Schwann cells to varying concentrations of BDNF, GDNF, CNTF, EGF, and SDF-1. BDNF
is widely reported to enhance synaptic vesicle exocytosis and neurotransmitter release279 as well
as regeneration of axons into the distal stump, as there is an upregulation of BDNF mRNA in
axotomized motor neurons as well as SCs distal to injury252 . GDNF is a known survival factor
for neurons and has been shown to stimulate migration of Schwann cells 95 thus leading to
subsequent enhancement of axonal regeneration280 . CNTF is a cytosolic molecule, expressed
selectively by SCs and astrocytes. Their endogenous release from lesioned SCs supports the
survival of motor neurons undergoing rapid degeneration

281 .

Whereas EGF and SDF-1 are

shown to be important for stimulating migratory responses within glial cell populations. Hence,
we tested these growth factors to elucidate their influence on S42 SCs. Initial experiments
illustrated that S42 SCs responded to BDNF in a dose-dependent manner, illustrating that
increasing concentrations resulted in increased number of motile cells traversing the transwell
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membrane. SC chemotactic response at sites of injury in the PNS can aid in effectively
maintaining growth factor release in order to improve repair. This behavior is important as
BDNF is implicated in increasing the levels of the synaptic vesicle proteins, synaptophysin, and
synapsin 1 in the spinal neurons

251 ,

enhance both spontaneous and evoked synaptic transmission

at NMJs 279, 282, and therefore could aid in developing an in vitro model for nerve repair in adults.

Cells stimulated with GDNF showed the inversed response with lower concentrations resulting
in greater cell motility and higher GDNF concentrations resulted in fewer populations of cells
were stimulated to traverse the transwell membrane. Whereas, CNTF showed the highest
chemoattraction for S42 SCs at 100ng/mL similar to that of EGF. EGF is known to be an
important mediator of cell proliferation and migration in the adult brain

283 ,

but it does not seem

to have as large a stimulatory response from SCs in the PNS. SDF-1 only showed significant cell
stimulation at 200ng/mL, indicating that only higher concentration of SDF-1 can stimulate adult
S42 cells. This can be of importance for combinatory reparative studies as SDF-1 has been
indicated to increase stem-cell migration and their fusion with myoblasts in vitro for skeletal
muscle regeneration

273 .

Traditional in vitro culture techniques have elucidated significantly to our understanding of how
cells behave. But these models lack the ability to provide controlled environments to enable
precise probing of cells. Microfluidic technologies facilitate the development of powerful
platforms to grow and manipulate cells such as neurons in order to model and study axon
injuries. Therefore, to further delineated S42 Schwann cell migratory behavior a microfluidic
platform, called the Lane system, was utilized to generate concentration gradients of BDNF. As
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well as a co-culture with motor neurons (MNs) using two separate seeding conditions: series and
parallel. Using the Lane system, we were able to image real-time cell behavior in response to
100ng/mL of BDNF. S42 migration was observed and BDNF was shown to not be effective in
the parallel seeding condition. The cell distribution in the percent motility bins are similarly
distributed for + and – BDNF conditions. Whereas, the series condition showed larger
distributions of cell motility for +BDNF condition.

Overall, S42 Schwann cells did not exhibit a highly directional migratory behavior towards
BDNF. Although, the total cell path length is the highest for the +BDNF series condition,
indicating the ability of S42s to be stimulated to traverse larger distances. In this case, 15% of
cells in +BDNF series condition traveled between 100-150 m compared to the 5% of cells seen
in +BDNF parallel condition. The CSI values, for control samples, indicate that BDNF causes
morphological changes where S42 SCs appear more circular when exposed to BDNF, but these
effects are minimized in the presence of motor neurons, regardless of seeding condition.

We further probed this SC-MN seeding conditions and hypothesized that the parallel seeding
results

in

down-regulation

of

TrkB

or

saturation

of

TrkB.

Results

from

the

immunocytochemistry data elucidated that the parallel seeding condition showed significant
down-regulation of TrkB when compared to the series and control conditions at 10 min, to
exogenous BDNF stimulation. For long-term BDNF stimulation, 2h in this case, resulted in
receptor down-regulation as is indicated by the significant drop from 10 min to 2h in both,
control and series conditions. The data here confirmed that seeding SC-MNs as a mixed
population, in the parallel condition, is causing TrkB receptor down-regulation when compared
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to the other conditions. This could mean that MNs or SCs are producing BDNF or that their
communication is causing receptor modulation. Further studies are needed to confirm this
behavior.

4.6. Conclusion
Our results are among the first to illustrate the dose-dependent response of BDNF on adult S42
Schwann cells. As well as, utilizing microfluidics to deduce SC migratory behavior towards
BDNF in a controlled microenvironment. Motile SCs, in the series condition traversed longer
distances within the μLane system in the presence of BDNF versus no BDNF. This was also true
when compared to the parallel conditions in the presence of BDNF. We also show that parallel
seeding has a similar effect on TrkB expression as continuous exogenous BDNF stimulation.
Future work will investigate adult SC behavior using populations of primary adult cells as well
as incorporation of growth factors in a tri-culture model to develop an NMJ repair model. Further
studies are also needed to elucidate the mechanisms causing TrkB down-regulation within mixed
population cultures.
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Tables:
Table 4: Schwann cell migratory parameters in response to BDNF (100 ng/mL) within the
µLane system.

Table 5: Quantitative metrics to elucidate Schwann cell behavior within the µLane system.
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Supplemental Figure:

*
*

*

Figure 25: Growth factor transwell migration of Schwann cells. This graph shows the
relative number of cells measured per transwell to indicate cell migration towards increasing
growth factor concentrations (ng/ml). *indicates p<0.05 against control
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5. Time-Dependent Addition of Neuronal and Schwann Cells
Increase Myotube Viability and Length in An In vitro Tri-Culture
Model of the Neuromuscular Junction
5.1. Chapter Summary
The neuromuscular junction (NMJ) is a specialized chemical synapse between motor neurons
and muscle fibers that enables voluntary movement of somatic muscle. Study of NMJ physiology
and pathology has used various animal models and cell lines to recapitulate critical features of
neuromuscular disease and increase our understanding of NMJ disruption. In vitro co-culture
platforms have also been used to evaluate NMJ development using different combinations of
motor neurons (MNs), glial Schwann cells (SCs), skeletal muscle (SKM) and biomaterials to
advance translation of regenerative therapies. Schwann cells (SCs) of the peripheral nervous
system are essential to the development and function of the NMJ. Although recent evidence has
revealed the significant roles of these glia in NMJ remodeling and regeneration, SCs have been
largely overlooked in NMJ culture models. In this report, we use a compartmentalized,
microfluidic platform to develop a novel, tri-culture model of the three cell types that comprise
the NMJ: SKM, MNs and SCs. Results illustrate reproducible differentiation of SKM myotubes
with increased viability and length following the time-dependent addition of neuronal and glial
cells. The data point to Schwann Cells as key players to stabilize and maintain in vitro NMJ
models that will aid development and testing of emerging therapies for neuromuscular
dysfunction.
Keywords

Neuromuscular Junction; Schwann cells; Neurons; C2C12; Co-culture; Differentiation

103

5.2. Introduction
The neuromuscular junction (NMJ) converts action potentials into somatic muscle contraction
via coordinated responses between motor neurons (MNs), skeletal muscle cells (SKM) and
Schwann cells (SCs), as shown in Figure 26284 . MNs communicate with glial SCs to coordinate
release of the neurotransmitter, acetylcholine (ACh) from the motor terminals of MNs peripheral
axons, which comprise the NMJ pre-synaptic bulb. Packets of Ach then diffuse across the socalled NMJ synaptic cleft, which is defined as the nanometer gap-spacing between MNs and
SKM membranes. ACh molecules then bind to ACh surface receptors (AChR) on the membrane
of contractile muscle fibers (SKM), called the post-synaptic motor end plate, to achieve
movement.

Figure 26: Schematic of the Neuromuscular Junction (NMJ). This schematic illustrates the
major cellular components at the NMJ synapse. Schwann cells (SCs, blue) cap the end of the
Motor Neuron (MNs, yellow) whose motor terminals comprise the pre-synaptic bulb. Packets of
acetylcholine (ACh, dots) released from MNs transport across the nanometer gap-spacing
between the MNs and Skeletal Muscle (SKM), called the synaptic cleft. Receptors of ACh then
cluster on the surface of SKM, in regions called the motor end plate, to enable SKM contraction.
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NMJ disruption is a hallmark of neuromuscular disease

87, 88, 285, 286 ,

prompting advances of

numerous in vivo models that recapitulate critical features of NMJ development and pathogenesis
75, 79, 114, 287-290 in both
90, 91

vertebrates

79, 114, 287, 288

and invertebrates

75, 289, 290 . Several

have used two-dimensional co-culture of heterologous cells

270, 291, 292

dimensional tissue constructs to incorporate progenitor and stem-like cells

in vitro models

as well as three-

90, 91

in the study of

NMJ formation. Such established co-cultures have helped advance fundamental models of the
myelination process

56, 91, 94, 293, 294 as well

Emerging

have begun to

studies

development and regeneration

as innervation

develop

90, 91, 112, 113 ,

86, 112 .

microfluidic environments to

evaluate NMJ

as microfluidics are able to replicate unique NMJ

anatomical constraints and cellular interactions using precise and highly-controlled approaches
295-297 .

Microfluidics can reproduce the chemical and physical microenvironment of the spinal

cord in which the neuronal cell bodies reside

113, 298 ,

as well as evaluate the collective interactions

of, both, peripheral glia and neuronal axons required for functional synapse across the central to
peripheral nervous system (NS)

294, 295, 297, 299 .

84, 114, 303

as well as

functional motor units in the form of muscle cells cultured with spinal cord explants

298, 304-306 ,

examined co-cultures of neuronal-glial

94, 300-302

Although many existing microsystems have

and neuronal-muscle cells

few platforms have evaluated the integrated behavior of neuronal, glial and muscle cells of the
NMJ

307, 308 .

Further, while a small number of microfluidic studies have incorporated CNS-

derived astrocytes and oligodendrocytes in NMJ models

113, 294 ,

these studies disregard the

significant roles of PNS-derived Schwann cells in NMJ remodeling and synaptic development
following nerve injury

309, 310.
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Schwann cells (SCs) are known for their regenerative and maintenance capacity

311, 312

as well as

their ability to modulate synapse activity via changes in Ca2+ and release growth factors, such as
Glial-cell derived neurotrophic factor (GDNF), Ciliary neurotrophic factor (CNTF) and Brain
derived neurotrophic factor (BDNF)311 . SCs also promote post-synaptic NMJ signaling and
synaptogenesis in nerve-muscle contacts (in Xenopus

313 ),

where SCs expression of TGF-B in

Xenopus models was seen to double the size of AChR clusters by 3 times more than control. In
addition, neurons treated with SC-CM (Schwann cell-conditioned medium) illustrated increased
AChR clustering as a result of TGFβ1-induced agrin expression in spinal neurons

313 .

In this report, we used a tri-culture, microfluidic platform to evaluate the role of SCs towards the
differentiation of skeletal muscle (SKM) cells into SKM myotubes, a central element of
reparative therapies that utilize stem like-cells to recapitulate regeneration

314-318 .

The three

distinct NMJ cellular populations were introduced in a time-dependent manner to facilitate
integrated cellular behaviors at the microscale as seen in vivo. A compartmentalized microfluidic
device previously developed by our group

319

was used to evaluate differentiation, growth and

viability of SKM myotubes for over two weeks in vitro when cultured sequentially with MNs
followed by SCs. Our results illustrate reproducible differentiation of progenitor SKM cells into
SKM myotubes with increased viability and longer average lengths

320

following time-dependent

and sequential addition of Schwann cells in a tri-culture model. These data highlight the
importance of PNS-derived SC, surprisingly neglected in the majority of published NMJ models.
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5.3. Methods and Materials
5.3.1. Cell culture
A neuronal cell line (B35, ATCC CRL-2754), Schwann cell line (S42, ATCC CRL-2942) and
myoblast cell line (C2C12, ATCC CRL-1772) were cultured independently, in co-culture and in
tri-culture with one another. C2C12 and B35 cells were thawed, plated, and cultured in sterile
Dulbecco’s Modified Eagle Medium (DMEM, ATCC Cat. No. 30-2002) containing 10% fetal
bovine serum, and 1% penicillin-streptomycin. Before passaging, plates are washed 1x with PBS
without Ca or Mg; followed by treatment of cultures to 0.25% trypsin for C2C12s (Gibco Cat.
No. 25200) and 0.05% trypsin (Gibco Cat. No. 25300) for 4 mins at 37C and centrifugation at
200Xg for 4 mins. Cells were cultured (37C, 95% humidity, 5% CO2) and passaged (80-90%
confluency) on sterile tissue culture treated plastic petri dishes at a density of 500-1000 cells per
cm2 . Similarly, S42 cells were thawed and plated as stated in the above culture conditions for
C2C12 cells. But S42 cells are plated on culture flasks treated with 15ug/mL poly-L-lysine
(Sigma Cat. No. P-9155) for at least 2 hours at 37C. Before using the flasks, poly-L-lysine
solution is removed, flask is rinsed once with DPBS and allowed to air dry, uncapped, in an
upright position in a biological cabinet for 30 minutes before introducing cells.

5.3.2. Rat Dorsal Root Ganglion (DRG) co-cultures
DRG were isolated using well-established protocols described by a number of research groups
321, 322

Briefly, pregnant Sprague-Dawley rats were asphyxiated via CO 2 , abdominal muscle and

suspensory ligaments incised, with blunt forceps embryos near cervical insertion were obtained,
and placed in sterile 10cm tissue culture dishes with Leibovitz’s L-15 medium (Gibco 11415064). Embryos were placed under dissection microscope, the ventral (belly) portion was removed
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to isolate the dorsal (back) structures containing the spinal cord, slowly working through to
remove excess tissue surrounding the DRGs. DRGs were then plucked off using forceps and
transferred to a 6cm dish with L-15 medium. Using forceps, deposit 1 DRG in 185 µL Cmedium

322

onto the center of each Matrigel (BD Biosciences, 356230; 1:10 dilution in DMEM)

coated coverslip. Cells were grown and purified for 18-21days and cycled between Neurobasal
Medium (NB, Gibco 21103-049) and NB medium containing 10 µM FdU (Sigma F-0503) and
10 µM uridine (Sigma U-3003) to eliminate dividing cells such as fibroblasts. On day 19,
Schwann cells were added onto purified DRG explants at a final concentration of 1x10 5
cells/400µL. From days 22-36, cultures were maintained in C-medium containing 50 µg/mL
ascorbic acid (vitamin C; Sigma A4544). Medium was changed every 2 days for myelination to
proceed over the next 14 days.
5.3.3. Differentiation
C2C12 cells were grown on, both, tissue culture treated plastic dishes and on plates coated with
Matrigel (Growth Factor Reduced- BD Catalog # 354230). Matrigel (MGL) was thawed
overnight on ice at 4o degrees and further diluted 1:2 in Dulbecco’s Modified Eagle Medium/
Nutrient Mixture F-12 (DMEM/F-12, Gibco Catalog # 11320) and made into 1 mL aliquots
stored at -20o . These aliquots were then thawed overnight at 4 o degrees on ice and further diluted
1:50 in DMEM/F-12. Dishes of 100 mm diameter were coated with 6 mL of 1:50 MGL solution
for all tests. Once MGL was diluted it was used within 2 weeks. Dishes were coated for 1 hour at
room temperature and then washed 2 times with 1x PBS.

Cells were seeded at a density of 10,000 cells per cm2 in proliferation media and allowed to
attach overnight, followed by 1x wash with Hank’s Balanced Salt Solutions (HBSS,
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ThermoFisher Catalog #1402592). Further, cell culture medium was changed from proliferation
media (10% FBS) to differentiation media (0.5% heat inactivated FBS) the following day.
Media was changed every 2 to 3 days thereafter.
5.3.4. Fusion Index
C2C12 cells were washed 3x with PBS followed by fixation in Paraformaldehyde (PFA) for 10
mins. Cell plates were then rinsed 2x and permeabilized with 0.1% Triton X-100 in PBS for 10
mins, rinsed 2x with PBS, and stained with a nuclear stain, DAPI (Hoechst 33342,
ThermoFisher). The fusion index was calculated as the ratio of the nuclei number in myotubes
with two or more nuclei versus the total number of nuclei

323, 324 .

Image J plug-in analyze

particle was utilized with high contrast, and watershedding to visualize nuclei fusion, as per
Equation (1).

𝐹𝑖 =

𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑛𝑢𝑐𝑙𝑒𝑖 𝑖𝑛 𝑚𝑦𝑜𝑡𝑢𝑏𝑒𝑠
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑛𝑢𝑐𝑙𝑒𝑖

(Eqn. 1)

5.3.5. Immunostaining
Samples were prepared on No.1 confocal coverslips (Electron Microscopy Sciences, 63758-01)
coated with Matrigel (MGL) at a concentration of 100 mg/ml and control (CTRL) with C2C12
cells plated on uncoated well plates. Cells were seeded at a density of 5,000 cells per 500 ml,
incubated on substrates, and differentiated for 10 days. After 10 days, cell medium was aspirated,
substrates were rinsed 3x with 1X PBS, and fixed with 2-4% formalin for 10 min. Substrates
were then rinsed 3x, permeabilized with 0.1% Triton-X in PBS for 10 min and incubated for 60
min with 1% blocking solution (PBSA). After incubation, the substrates were washed with 1%
PBS-BSA solution, exposed to 1 g/ml of -actinin, 25μg/ml of anti-neurofilament-M+H, and

109

5μg/ml of α-bungarotoxin conjugated antibodies, and incubated overnight at 4 °C. Following,
substrates were washed with 0.2% PBS-BSA, incubated with 10μg/ml goat anti-rabbit IgG
(Invitrogen, A32723), and 10μg/ml goat anti-mouse IgG (Invitrogen, A32732) secondary
antibodies for 30 min. Samples are then rinsed 2x with 0.2% PBS-BSA, incubated with DAPI
(Hoechst 33342) for 5 min, rinsed again 2x with PBS.

DRG cell cultures were immunostained with myelin basic protein (MBP) and neurofilament
(NF). Samples were quantified for MBP+ segments in n=12 micrographs to show presence of
myelination as a total average, as per Equation (2). Each segment represents an internode made
by a single SC such that the number of internodes observed was equal to the number of
myelinating SC.
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑀𝐵𝑃+ 𝑠𝑒𝑔𝑚𝑒𝑛𝑡𝑠
𝑁𝑠𝑐 =
𝐴𝑟𝑒𝑎 𝑜𝑓 𝑚𝑖𝑐𝑟𝑜𝑔𝑟𝑎𝑝ℎ

(Eqn. 2)

5.3.6. Microfluidic Platform
The Mμn system was designed and fabricated as described previously by our group

319, 325 .

It

consists of two large cell chambers that are connected by a nanoarray of channels 3 µm in
diameter and 10 µm in length, as shown in Figure 27. In brief, devices were patterned via
photolithography and micromolded using polydimethylsiloxane (PDMS) (Sylgard 184, Dow
Corning, Midland, MI) to create elastomeric stamps of the design. Mμn devices were assembled
by bonding PDMS to chemically-cleaned glass slides via ozone plasma (Electro-technic Products
Inc., Chicago, IL). Two photomasks were designed in 2D using computer aided design software,
AutoCAD 2017 (Autodesk Inc.). The first mask consisted of the device design with open
channels in the center (channel mask), while the second mask contained a 100µm-wide strip that
110

blocked

the channel array from further exposure (seeding region mask). A two-step

photolithography protocol was performed to produce a 5μm-thick channel array connecting two
50μm-thick cell seeding regions and inlet/outlet ports as seen.

Figure 27: Schematic of the Mμn system used for single, co- and tri-cultures of NMJ cell
types. Two cell seeding regions (SR) of 1-mm-width and 10-mm-length are connected by a
nanoarray of channels having 800-nm-diameter and 100-μm-length, spaced 10μm apart. SR are
connected to independent inlet and outlet ports for parallel loading of cells and reagents, as
needed.

5.3.7. Viability Assay
Myotubes cultured within the microdevice were stained with Calcein AM (ThermoFisher,
C3100MP) at 2.5µM concentration to detect live cells, as well as DAPI nuclear staining prepared
as per manufacturer protocol (Hoechst 33342) to detect dead cells per area. Recorded grayscale
images were processed using ImageJ to determine the portion of live cells. In short, images were
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binarized and nuclei were separated using standard watershed commands

326 .

Cells were counted

using the built in Particle Analysis command with a minimum size threshold to prevent
recording noise

326 .

5.3.8. Analysis
The average cell morphology was analyzed using the cell shape index (CSI)
Equation (3) and used previously by our group and others

𝐶𝑆𝐼 =

101, 273-276 as shown

273

described by

in Figure 28:

4𝜋𝐴
𝑃2

(Eqn. 3)

Where A and P represent the surface area and perimeter of individual cells, respectively.
Between 15-50 cells for each testing condition were used to determine the respective, average
values of CSI reported. CSI was also used to define an elongation rate, ER, of SKM defined in
Equation (4):

𝐸𝑅 =

(𝐶𝑆𝐼𝑡2 −𝐶𝑆𝐼𝑡1 )
𝐶𝑆𝐼𝑡1

× 100%

(Eqn. 4)

Where t1 and t2 represent different time points for measurement of CSI values.

To measure myotube length, recorded grayscale images of myotube differentiation were
analyzed using ImageJ and the available plugin Ridge Detection to automatically detect ridges
and lines for determining myotube length. Parameters (sigma, upper intensity and lower
intensity) were set for each image to optimize the detection algorithm. Sigma is used based on
the expected ridge width and is used to set the steepness of the derivative calculation used in the
detection algorithm.

The upper and lower intensities are used to set the thresholds for

determining the possible pixel values of ridges

327 .
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Figure 28: Description of the Cell Shape Index (CSI) used to quantitatively describe cell
morphology. CSI is a dimensionless parameter measured by diving the cell surface area by its
perimeter, as shown. (A) Cells with an idealized, rounded morphology will exhibit a CSI value
of 1.0. (B) A more typical cell morphology will exhibit average CSI values between 1.0 and 0.0.
(C) Cells with an idealized, elongated morphology will exhibit a CSI value of 0.

5.3.9. Imaging
Cell images were gathered using a Nikon TE2000 epi-fluorescence, inverted microscope
equipped with short-and-long-range objectives and a cooled CCD camera (CoolSNAP EZ,
Photometrics, Tucson, AZ). Images were obtained in both phase-contrast and fluorescence
modes (for stained cultures) and analyzed using the National Institute of Health (NIH) ImageJ
software.
Confocal imaging via Zeiss LSM 710 microscope was utilized to visualize the integrin
expression as well as DRG co-culture of cells seeded on each matrix. Mean values of integrin
expression were assessed by measuring the fluorescence intensity of individual cells (total
sample size n=15) using Image J software and their protocol for measuring cell fluorescence

326 .

5.3.10. Statistical Analysis
Statistical significance of data points was analyzed using the post-Tukey and student t-tests, with
two-tailed distributions and two sample unequal variance assumptions. One-way analysis of
variance (ANOVA) was performed using JMP statistical software (SAS Institute, Cary, North
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Carolina, USA) for significant differences between testing conditions. Significance level was set
to p<0.001 unless otherwise noted in the results section.

5.4. Results
5.4.1. PNS Co-culture of Neural Cells
The first experiment of this study examined time-dependent behaviors of PNS-derived neural
cells in a co-culture model of primary dorsal root ganglion (DRGs) and Schwann cells (SCs) on
laminin, as shown in Figure 29. The figure illustrates the significance of in vitro models able to
investigate NMJ formation via the influence of glia, which have been shown within the last
decade to be a crucial stabilizing and supportive influence for the NMJ

67, 310 .

SCs were seen to

extend and begin wrapping around neuronal axons in manners demonstrated to be suggestive of
the SC myelination process in vitro

90, 94, 300, 301 .

Fluorescence staining of myelin basic protein

(MBP) and neurofilament validated cellular interactions in co-culture between neurons and glia
within the PNS. The average number of internodes per surface area of micrographs was
measured as N SC= 113.5 segments per 1.5 x 105 µm2 , as per Equation (2). To mimic these stable
results for an NMJ model, we developed a robust, tri-culture model of SKM cells within a MNSC co-culture to recapitulate the temporal patterns of neuronal and glial co-differentiation

306 .
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Figure 29: Primary cultures of dorsal root ganglions (DRGs) cultured with Schwann cells
(SCs). (A) One-week post SCs seeding onto DRG cultures on coverslips, with SCs extending
processes and beginning the myelination process. (B) SCs and MNs co-cultured within the
microdevice, arrows point to SCs extending processes (C, D) Fluorescent images of DRG-SC
co-cultures (n=6 independent experiments); Green dye: Myelin basic protein; Blue dye:
Neurofilament; Scale Bar: 100µm

5.4.2. Formation and Characteristics of SKM cells into SKM Myotubes
SKM cells were first observed to grow and differentiate in culture lacking interaction with neural
cell types. SKM plated upon substrates treated with Matrigel (MGL) and untreated (CTRL) were
observed to differentiate into myotubes over 10 days. As seen in Figure 30 A & B, a large
number of cells with highly-elongated morphology was seen upon MGL-coated substrates (MGL
+/+), while a smaller number of less-elongated cells were seen upon CTRL (MGL-/-), although
each condition contained populations of both. Cells for both conditions were then stained for αactinin, Figure 30C, a marker used to identify cell populations that have begun to differentiate
into myotubes

328 .

This marker was expressed in 98% of cells upon MGL substrates but only 2%

115

of cells upon CTRL. Changes in the average morphology of cells upon MGL +/+ and CTRL
were measured via CSI and demonstrated significant cell elongation from an average CSI value
of 0.14±0.05 at Day 1 (p = 2.22e-06 ) to an average CSI value of 0.04±0.01 at Day 10 (p = 1.86e06 ).

By contrast, the morphology of cells upon CTRL exhibited less elongation with an average

CSI value of 0.44±0.08 at Day 1 and 0.24 ± 0.09 on Day 10, or an elongation rate of 86%.
Further, data in Figure 30E illustrates SKM differentiation seen upon CTRL plates, MGL-/+,
where a small population of cells differentiated into myotubes exhibiting an average CSI of 0.08
± 0.04 over time. Similarly, in MGL treated plates approximately 2% of the population of SKM
cells did not differentiate (MGL+/-), maintaining an average of CSI of 0.36 ± 0.02. High
statistical significance (p<0.01) between elongation rates (ER) at each day was observed.
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Figure 30: Differentiation of C2C12 myoblast cells into myotubes. Brightfield image of cells
(A) adhered upon Matrigel-coated (MGL) substrates after 10 days and (B) undifferentiated cells
in culture adhered upon non-coated plastic. (C) Fluorescence image of α-actinin staining for cells
adhered upon MGL after 6 days. Blue dye: DAPI; Green: α-actinin. (D) Mean values of α-actinin
expression in cell samples adhered with and without MGL (n=4 independent experiments). (E)
Changes in cell shape index (CSI) over 10 days for cells adhered with and without MGL. Here /+ and -/- represent cells cultured without MGL that did and did not differentiate, respectively.
And +/- indicates C2C12 cells that did not differentiate when cultured on MGL and +/+ indicates
cells that did differentiate. All MGL+/+ data points were statistically significant from control
(MGL-/-) (p<0.01). Scale Bar = 100 µm; n=3 independent experiments.

5.4.3. Increased Numbers of Myotubes per Unit Area (N T/A) and Tube Length (LT)
over Time
The number of differentiated myotubes upon MGL+/+ were seen to increase exponentially after
10 Days in culture, as per Figure 31C. The average number of myotubes observed on Day 1 was
NT /A = 2.3±1.2μm per mm2 and increased to NT /A = 42.4±3.2μm per mm2 by Day 10. Similarly,
the average length of myotubes was seen to increase over time to a maximum and then decrease.
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The average length of myotubes was measured to be LT = 307±77.9μm on Day 1 and increased
to a peak average length of LT = 1307.6±89.2μm on Day 8 before decreasing to LT =
735.4±153.1μm on Day 10. Further, the percent fusion index, F i, was calculated every other day
for SKM myotubes in culture. Figure 31E shows a linear increase in F i until reaching a
maximum at Day 7 of Fi = 88.8±10.5%. No significant increases were observed through Day 11
of testing.

Figure 31: Differentiation of C2C12 cells into myotubes over time. Brightfield image of
C2C12 cells (A) adhered upon Matrigel-coated (MGL) substrate in 100mm dishes, on Day 1 of
the differentiation process and (B) show large, elongated myotubes in culture after 9 days of
differentiation in coated dishes. (C) The total number of myotubes per unit area increases over a
10-day period and (D) the average length of myotubes increases over time to reach a maximum
and then decrease. (E) Percent fusion index, Fi, was measured to increase for the first 7 days and
then plateau. (F) The average length of myotubes over time was measured using Ridge detection
analysis via NIH ImageJ. Scale Bar: 100µm; n=6

5.4.4. SKM Myoblast Tri-culture with Neural-Glial Cells
The next experiments examined the formation of myotubes when in contact with MNs and SCs
cells individually and collectively. Figure 32 illustrates the growth of SKM in isolation and
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alongside collective cell interaction. The addition of each cellular component was done in a timedependent manner, where MNs were added into SKM culture on Day 5 and SCs were added on
Day 9. A significant increase in the length and viability of SKM myotubes in tri-cultures of
[SKM+MN+SC] was measured in contrast to co-cultures of [SKM-SKM], [SKM+MN] and
[SKM+SC] cells over 11 days. An increase in the number of myotubes per unit area, N T /A, in triculture was measured on Day 7 (N T /A = 16.3±2.0μm) compared to [SKM-SKM] cultures (Day
7: N T /A = 10.6±3.6μm), [SKM+MN] co-culture (N T /A =10.2±1.4μm) and [SKM+SC] co-culture
(NT /A =10.1±1.3μm), as shown in Figure 32A.

Tri-cultures produced a 55% increase in the

number of myotubes per unit area compared to control [SKM-SKM] by Day 7 of growth. SCs
were added on Day 9 and 2-fold increase in NT /A of [SKM+MN+SC] tri-culture was observed
compared to [SKM+MN] and a 72% increase when compared to control [SKM-SKM] on Day
11. Further, the number of myotubes per area in [SKM-SKM] cultures on Day 11 was N T /A =
8.2±1.5μm, in [SKM+MN] co-culture was NT /A = 6.5±0.8μm, and in [SKM+SC] co-culture was
measured to be NT /A = 8.3±1.7μm. These values were significantly lower from [SKM+MN+SC]
tri-cell cultures at N T /A= 14.0±1.1μm, as seen on Day 11 of Figure 32A. No significant
differences in NT /A were measured between [SKM+MC] and [SM+SC] co-culture groups on days
7, 9, and 11. However, on day 11, NT /A values in [SKM-SKM] cultures (NT /A = 8.2±1.5μm) were
significantly higher than that of [SKM+MN] co-cultures (N T /A = 6.5±0.8μm). The average length
of myotubes was similarly measured over time and shown in Figure 32B. With the timedependent addition of MNs and SCs in [SKM+MN+SC] tri-cultures as well as [SKM+MN] and
[SKM+SC] co-cultures, the overall average length of myotubes was greater than [SKM-SKM]
cultures. On day 7, [SKM+MN] groups showed significant differences of LT values (LT
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=344.84±40.96μm) against [SKM+MN+SC] tri-culture (LT =273.38±23.08μm) and [SKM+SC]
co-culture (LT =304.8±35.82μm).

Figure 32: Motor neurons (MNs) and Schwann cells (SCs) aid C2C12 (SKM) survival and
increase myotube length over time in the Mn microfluidic system. (A) Graph displays time
dependent addition of MNs (Day 5) and SCs (Day 9) to illustrate increases in the number of
SKM differentiated myotubes per unit area. (B) The average length of myotubes increased over
10 days (p=0.003), while no significant increases were seen in SKM-MC and SKM-SC coculture groups, separately. A sample of n=3 for each condition were used; * indicates p<0.05, **
indicates p<0.001

The addition of SCs showed a slight, but statistically significant increase in the maintenance of
myotube length on Day 11 at LT = 293.73±27.03μm in [SKM-MN-SC] tri-cultures versus [SKMSC] co-cultures at LT = 307.42.42±42.66μm, as shown in Figure 32B. Both groups were
statistically significant compared to [SKM-SKM] cultures on day 11 (p<0.05).
Further, tri-cultures [SKM+MN+SC] were stained for the presence of alpha-bungarotoxin with
respect to control [SKM-SKM] within the Mμn system, Figure 33 C & D. Mean fluorescence
intensity of alpha-bungarotoxin expression was calculated in Figure 33E and showed a
significant increase in expression versus control cultures, p<0.05.
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Figure 33: Images of NMJ co-and tricultures within the Mn microfluidic system over
time. (A) The addition of SCs in culture with SKM+MN display cell-to-cell interaction as
highlighted by white arrow. (B) SKM-SKM only cultures illustrate long, tubular-like
morphology to indicate SKM differentiation on MGL. (C) Fluorescence image of alphabungarotoxin (α-BTX) and neurofilament (NF+H) staining for tri-cultures [SKM+MN+SC]
adhered upon MGL after 12 days. Blue dye: DAPI; Red: α-BTX; Green: NF+H. (D) Control
samples, [SKM-SKM], stained with α-BTX and DAPI (E) Mean values of α-BTX expression in
culture samples within microdevices. Scale Bar: 50 µm & 200 µm; n=4 independent experiments

5.4. Discussion
Degeneration of the NMJ is a key and early pathological feature of many muscular dystrophies
and

demyelinating disorders.

Traditional in

vitro

systems have greatly advanced

our

understanding of neuronal behavior in the presence of SCs and SKM cells but cannot guide
axons or enable controlled manipulation of cells. Microfluidics has become a powerful tool for
researchers in the Nervous System (NS)

56, 104, 296, 308, 314, 329, 330 ,

as these systems enable precise

control, monitoring and manipulation of cellular microenvironments. A small, but growing
number of researchers have developed microfluidic systems to evaluate mechanisms of NMJ
formation and maintenance with mixed success

114, 294, 331 .

Our project utilized microfluidics for
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two goals. One, experiments incorporated SCs to build a tri-culture NMJ model, and two, we
mimicked the time-dependent and sequential addition of SKM, MNs and SCs cells seen in vivo
to influence myotube maturation and length over time. We used a compartmentalized,
microfluidic system, called the MμN, that consisted of parallelized microchannels representing
geometric and chemical cues experienced by cells

319 .

The MμN enabled this study to evaluate

NMJ formation over time that approximates its step-wise formation in vivo, following series of
cues involving each cellular component.

Numerous SKM+MN co-culture models exist to study NMJ development and disruption
91

75, 76, 90,

aided via genetic techniques and suitable animal models. This project used C2C12 cells

332-334

as a model system for SKM differentiation because of their extensive use for in vitro models of
muscular dystrophies. Further, the cells are marked by myoblast proliferation and progressive
fusion that form large multinucleated myotubes which synthesize muscle-specific proteins

335 .

Differentiation of myoblasts into SKM is well-known to depend on physiochemical cues of the
surrounding extracellular matrix (ECM). However, numerous studies have reported inconsistent
differentiation on single protein matrixes such as Laminin, Collagen and Fibrin

336-338

. This

project selected Matrigel as ECM because a large number of publications have demonstrated its
abilities to promote myotube maturation
markers: Pax7, MyoD, and myogenin

339 .

339, 340

via expression of the well-established muscle

The underlying mechanisms of these cellular responses

is only partially understood but points towards maintenance of the muscle differentiation process
336 .

The positive effects of MGL were apparent in our data where myotubes maintained a highly

elongated and multinucleated state on MGL versus CTRL over time, as measured by CSI (Figure
30E). In contrast, myotubes developed without MGL did not a achieve highly elongated
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morphology and resulted in wider and shorter dimensions, as previously reported when C2C12
SKM cells were grown on collagen I

339 .

Initial experiments illustrated that the myotube differentiation process required up to 10 days in
vitro when supporting MN or SC cells were not present
groups

320, 323 .

320 ,

as similarly reported by several

Time-dependent addition of MNs and SCs generated large numbers of myotubes

hundreds of microns in length with a more highly-elongated morphology than control (SKMSKM) that lacked MNs and SCs (Figure 32). Fluorescent immunostaining was performed to
validate differentiation of myotubes, highlighting the presence of mature, z-line striation bands
seen in mature muscle

328, 341

(Figure 30C). The time-dependent, sequential addition of MNs and

SCs increased the number (N T /A) and length (LT ) of myotubes maintained over 14 days versus 10
days when SKM-derived cells were present alone in culture (Figure 32)
the

importance

of

the

synergistic

relationship

between

each

67 .

Our data highlights

cellular

component

in

[SKM+MN+SC] tri-cultures versus [SKM-SKM], [SKM+MN], and [SKM+SC] co-cultures
(Figure 32). In the tri-cell cultures, the average number of myotubes per unit area (N T /A) was
approximately 70% higher than control groups [SKM-SKM] by Day 11. Specifically,
[SKM+MN+SC] groups exhibited a 2-fold increase (116%) against [SKM+MN] co-cultures and
a 70% increase when compared to [SKM+SC] co-cultures in the maintenance of the number of
SKM myotubes per unit area. The data demonstrate a degree of stability in our microdevice
system. Throughout the 11 days of culture, the overall SKM myotube lengths are maintained
within groups providing a consistent system to help differentiate SKM myotubes. This was
further

validated

by

examining

the

presence

of

alpha-bungarotoxin

in

tri-cultures

[SKM+MN+SC] versus control [SKM-SKM] where there was a significant increase in its’
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expression in tri-cultures, which demonstrates the interdependent relationship of the cellular
components.

5.5. Conclusion
Our results are among the first to illustrate the significance of Schwann cells on the development
and viability of an in vitro NMJ culture platform. Microfluidically-controlled testing platforms
able to evaluate the effects of time-dependent cell to cell interactions and connectivity will
greatly aid regenerative strategies that seek to recapitulate NMJ formation. Future work will
investigate a tri-culture, microfluidic model using populations of stem-like cells, as well as
include controlled biochemical environments growth factors known to be secreted by Schwann
cells during NMJ development and repair.
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Supplemental Figure:

Figure 34: Percent Viability of C2C12 myotubes within the Mn device over time. C2C12
differentiated myotubes were cultured in the microdevice and stained with Calcein AM and
DAPI to visualize live and dead cells. Data showed no significant difference in percent viability
at each time point. n= 6 independent experiments.
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6. Summary
6.1. Summary
Understanding the mechanisms of cell migration and interaction with the microenvironment is
not only critical to the significance, function, and biology of cells, but also has tremendous
relevance and impact on physiological processes and diseases such as wound healing, neuron
guidance, cancer metastasis, and morphogenesis. External guidance factors such as physical,
ECM rigidity, and contact guidance cues of the microenvironment promote directional and/or
chemotactic

migration

and

can

target

specific

changes in cell motility and

signaling

mechanisms45 .
Taken together, this thesis has advanced our understanding of NG populations, specifically in the
realm of cell migratory response to external stimuli, the interdependent relationship between NG
populations, and lastly in the development of a tri-culture model to highlight glial significance at
the NMJ for future repair strategies to acute spinal cord damage. In vivo, the interaction of
neurons and glia are crucial for the development of the nervous system (NS). These interactions
are facilitated by the fine-tuned migration of neurons and glia along dedicated trajectories.
Neurons are widely known to conduct electrical impulses/currents, elucidating their role in the
transfer of information throughout the NS. Glial cells, in the central (CNS) and peripheral
nervous systems (PNS), are mostly known to support the nervous tissue. The global objective for
this project was to examine emergent NG behavior in response to chemical stimuli within
microfluidic environments. Understanding how the environment stimulates NGs to precise
locations in the nervous system is of fundamental importance in biology and medicine, as
abnormal migration is the basis of a variety of human neurological diseases and dysfunction 6 . In
this body of work, we observed the synergistic relationship of NGs in three cellular models

126

encompassing the central and peripheral NS. Hence the following aims are proposed to help
elucidate their influence.

Aim 1: Evaluate the chemosensitivity of transformed-glial progenitor cells (t-GPCs). In the
brain, cell migration is important during development, plasticity, function, and repair. In
addition, it’s also important in cancers and diseases as it is well accepted that cancer cells have
progenitor and stem-cell like properties in that they have the ability to de-differentiate. The focus
of this aim is on directed cell migration to external chemical cues also known as chemotaxis. We
utilize GPCs from Medulloblastoma (MB), which is a CNS glial tumor that metastasizes to the
spinal column. Due to these cells ability to retain their stem and progenitor like properties we
refer to them as t-GPCs. MB provided a model for t-GPCs, believed to be critical for motility
and metastasis. These studies include:
1A: Identify growth factors with highest chemosensitivity for t-GPCs.
1B: Measure in vitro migratory behavior of t-GPCs in controlled microenvironments.
Summary: The behavior of transformed NG progenitors was examined (in the form of
Medulloblastoma (MB)), known to emulate developmental processes, to external stimuli
using controlled microenvironments. We used a microfluidic system called the bridged

lane, which allows for steady-state, 1D, controllable concentration gradients along the
length of its’ microchannel. The system was used to evaluate in vitro migratory responses
of MB-derived cells such as the fraction of motile cells, directionality, and cell path
length under Epidermal Growth Factor (EGF) and stromal cell-derived factor 1-alpha
(SDF-1) stimulation. The data demonstrated MB cells traverse from high to low ligand
concentration gradients and respond strongly to EGF in a dosage and gradient-
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dependent manner while exhibiting increased EGF-R activation. In addition, high
concentration gradient fields of EGF caused more cells to move longer distances in a
highly directional manner as opposed to SDF-1. This work provides evidence that EGF
and its receptor play an important role in MB migration than previously documented.

Aim 2: Examine how GPC chemotaxis is influenced by NG collective behavior. Analyzing
migration responses of neural-glial progenitor cells derived from Drosophila Melanogaster
towards fibroblast growth factor (FGF). These studies include:
2A: Evaluate the behavior of GPCs collectively with Neuronal Progenitor Cells (NPCs).
2B: Examine the collective chemotaxis behavior in a microfluidic environment.
Summary: A more comprehensive neural model was utilized to examine the collective
behavior of neural progenitors in response to chemotactic stimulation. Experiments
examined the collective behavior of NG progenitor cell populations in response to
stimulation via fibroblast growth factor (FGF) gradients using a developmental model of
the central nervous system (CNS) in the Drosophila Melanogaster, 3rd instar larvae
stage. Surprisingly, our data demonstrated that cells migrated larger distances and with
higher directionality within collective groups of both neuronal and glial progenitors than
in populations of glia only.

Aim 3: Manipulate collective NG behavior to develop an in vitro model of the
Neuromuscular Junction (NMJ). SCs originate from the highly motile neural crest. However,
the guidance signals for these SCs are unknown. Neurotrophins are expressed early in
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developing embryos and have been shown to be critical for the survival and pattering of glia and
neurons

125 . These

studies aim to examine:

3A: Modality of collective chemotactic NG response in the PNS.
3B: Examine the influence of NG response for tri-cellular NMJ model.
Summary: This model was developed to build upon our previous understanding of
coordinated NG responses. We also hypothesized that glial involvement is much more
dynamic and is necessary for synaptogenesis as well as overall remodeling and regeneration.
Therefore, we moved into a larger system in the PNS-the Neuromuscular Junction (NMJ), to
further our understanding into NG responses for repair strategies. Initially this study probed
the guidance cues and migratory patterns of NGs towards various growth factors to
elucidate emergent NMJ response. Our data illustrated there is a co-culture effect on
receptor expression dependent on stimulation time. This study aimed to identify different
growth factors potential for migratory response. BDNF was utilized in microfluidic studies,
as it is known for its maintenance capacity upon neurons & to observe its collective response
on NGs. Subsequently, the experiments utilized a compartmentalized microfluidic platform to
demonstrate reproducible differentiation of skeletal myotubes with increased viability and
length following the time-dependent addition of NG cells. Our data validated our hypothesis
and showed that NG interactions are important in their maintenance capacity for the number
of SKM myotubes present for the tri-culture model. We further validated this response by
observing mean fluorescence activity in tri-cultures versus SKM myotubes alone (control).
Results

displayed

higher presence of

alpha-bungarotoxin,

post-synaptic nicotinic

acetylcholine receptor marker on SKM myotubes, in tri-cultures versus control samples.
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6.2. Limitations
The primary limitation of this work is the challenge of in vitro systems generally. While the
µLane provides controlled concentration gradients, the system is not suitable for studying effects
of external stimuli in a compartmentalized way for multi-cellular system applications. The Mµn
platform, although it mimics the geometry and diffusible signaling across its compartments, still
lacks the specificity required to study NMJ models. NMJs are quite complex and if we are to
fully grasp and parse out the mechanisms involved in an in vitro model, a new system design is
needed.

Another limitation to this study is the rigorous complexity of obtaining progenitor NGs from
Drosophila brains and keeping these cell populations alive to perform any long-term, 24h,
microfluidic and mechanistic studies to further our understanding of developmental processes.
We have tried to optimize cell survival of NGs from 12%

342

to 40% after 24 of dissection (Pena

et al., in submission), which previously has not been reported.

Further for subsequent studies utilizing C2C12 cells, one issue that has been widely noted by
various collaborators is that the spontaneous twitching associated with them is not consistently
observed. One potential could be that a high passage of these cells could yield an absence of
contractions. Hence it has been suggested that these cells be used between passages 2-7, if
contraction is to be considered a marker of a functional NMJ. Subsequently, optogenetics could
be utilized to control the contractile behavior of C2C12 cells. A limitation for the in vitro NMJ
model that was developed herein utilized two cell lines-SCs and MNs. For proof of concept and
initial model development within a microfluidic system, cell lines provide the robustness needed
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for experimentation but to really understand emergent or collective NG behavior at the NMJ
primary cells are a must.

6.3. Future Works
For future work, C2C12 SKM contraction can be explored to develop a more controlled
emergent NMJ response model since SKM contraction is considered to be a sign of a mature
myotubes. One could explore staining with alpha-actinin of SKM myotubes for maturation as
another indicator. Further C2C12 myoblasts can be electrically stimulated or mechanically
stretched to make sure cells have reached their differentiated state. A follow up study could
utilize optogenetic C2C12s, which are readily available for our use through our collaborators at
MIT. Another theory to explore is that C2C12 cultures should only contract when they are
exposed to motor neurons and glia as they provide an environment more conducive for
contraction. The exact mechanisms as to why is yet to be elucidated, but some studies have been
performed to shed some light into this and hypothesize that trophic support and the support from
end-to-end organ, MN-MC contact, is necessary for proper functioning. In addition, our work
primarily utilized cell lines to establish an NMJ model with some preliminary work with stemcells (work not shown) and co-cultures between DRGs and purified rat SCs (Chapter 5). To
further our understanding of glial influences, specifically at the NMJ, a shift towards utilizing
primary/progenitors cell populations is a necessary next step.

Axonal extension is influenced by a variety of external guidance cues; therefore, the
development and optimization of a multi-faceted approach is probably necessary to address the
intricacy of functional regeneration following nerve injury for repair. To that end, below we have
briefly explored the influence of glial cells within retinal models as well as exploring
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applications of galvanotaxis, movement towards or away from an electric current. Further we
have proposed a microfluidic device design, taking into account a multi-faceted approach, with
some initial characterization.

Schwann cells with retinal models: The adult mammalian central nervous system (CNS) does
not repair after injury. However, researchers have shown that the neonatal CNS is capable of
repair and importantly of allowing regenerating axons to re-navigate through the same pathways
as they did during development. This phase of neonatal repair is restricted by the fragility of
neurons after injury and a lack of trophic factors that enable their survival

343 .

Electro-Stimuli Response: Electrical cues can affect cellular behavior (electrotaxis) and suggest
possible practical therapeutic strategy to activate signaling pathways that would contribute to
control cell functionality

45 .

Recent studies have shown that cells can directionally respond to

applied electric fields (EFs), in both in vitro and in vivo settings. Applied electric fields may have
a potential clinical role in guiding cell migration and present a more precise manageability to
change the magnitude and direction of the electric field than most other guidance cues such as
chemical cues alone45 .

The current understanding of how EFs affect cells directly is that the cells sense the EFs through
matching pathways involved in chemotaxis but do not operate simply by modulating the
chemotactic systems of cell

45, 344 .

Microfluidic chambers hold great promises for better field

shaping and control in order to analyze and compare multiple –taxis and electrotaxis of cells.
Most of these devices are fabricated in polydimethylsiloxane (PDMS, a transparent flexible
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polymer)

or

PMMA

and

provide

immobilization and live imaging of cells

excellent

scalable

environments

for

manipulation,

45, 345, 346.

Response of neurons to EF: Electrical stimulation in the field of neuroscience is well
established as a concept and is a powerful and broadly applicable therapeutic technology
utilizing the voltage sensitivity of transmembrane ion channels and other fundamental processes
of cellular electrical signaling

347 .

The ability to direct the outgrowth of neuronal processes

through the use of an extracellular electric field is renowned as galvanotropism. Recent research
has shown therapeutic potential of EFs to promote nerve growth and axon regeneration under
electrical stimulation or guiding long distance migration but the guidance effect of EFs for cell
migration and neurite outgrowth has significant interspecies difference and has shown to be cell
type dependent. For example, neuritis from Xenopus neurons have been shown to respond to
field of less than 10mV mm-1 growing toward the cathode

348 .

The neurons were shown to not

only orient their neuritis towards the cathode but also extended longer processes in the presence
of a field (i.e. rat neurons grow perpendicular in an EF)

349 .

not respond to an 100 mV mm-1 applied EF in vitro at all

350 .

Whereas neurons from zebra fish do

Further, a change in field polarity changes direction of neuron migration as well. High field
strengths (>10mV mm-1 ) promotes clear and sustained directional migration towards the cathode.
Furthermore, reversing the field direction with a high exogenous potential (50mV mm-1 ) caused
cells to steer off course and move in the direction of the imposed field

45 .
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Calcium has been widely thought to play a controlling role in neurite outgrowth but has shown
inconclusive evidence. Neurite outgrowth of neurons co-cultured with Schwann cells and
electrical stimulation was examined by Koppes et al. 351 in the presence of both biophysical and
cellular cues. Following 8h of electrical stimulation (0-100 mV mm-1), a moderate electric field
of 50 mV mm-1 resulted in significantly greater neurite outgrowth (114%) than both the
unstimulated controls and all other field magnitudes test (10, 100 mV mm-1)

351 .

This electrically

induced increase in neurite length may promote regrowth following injury. Based on these
studies we have designed a compartmentalized microfluidic device with the capacity for
electrical stimulation to study various aspects of cell behavior within NG populations either in
the CNS or PNS. Below are details on device fabrication and preliminary results from
computational modeling, which was further, validated with dextran within our device.

(Preliminary Data)

6.4. Methods and Materials
6.4.1. System Fabrication
The system is fabricated using conventional multistep photolithography to create a master mold
and elastomeric molding to stamp this mold into polymer of polydimethylsiloxane (PDMS). The
design was imprinted onto a 4-in-diameter silicon wafer in a 2-step process. The first 10 um
layer, composed of the negative photoresist polymer SU-8 10 (MicroChem, Westborough, MA)
was spin-coated at 3000 rpm for 30 seconds onto the wafer surface using a Laurel WS 650 spin
coater (Laurel, North Wale, PA). The wafer was then soft baked, on a hot plate, at 65o C for 2
min, followed by an additional 5 min at 95 o C. Exposure was performed using the open channel
mask via an automated mask aligner (EVG620, EV Group, Austria) with an exposure dose of
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180 mJ/cm2. The wafer was then post-baked at 65o C for 1 min followed by an additional 2 min
at 95o C.

The photoresist was developed in PEGMA developer (MicroChem Corp.,

Westborough, MA) for 5-10 min and rinsed with isopropyl alcohol and deionized water. The
wafer was then dried under nitrogen and dehydrated prior to the second step of lithography. The
next layer used photoresist SU-8 2075 (MicroChem, Westborough, MA) spun on at 4000 rpm for
30 sec. The resist was then prebaked for 2 min at 65 o C followed by an additional 7 min at 95 o C.
The wafer and second mask were aligned via mask aligner and exposed at 180 mJ/cm2 . The
wafer was then baked for 1 min at 65 o C and 6 min at 95o C. The wafer was developed in
PEGMA developer for ~5-10 min with slight agitation.

The wafer was then rinsed with

isopropyl alcohol and deionized water and dried under nitrogen.
To improve contact molding reliability and master longevity, the finished wafer was then
silanized, by liquid deposition. Wafer was submerged mixture of methanol, water and
Trichloro(1H,1H,2H,2H-perfluorooctyl) silane mixed at a ratio of 20 mL:1 mL:100 uL,
respectively, and gently agitated for 1-2 hours. The wafer was rinsed consecutively with
isopropyl alcohol and deionized water, and dried under nitrogen. Elastomer molds were cast with
polydimethylsiloxane (PDMS) (Silgard 184, Dow Corning). PDMS prepolymer was mixed at a
ratio of 9:1 with its curing agent to a final volume of 30 mL. This mixture was then poured onto
the master and degassed for 20 mins in a restricted light environment to remove air bubbles. The
PDMS was baked until set for 20 mins at 75 o C and then demolded. The devices were assembled
by ozone plasma bonding the PDMS casts to cleaned glass coverslips (#1.5, VWR). The fluidic
seal was tested by flowing deionized water or phosphate buffered saline (PBS) at 1 mL/min
through both sides of the device via syringe pump (NE-1000, Newera Syringe Pump Systems,
Farmingdale, NY). For electric field studies, silvered PDMS electrodes were inserted on either
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side of the culture chambers in the designated electrode wings. To create the silvered PDMS,
PDMS pre-polymer was mixed with powdered silver (2-3.5 um, Sigma Aldrich, #327085-50g) to
a final concentration of 80 wt% silver. The resulting mixture was mixed at a ratio of 9:1 with the
curing agent to a final volume of 5 mL. This mixture was then cast into disks .5cm in height and
degassed as above. The silvered PDMS was baked until set for 20mins at 75 o C . Once cooled,
1.5mm cylinders were punched out using a 1.5mm biopsy punch (Harris Uni-core).

Platinum

wires were inserted into each cylinder before inserting finished electrodes into electrode wings.
6.4.2. Computational Model
A two-dimensional, coupled multiphysics numerical simulation of molecular transport within the
µCricket device was performed using both pressure-driven creep flow and electric fields within
the device. These simulations utilized a two-way coupled finite element model of the device
created using COMSOL Multiphysics 5.3a (COMSOL Inc., Burlington, MA). First, the model
solves the continuity equations for flow velocity and current density at steady state:
∇ ∙𝒖=0

(Eq. 1)

∇∙𝒊 = 0

(Eq. 2)

Here u denotes the velocity (m/s) and i represents the current-density vector (A/m2 ). The
velocity includes two driving forces of pressure and electro-osmotic force given by the velocity
equation:
𝒖=−

𝐴
𝜖 𝜁
∆𝑝 + 𝑤 ∇𝑉
8𝜇𝐿
𝜇

(Eq. 3)

Where A is the cross-sectional area of the channel, µ is the dynamics viscosity (Pa*s), L is the
length of the channel (m), p is the pressure (Pa), 𝜖𝑤 is the fluid’s permittivity (F/m), 𝜁 is the zeta
potential (V) and V is the electric potential (V). The current density is defined as:
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𝒊 = −𝜅∇𝑉

(Eq. 4)

Where 𝜅 denotes the conductivity (S/m). At the solid walls, the normal velocity component goes
to 0:
𝒖∙𝒏 = 0

(Eq. 5)

Flow was modeled as creep flow with a mean inflow rate of 1e-9m^3/s. This flow rate was
chosen because it imposes a fluidic shear stress within the culture chambers below the 5 dynes
threshold known to affect cell behavior352 . The electrode voltages were set at ±1V to achieve an
electric field of intensity 100mV/mm, a biologically representative value 353 .
Second, the mass transport was modeled via COMSOL’s Transport of Dilute Species package
using the velocity and electric potential parameters from the above equations to solve the masstransport equation for an injected tracer:
𝜕𝑐
+∇∙ 𝑵 = 0
𝜕𝑡

(Eq. 6)

Where c is concentration and N is the flux vector given by the Nernst-Planck equation354 :
𝑵 = −𝐷∇𝑐 − 𝑧𝑢 𝑚 𝐹𝑐∇𝑉

(Eq. 7)

+ 𝑐𝒖
Here D denotes the tracer’s diffusivity (m2 /s), c gives the concentration (mol/m3 ), z represents
the tracer’s partial charge number, F is Faraday’s constant (C/mol), and um is the mobility of the
tracer (mol*m2 /(J*s)) given by the Nernst-Einstein equation355 :
𝑢𝑚 =

𝐷
𝑅𝑔 𝑇

(Eq. 8)

Where Rg = 8.314 J/(mol*k) is the gas constant and T (K) is the temperature.
An effective diffusivity of 4.57 x10-7 cm2 /s was used to model transport of BDNF through
tissue356 . All physical boundaries of the microsystem were regarded as insulated boundaries of
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mass transfer, momentum transport and electron transport. The boundary conditions for the
current-density balance are insulating for all boundaries except the electrode surfaces, where the
potential is fixed.

6.5. Results
6.5.1. System Design
The µCricket device was designed to facilitate parallel or uneven flow in three cell culture
compartments connected by an array of microchannels (n=500), Figure 35A. This system was
adapted from a design previously developed by our laboratory325 to incorporate controlled
galvanic and chemical fields across three chambers. The three cell culture compartments are 600
µm -wide by 10 mm-long by 50 µm in height. Within the two outer cell culture compartments
are an array of 70 µm -diameter micropillars situated 400 µm from the edge of the compartment
and 200 µm from the array.

The culture regions are separated by an array of 50 µm-long

channels spaced 10 µm apart, Figure 35B. Each channel is 3 µm-wide by 5 µm in height,
preventing full bodied cellular migration of neural cells of diameter greater than or equal to 10
µm

357, 358 ,

while still facilitating the transport of small molecules from one side to the other.

Lastly, silvered PDMS electrodes are located on either side of the culture chambers in the
designated electrode wings. A finished µCricket can be seen in Figure 35C. The microchannel
array was designed as a barrier to restrict neural cells to their designated seeded culture
compartments, while enabling transport to generate stable, steady-state chemical concentration
gradients across the channel array. The concentration profile, or distribution, of these gradients
across the microarray and opposite cell compartments is dependent upon the input flow rates, Q1
and Q2 and Q3, Figure 36. As Q1 Q2 and Q3 are independent of one another, the flow rates can
be changed with respect to each other, to provide the desired transport ratios, Q1:Q2:Q3.
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Controlling this ratio allows for the control of the pressure differential across the channel array.
When Q1 = Q2 = Q3, Figure 36A, the system is in a state of even flow. When Q1 ≠ Q2 ≠ Q3,
the system is in a state of uneven flow, Figure 36B. While the flows can be set in counter-flow,
all flows used in this study are in a parallel state.

These flow characteristics were modelled

computationally and verified using fluorescently tagged dextran, Figure 36C and D.

The purpose of this design is to create a compartmentalized model to study multiple cellular
systems in a time-dependent manner to observe their collective behavior. Generating multiple
compartments allows the user to test multiple variables affecting a system of study such as
axonal regeneration for a nerve injury model, with high precision. In this system, the slivered
electrodes provide for electrical stimulation of cellular systems to approach wound-healing
mechanisms in combination with cell migratory events. As discussed previously, EF stimulation
of neurons helps in axonal regeneration events and thus, this system can provide a controllable
way to observe these events. The pillars are important for two reasons 1) they act to isolate
neurons closer into the channels so when you load cells at low speeds, they will be closer to the
channel and 2) when applying higher flow rates, the pillars will provide a barrier thus reducing
the effects of shear on the cells.
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A

C

D

B

Figure 35: Device Schematic of cricket. (A) Dimensioned CAD mask of the µCricket device.
(B) Magnified view of red box in the center of the device, highlights the large seeding chambers
separated with a nanoarray, along with micro-pillars spanning the entire length of the seeding
chambers. (C) Image of the bonded cricket with electrodes in place. (D) Computational
modeling of electric fields within the cricket.
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Figure 36: µcricket characterization. (A) Computationally determined 2D chemical
concentration profile within the device with equal flow ratios, 1:1:1. (B) Computationally
determined 2D chemical concentration profile with the device with flow ratios 1:20:1. (C)
Computationally determined 1D chemical concentration profile across the observation window
demonstrating flow control. (D) Experimental validation of flow control using 10kD
fluorescently tagged dextran.

6.6. Conclusion
We have designed a microfluidic system that allows for compartmentalized separation of cellular
systems. This allows for ease of controlled, systematic, and time-dependent studies of multicellular systems especially for the study of nerve damage repair. Further understanding of the
mechanistic changes induced in neurons and Schwann cells by the application of the biophysical
forces generated during electrical stimulation will allow for appropriate applications of this
stimulus in vivo for neural engineering solutions relevant to peripheral and central nervous
system injuries.
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